var title_f32_35_33328="Sorafenib HFSR";
var content_f32_35_33328=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F81824&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F81824&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Hand-foot skin reaction in patients given sorafenib",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 444px; height: 286px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Note patchy hyperkeratosis on plantar pressure areas.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Robert, C, Mateus, C, Spatz, A, et al. Dermatologic symptoms associated with the multikinase inhibitor sorafenib. J Am Acad Dermatol 2009; 60:299. Illustration used with the permission of Elsevier Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_35_33328=[""].join("\n");
var outline_f32_35_33328=null;
var title_f32_35_33329="Roux en Y gastric bypass";
var content_f32_35_33329=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F79256&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F79256&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Roux-en-Y gastric bypass",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 422px; height: 572px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This figure depicts the stomach's appearance after Roux-en-Y gastric bypass, which creates a small stomach pouch by dividing the stomach and attaching it to the small intestine. The pouch is only able to hold about an ounce of food, causing a feeling of fullness after consuming a very small amount; over time, the pouch stretches to hold about one cup. In addition, the body absorbs fewer calories since food bypasses the majority of the stomach as well as the upper small intestine (duodenum). This intestinal arrangement (Roux-en-Y) seems to cause decreased appetite and improved metabolism by changing the release of various hormones.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_35_33329=[""].join("\n");
var outline_f32_35_33329=null;
var title_f32_35_33330="Technetium Tc-99m pyrophosphate: Drug information";
var content_f32_35_33330=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"11\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Technetium Tc-99m pyrophosphate: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?36/41/37522?source=see_link\">",
"    see \"Technetium Tc-99m pyrophosphate: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F13210200\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Technescan&trade; PYP&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F13210218\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Radiopharmaceutical",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F13210271\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Blood pool imaging (gated equilibrium ventriculography):",
"     </b>",
"     I.V.: 15-30 mCi (555-1110 MBq)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Blood pool imaging (GI bleeding):",
"     </b>",
"     I.V.: 20-30 mCi (750-1100 MBq)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Myocardial infarction imaging:",
"     </b>",
"     I.V.: 10-15 mCi (370-555 MBq)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Skeletal imaging:",
"     </b>",
"     I.V.: 5-15 mCi (185-555 MBq)",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F13210272\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Blood pool imaging (gated equilibrium ventriculography):",
"     </b>",
"     I.V.: 0.2-0.4 mCi/kg (7-15 MBq/kg); minimum dose: 2-4 mCi (70-150 MBq)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Blood pool imaging (GI bleeding):",
"     </b>",
"     I.V.: 0.3-0.4 mCi/kg (10-15 MBq/kg)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Skeletal imaging:",
"     </b>",
"     I.V.: 250-300 microcuries/kg (9-11 MBq/kg); minimum dose: 0.5-1.0 mCi (20-40 MBq)",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F13210225\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Skeletal imaging agent to detect areas of altered osteogenesis; cardiac imaging agent used as an adjunctive agent for the diagnosis of acute myocardial infarction; blood pool imaging agent; detection of GI bleeding sites",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F13255278\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Other safety concerns:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Radiopharmaceutical: Use appropriate precaution for handling, disposal, and minimizing exposure to patients and healthcare personnel. Use under supervision of experienced personnel. Should be stored in original lead container or adequate radiation shield.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F13210219\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Special handling:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Radiopharmaceutical: Use appropriate precautions for handling, disposal, and minimizing exposure to patients and healthcare personnel. Use only under supervision of individuals who have received training in the handling of radioactive materials and who are authorized by the applicable regulatory authority.",
"     <b>",
"      Note:",
"     </b>",
"     Contents of kit are not radioactive; however adequate shielding is required after addition of radioactive material.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Heparin: Concurrent use may impair blood pool images.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F13210221\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F13210222\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal studies have not been conducted. There are no adequate and well-controlled studies in pregnant women. Radiopharmaceuticals have the potential to cause fetal harm. Use during pregnancy only if clearly needed.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F13210223\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F13210224\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     In one report, 0.15% to 0.44% of the administered dose of technetium Tc 99m pyrophosphate was excreted in breast milk, resulting in &lt;100 mrem (1 mSv) effective dose to the infant (Stabin, 2000); therefore, interruption of breast-feeding is not necessary (U.S. Nuclear Regulatory Commission, 1977).",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     In another report, radioactivity excreted in breast milk following technetium radiolabeling of red blood cells",
"     <i>",
"      in vivo",
"     </i>",
"     was sufficient to result in an effective dose to the infant &gt;100 mrem (1 mSv) if breast-feeding had not been interrupted (Mountford, 1989). Therefore, the patient must be instructed to interrupt breast-feeding for 6 hours following administration of 20 mCi technetium Tc 99m red blood cells labeled",
"     <i>",
"      in vivo",
"     </i>",
"     (U.S. Nuclear Regulatory Commission, 1977).",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Donohoe KJ, Brown ML, Collier BD, et al, \"Society of Nuclear Medicine Procedure Guideline for Bone Scintigraphy,\" 2003. Available at file://interactive.snm.org/docs/pg_ch34_0403.pdf. Last accessed August 31, 2011.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Ford PV, Bartold SP, Fink-Bennett DM, et al, \"Procedure Guideline for Gastrointestinal Bleeding and Meckel&rsquo;s Diverticulum Scintigraphy. Society of Nuclear Medicine,\"",
"      <i>",
"       J Nucl Med",
"      </i>",
"      , 1999, 40(7):1226-32. Available at file://interactive.snm.org/docs/pg_ch09_0403.pdf. Last accessed August 30, 2011.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?32/35/33330/abstract-text/10405149/pubmed\" id=\"10405149\" target=\"_blank\">",
"        10405149",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mountford PJ and Coakley AJ, \"A Review of the Secretion of Radioactivity in Human Breast Milk: Data, Quantitative Analysis and Recommendations,\"",
"      <i>",
"       Nucl Med Commun",
"      </i>",
"      , 1989, 10(1):15-27.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?32/35/33330/abstract-text/2645546/pubmed\" id=\"2645546\" target=\"_blank\">",
"        2645546",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Scheiner J, Sinusas A, Wittry MD, et al, \"Society of Nuclear Medicine Procedure Guideline for Gated Equilibrium Radionuclide Ventriculography,\" 2002. Available at file://interactive.snm.org/docs/pg_ch01_0403.pdf. Last accessed August 30, 2011.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Stabin MG and Breitz HB, \"Breast Milk Excretion of Radiopharmaceuticals: Mechanisms, Findings, and Radiation Dosimetry,\"",
"      <i>",
"       J Nucl Med",
"      </i>",
"      , 2000, 41(5):863-73.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?32/35/33330/abstract-text/10809203/pubmed\" id=\"10809203\" target=\"_blank\">",
"        10809203",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      U.S. Nuclear Regulatory Commission, \"Regulatory Guide 8.39. Release of Patients Administered Radioactive Materials,\" 1977.",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16816 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-199.231.185.123-2EEB765D3A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_35_33330=[""].join("\n");
var outline_f32_35_33330=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13210200\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13210218\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13210271\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13210272\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13210225\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13255278\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13210219\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13210221\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13210222\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13210223\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13210224\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/16816\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/16816|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?36/41/37522?source=related_link\">",
"      Technetium Tc-99m pyrophosphate: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_35_33331="Allergic contact dermatitis hand";
var content_f32_35_33331=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F82993&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F82993&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Allergic contact dermatitis of the hand",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_35_33331=[""].join("\n");
var outline_f32_35_33331=null;
var title_f32_35_33332="Simethicone: Drug information";
var content_f32_35_33332=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Simethicone: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?5/43/5812?source=see_link\">",
"    see \"Simethicone: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?27/9/27795?source=see_link\">",
"    see \"Simethicone: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F221168\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Equalizer Gas Relief [OTC];",
"     </li>",
"     <li>",
"      Gas Free Extra Strength [OTC];",
"     </li>",
"     <li>",
"      Gas Relief Ultra Strength [OTC];",
"     </li>",
"     <li>",
"      Gas-X&reg; Children's Tongue Twisters&trade; [OTC];",
"     </li>",
"     <li>",
"      Gas-X&reg; Extra Strength [OTC];",
"     </li>",
"     <li>",
"      Gas-X&reg; Maximum Strength [OTC];",
"     </li>",
"     <li>",
"      Gas-X&reg; Thin Strips&trade; [OTC];",
"     </li>",
"     <li>",
"      Gas-X&reg; [OTC];",
"     </li>",
"     <li>",
"      Gax-X&reg; Infant [OTC];",
"     </li>",
"     <li>",
"      Infantaire Gas [OTC];",
"     </li>",
"     <li>",
"      Infants Gas Relief Drops [OTC] [DSC];",
"     </li>",
"     <li>",
"      Little Tummys&reg; Gas Relief [OTC];",
"     </li>",
"     <li>",
"      Mi-Acid Gas Relief [OTC];",
"     </li>",
"     <li>",
"      Mylanta&reg; Gas Maximum Strength [OTC];",
"     </li>",
"     <li>",
"      Mylicon&reg; Infants' [OTC];",
"     </li>",
"     <li>",
"      Mytab Gas Maximum [OTC];",
"     </li>",
"     <li>",
"      Mytab Gas [OTC];",
"     </li>",
"     <li>",
"      Phazyme&reg; Ultra Strength [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F221169\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Ovol&reg;;",
"     </li>",
"     <li>",
"      Phazyme&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F221179\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antiflatulent",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F221170\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Flatulence/bloating:",
"     </b>",
"     Oral: 40-360 mg after meals and at bedtime, as needed",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F221175\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?27/9/27795?source=see_link\">",
"      see \"Simethicone: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Flatulence/bloating:",
"     </b>",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Infants and Children &lt;2 years or &lt;11 kg: 20 mg 4 times/day, as needed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Children &gt;2 years or &gt;11 kg: 40 mg 4 times/day, as needed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Children &gt;12 years: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F221171\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F221159\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, softgel, oral: 125 mg, 180 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gas Free Extra Strength: 125 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gas Relief Ultra Strength: 180 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gas-X&reg; Extra Strength: 125 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gas-X&reg; Maximum Strength: 166 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Mylanta&reg; Gas Maximum Strength: 125 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Phazyme&reg; Ultra Strength: 180 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Strip, orally disintegrating, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gas-X&reg; Children's Tongue Twisters&trade;: 40 mg (16s) [cinnamon flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gas-X&reg; Thin Strips&trade;: 62.5 mg (18s) [cinnamon flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gas-X&reg; Thin Strips&trade;: 62.5 mg (18s, 32s) [peppermint flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Suspension, oral [drops]: 40 mg/0.6 mL (30 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Equalizer Gas Relief: 40 mg/0.6 mL (30 mL) [contains sodium 0.15 mg/0.6 mL]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gax-X&reg; Infant: 40 mg/0.6 mL (30 mL) [ethanol free; contains sodium benzoate]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Infantaire Gas: 40 mg/0.6 mL (30 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Infants Gas Relief Drops: 40 mg/0.6 mL (30 mL [DSC]) [vanilla flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Little Tummys&reg; Gas Relief: 40 mg/0.6 mL (30 mL, 45 mL) [dye free, ethanol free; contains sodium benzoate; strawberry flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Mylicon&reg; Infants': 40 mg/0.6 mL (15 mL, 30 mL) [dye free, ethanol free; contains sodium benzoate; non-staining formula]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Mylicon&reg; Infants': 40 mg/0.6 mL (15 mL, 30 mL) [ethanol free; contains sodium benzoate]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, chewable, oral: 80 mg, 125 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gas-X&reg;: 80 mg [scored; contains calcium 30 mg/tablet; cherry cr&egrave;me flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gas-X&reg;: 80 mg [contains calcium 30 mg/tablet; peppermint cr&egrave;me flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gas-X&reg; Extra Strength: 125 mg [contains calcium 45 mg/tablet; cherry cr&egrave;me flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gas-X&reg; Extra Strength: 125 mg [contains calcium 45 mg/tablet; peppermint cr&egrave;me flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Mi-Acid Gas Relief: 80 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Mylanta&reg; Gas Maximum Strength: 125 mg [scored; cherry flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Mylanta&reg; Gas Maximum Strength: 125 mg [mint flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Mytab Gas: 80 mg [peppermint flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Mytab Gas Maximum: 125 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F221147\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Excludes orally disintegrating strip",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F221161\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Shake oral suspension (drops) before using; mix with water, infant formula, or other liquids.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F221160\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Postoperative gas pain or for use in endoscopic examination; relief of bloating, pressure, and discomfort of gas",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F221183\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Simethicone may be confused with cimetidine",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Mylanta&reg; may be confused with Mynatal&reg;",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Mylicon&reg; may be confused with Modicon&reg;, Myleran&reg;",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F221177\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined: Gastrointestinal: Loose stools",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F221163\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to simethicone or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13300043\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F221154\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F221167\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Food: Avoid carbonated beverages and gas-forming foods.",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F14186485\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Simethicone is not absorbed systemically following oral administration. Systemic absorption would be required in order for simethicone to cross the placenta and reach the fetus.",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F14186486\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Due to lack of systemic absorption, simethicone is not expected to be excreted in breast milk.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F221164\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Should be taken after meals.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16323846\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (Gas-X Extra Strength Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     125 mg (30): $5.38",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (Mylanta Gas Relief Maximum Str Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     125 mg (24): $3.78",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (Phazyme Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     180 mg (36): $7.30",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (Simethicone Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     180 mg (60): $3.05",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Chewable",
"     </b>",
"     (Gas-X Extra Strength Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     125 mg (18): $4.07",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Chewable",
"     </b>",
"     (Gas-X Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     80 mg (36): $5.33",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Chewable",
"     </b>",
"     (Mylanta Gas Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     125 mg (24): $3.78",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Chewable",
"     </b>",
"     (Phazyme Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     125 mg (18): $3.43",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Chewable",
"     </b>",
"     (Simethicone Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     80 mg (100): $6.30",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     125 mg (60): $5.02",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Liquid",
"     </b>",
"     (Gas-X Infant Drops Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     20 mg/0.3 mL (30 mL): $8.38",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Murine Ear Otic)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     6.5% (15 mL): $4.55",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Strip",
"     </b>",
"     (Gas-X Childrens Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     40 mg (16): $5.51",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Strip",
"     </b>",
"     (Gas-X Extra Strength Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     62.5 mg (18): $4.07",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Suspension",
"     </b>",
"     (Mylicon Infants Gas Relief Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     20 mg/0.3 mL (15 mL): $6.23",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Suspension",
"     </b>",
"     (Mylicon Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     40 mg/0.6 mL (15 mL): $6.22",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Suspension",
"     </b>",
"     (PediaCare Infants Gas Relief Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     20 mg/0.3 mL (30 mL): $8.28",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Suspension",
"     </b>",
"     (Simethicone Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     40 mg/0.6 mL (30 mL): $5.94",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Bicarsim Forte Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     125 mg (60): $23.10",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Bicarsim Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     80 mg (60): $18.90",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F221165\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Aero-Red (ES);",
"     </li>",
"     <li>",
"      Aerox (PE);",
"     </li>",
"     <li>",
"      AF adult (GT);",
"     </li>",
"     <li>",
"      AF infantil (GT);",
"     </li>",
"     <li>",
"      De-Gas (AU);",
"     </li>",
"     <li>",
"      Degas (TH);",
"     </li>",
"     <li>",
"      Digesta (EC);",
"     </li>",
"     <li>",
"      Disflatyl (AT, CH, FI, PH, RU, SG);",
"     </li>",
"     <li>",
"      Espumisan (BG, CL, CZ, DE, EE);",
"     </li>",
"     <li>",
"      Flapex (CN);",
"     </li>",
"     <li>",
"      Gaseovet (EC);",
"     </li>",
"     <li>",
"      Gasocol (KP);",
"     </li>",
"     <li>",
"      Gastyl (MY);",
"     </li>",
"     <li>",
"      Gazim X (IL);",
"     </li>",
"     <li>",
"      Hedrin (IL);",
"     </li>",
"     <li>",
"      Infacol (IE);",
"     </li>",
"     <li>",
"      Lefaxin (AT);",
"     </li>",
"     <li>",
"      Liberan (MX);",
"     </li>",
"     <li>",
"      Minifom (FI, NO, SE);",
"     </li>",
"     <li>",
"      Mylom (TH);",
"     </li>",
"     <li>",
"      Neogasol (CN);",
"     </li>",
"     <li>",
"      Ovol (CR, DO, GT, HN, MY, NI, PA, SV);",
"     </li>",
"     <li>",
"      Restime (PH);",
"     </li>",
"     <li>",
"      Siligas (CO);",
"     </li>",
"     <li>",
"      Simethicone (PL)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F221150\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Decreases the surface tension of gas bubbles thereby disperses and prevents gas pockets in the GI system",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Hagemann TM, \"Gastrointestinal Medications and Breastfeeding,\"",
"      <i>",
"       J Hum Lact",
"      </i>",
"      , 1998, 14(3):259-62.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?32/35/33332/abstract-text/10205441/pubmed\" id=\"10205441\" target=\"_blank\">",
"        10205441",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mahadevan U and Kane S, \"American Gastroenterological Association Institute Technical Review on the Use of Gastrointestinal Medications in Pregnancy,\"",
"      <i>",
"       Gastroenterology",
"      </i>",
"      , 2006, 131(1):283-311.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?32/35/33332/abstract-text/16831611/pubmed\" id=\"16831611\" target=\"_blank\">",
"        16831611",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10264 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-118.195.65.248-47B75F185E-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_35_33332=[""].join("\n");
var outline_f32_35_33332=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221168\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221169\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221179\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221170\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221175\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221171\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221159\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221147\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221161\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221160\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221183\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221177\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221163\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13300043\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221154\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221167\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14186485\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14186486\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221164\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16323846\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221165\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221150\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10264\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10264|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?5/43/5812?source=related_link\">",
"      Simethicone: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?27/9/27795?source=related_link\">",
"      Simethicone: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_35_33333="Bowel resection and reapprox B";
var content_f32_35_33333=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F61001&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F61001&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 507px\">",
"   <div class=\"ttl\">",
"    Posterior mucosal running suture and mucosal suture continued anteriorly during bowel resection and reanastomosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 487px; height: 409px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of William J Mann, Jr, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_35_33333=[""].join("\n");
var outline_f32_35_33333=null;
var title_f32_35_33334="Vascular supply and drainage of the liver";
var content_f32_35_33334=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F50374&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F50374&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 555px\">",
"   <div class=\"ttl\">",
"    Vascular supply an drainage of the liver",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 535px; height: 489px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The segments of the liver are depicted together with their vascular supply and biliary drainage. Segment I, the caudate lobe, is located posteriorly.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_35_33334=[""].join("\n");
var outline_f32_35_33334=null;
var title_f32_35_33335="Cherry angioma2";
var content_f32_35_33335=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F63468%7EDERM%2F54605&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F63468%7EDERM%2F54605&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Cherry angioma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 365px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Lynne J Margesson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Cherry angiomas",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 325px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple red and violaceous papules are present on the trunk.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_35_33335=[""].join("\n");
var outline_f32_35_33335=null;
var title_f32_35_33336="Overview of the use of osteoclast inhibitors in early breast cancer";
var content_f32_35_33336=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Overview of the use of osteoclast inhibitors in early breast cancer",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/35/33336/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/35/33336/contributors\">",
"     Catherine Van Poznak, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/35/33336/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/35/33336/contributors\">",
"     Julie R Gralow, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/35/33336/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/35/33336/contributors\">",
"     Don S Dizon, MD, FACP",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?32/35/33336/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 28, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Breast cancer is the most common female cancer in the US, the second most common cause of cancer death in women, and the main cause of death in women ages 40 to 59 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33336/abstract/1\">",
"     1",
"    </a>",
"    ]. Systemic therapy used to treat early breast cancer can be associated with long term toxicity, including loss of bone mineral density (BMD).",
"   </p>",
"   <p>",
"    Bisphosphonates and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/53/21335?source=see_link\">",
"     denosumab",
"    </a>",
"    are potent inhibitors of osteoclast activity, appear to prevent therapy-related bone loss, and compliment nutritional (calcium and vitamin D), exercise, and lifestyle modifications. This topic will review the use of bisphosphonates in the adjuvant breast cancer setting. Adjuvant anticancer treatment modalities of breast cancer are discussed separately. Means to assess risk of fracture, using history, physical exam, algorithms such as FRAX, and imaging bone mineral density are reviewed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/42/29354?source=see_link\">",
"     \"Osteoporotic fracture risk assessment\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/28/40393?source=see_link\">",
"     \"Screening for osteoporosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     BREAST CANCER THERAPY-ASSOCIATED BONE LOSS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women with a history of breast cancer may be at increased risk of osteoporosis secondary to the adjuvant systemic therapies administered [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33336/abstract/2-5\">",
"     2-5",
"    </a>",
"    ]. Osteoporosis is associated with an increased risk of fracture and can be associated with significant morbidity, mortality, disfigurement and loss of self esteem, and health care expenditure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33336/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Estrogen, an important target for hormone receptor-positive breast cancer therapies, is also an important hormone for bone homeostasis. Therefore, anticancer therapies that decrease circulating estrogen levels or estrogen signaling may be associated with a decrease in bone mass.",
"   </p>",
"   <p>",
"    Adjuvant systemic therapies for breast cancer that are associated with an increased risk for bone loss include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Antiestrogen treatments (chemical or surgical ovarian ablation, aromatase inhibition, and in premenopausal patients,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/27/33208?source=see_link\">",
"       tamoxifen",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Chemotherapies that promote premature ovarian dysfunction",
"     </li>",
"     <li>",
"      Supportive medications, such as glucocorticoids [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/35/33336/abstract/5,7\">",
"       5,7",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Premenopausal women",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although less than a third of newly diagnosed breast cancer cases occur in premenopausal women, the risk of long term toxicity is of unique concern secondary to their anticipated life expectancy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33336/abstract/8\">",
"     8",
"    </a>",
"    ]. Premenopausal women who are treated with adjuvant chemotherapy are at risk for experiencing amenorrhea which may be temporary or permanent (menopause). The risk for premature ovarian dysfunction is influenced by the patient's age at time of therapy, surgical treatment performed (ie, removal of the ovaries), and the chemotherapy regimen used. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/33/41496?source=see_link&amp;anchor=H15#H15\">",
"     \"Acute side effects of adjuvant chemotherapy for early stage breast cancer\", section on 'Chemotherapy-induced amenorrhea'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Bone loss is expected with a surgical or chemically-induced menopause such as that due to chemotherapy or a gonadotropin-releasing hormone (GnRH) analog; however, the rate of loss may be more pronounced due to the rapid means by which the estrogen deprivation occurred. The cancer therapy-induced menopause occurs acutely and direct comparisons to a natural menopause, which typically occurs less briskly but over a longer period of time, has not been formally studied. It is unclear whether either mode of menopause ultimately has a greater impact on fracture.",
"   </p>",
"   <p>",
"    There is concern that women who experience premature menopause may be at increased risk for fracture, but the fracture risk is not established. Studies of chemotherapy-induced ovarian dysfunction, using bone mineral density (BMD) as a surrogate for fracture risk, have demonstrated that the rate of BMD loss may approach 3 to 8 percent at the lumbar spine within 12 months of initiating chemotherapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33336/abstract/9-12\">",
"     9-12",
"    </a>",
"    ]. As described in the following section, clinical trials investigating bisphosphonate therapy as a means of decreasing the rate of bone loss have confirmed that the bisphosphonates have the ability to either slow the rate of bone loss, or increase bone mass.",
"   </p>",
"   <p>",
"    Chemotherapy induced ovarian dysfunction may not lead to permanent menopause and bone mass may recover, at least in part, with the resumption of menses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33336/abstract/13\">",
"     13",
"    </a>",
"    ]. Similar results may occur with use of an GnRH analog and cessation of GnRH therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33336/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. Use of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/27/33208?source=see_link\">",
"     tamoxifen",
"    </a>",
"    in premenopausal women, however, which has both agonist and antagonist effects on the estrogen receptor, is associated with bone loss [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33336/abstract/13,15,16\">",
"     13,15,16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We suggest that premenopausal women be screened for bone loss in a similar fashion to that used for other premenopausal women at risk of bone loss (secondary to other causes, such as glucocorticoid-induced osteoporosis). For many premenopausal women exposed to significant risk factors, such as premature menopause secondary to cancer therapy, this includes a baseline dual energy x-ray absorptiometry (DEXA) scan, which may be obtained at or near the time of amenorrhea. Monitoring BMD over time will permit diagnosis of bone loss and aid in assessing the individual's risk for fracture, although the impact made on changing the rates of fracture has not been established. This is discussed in more detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/35/42553?source=see_link\">",
"     \"Evaluation and treatment of premenopausal osteoporosis\"",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H7\">",
"     'Premenopausal women with treatment-related bone loss'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/42/29354?source=see_link&amp;anchor=H17#H17\">",
"     \"Osteoporotic fracture risk assessment\", section on 'Clinical risk factor assessment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22072931\">",
"    <span class=\"h2\">",
"     Postmenopausal women",
"    </span>",
"    &nbsp;&mdash;&nbsp;Data generated from the Women's Health Initiative Observational Study (WHI-OS) demonstrated that women with a history of breast cancer diagnosed after the age of 55 have a higher risk of total fractures then that of those without a history of breast cancer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33336/abstract/17\">",
"     17",
"    </a>",
"    ]. Chemotherapy and its associated supportive therapies may have a negative effect on bone mass, although the direct effects of chemotherapy on the bone mass of this population are not well established. Preliminary data suggest that women receiving adjuvant chemotherapy but not endocrine therapy may lose 1 to 10 percent of their bone mass within one year of chemotherapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33336/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The effect of adjuvant endocrine therapy in this patient population is better studied. Adjuvant",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/27/33208?source=see_link\">",
"     tamoxifen",
"    </a>",
"    can promote stabilization to mild increase in bone mass in postmenopausal women, most likely secondary to the end organ specificity of this selective estrogen receptor modulator [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33336/abstract/16,19\">",
"     16,19",
"    </a>",
"    ]. In contrast to tamoxifen, adjuvant endocrine therapy with an aromatase inhibitor (AI) promotes bone loss and potentially osteoporotic fractures. AIs prevent the conversion of peripheral androgens to estrogens, the primary source of estrogen in postmenopausal women, which causes a rapid decline in estrogen levels and leads to bone loss. The evaluation and management of AI-induced bone loss are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/42/37545?source=see_link\">",
"     \"Evaluation and management of aromatase inhibitor-induced bone loss\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     PREVENTION OF TREATMENT-RELATED BONE LOSS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The foundation of preventing treatment related bone loss and maintaining bone health is adequate calcium and vitamin D, weight bearing exercises, and limiting or removing bone offending medications and behaviors, such as tobacco abuse. When a pharmacologic intervention is indicated, osteoclast inhibitors such as the bisphosphonates or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/53/21335?source=see_link\">",
"     denosumab",
"    </a>",
"    are the drugs of choice [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33336/abstract/20-22\">",
"     20-22",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/52/39754?source=see_link&amp;anchor=H2#H2\">",
"     \"Overview of the management of osteoporosis in postmenopausal women\", section on 'Nonpharmacologic therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Premenopausal women with treatment-related bone loss",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bisphosphonates in premenopausal women with chemotherapy-induced ovarian failure",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    ovarian suppression from gonadotropin-releasing hormone (GnRH) agonists have demonstrated preservation of bone mineral density (BMD), but there is presently no evidence for a decrease in fractures. The optimal time to intervene with a pharmacologic, bone directed intervention has not been defined. However, there is general consensus that premenopausal women with chemotherapy-induced ovarian failure",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    ovarian suppression from GnRH agonists are at high-risk for developing therapy-associated bone loss and that these women should be treated with bisphosphonates once they develop significantly decreased BMD (eg, T score of -2.5 or lower).",
"   </p>",
"   <p>",
"    Data from small trials is available to support the use of various bisphosphonates (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/3/9270?source=see_link\">",
"     clodronate",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?16/41/17047?source=see_link\">",
"     risedronate",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?2/62/3048?source=see_link\">",
"     pamidronate",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/1/9241?source=see_link\">",
"     zoledronic acid",
"    </a>",
"    ) in the management of treatment-related amenorrhea [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33336/abstract/12,23-25\">",
"     12,23-25",
"    </a>",
"    ]. The following is a summary of larger studies that have investigated the use of bisphosphonates in this setting:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the Cancer and Leukemia Group B (CALGB) Trial 79809, 166 women were randomly assigned treatment with immediate (upfront)",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?9/1/9241?source=see_link\">",
"       zoledronic acid",
"      </a>",
"      (4 mg every three months starting within three months of randomization), delayed zoledronic acid (same dosing starting one year after randomization), or no treatment [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/35/33336/abstract/26\">",
"       26",
"      </a>",
"      ]. For eligibility, women were at least 40 years old, had stage I to III breast cancer, and developed chemotherapy-induced ovarian failure. All women were prescribed calcium (1000 mg) and vitamin D (400 international units), with 100 percent self-reported compliance. At a median follow-up of one year, zoledronic acid resulted in the following significant outcomes when compared to placebo:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      A significant increase in lumbosacral BMD (a 1.2 percent gain versus a 6.7 percent loss).",
"     </li>",
"     <li>",
"      The majority of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?9/1/9241?source=see_link\">",
"       zoledronic acid",
"      </a>",
"      -related toxicities were mild (grade",
"      <span class=\"nowrap\">",
"       1/2);",
"      </span>",
"      grade 3 toxicities included fatigue, arthralgias, and bone pain in 1, 2, and 8 percent of women, respectively. There were no cases of osteonecrosis of the jaw or serious renal toxicity.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the Austrian Breast and Colorectal Cancer Study Group (ABCSG)-12 trial, a subgroup of 401 premenopausal women receiving adjuvant GnRH therapy with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?9/22/9574?source=see_link\">",
"       goserelin",
"      </a>",
"      plus either",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/27/33208?source=see_link\">",
"       tamoxifen",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?21/49/22294?source=see_link\">",
"       anastrozole",
"      </a>",
"      for three years were also treated with either",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?9/1/9241?source=see_link\">",
"       zoledronic acid",
"      </a>",
"      (4 mg every six months) or placebo [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/35/33336/abstract/14,27\">",
"       14,27",
"      </a>",
"      ]. This study showed the following results:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Treatment with placebo was associated with a statistically significant overall bone loss (a loss of 14.4 percent, mean T score reduction -1.4); women receiving",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?9/1/9241?source=see_link\">",
"       zoledronic acid",
"      </a>",
"      had stable BMD during the same time period.",
"     </li>",
"     <li>",
"      There was partial recovery of BMD two years after completing endocrine therapy and placebo (lumbar spine -6.3 percent). However, patients who received",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?9/1/9241?source=see_link\">",
"       zoledronic acid",
"      </a>",
"      showed a significantly increased lumbar spine BMD (+4 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/35/33336/abstract/27\">",
"       27",
"      </a>",
"      ]. Of note, the risk-benefit profile of increasing BMD in women with a normal BMD at baseline is unknown.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22073031\">",
"    <span class=\"h2\">",
"     Postmenopausal women with treatment-related bone loss",
"    </span>",
"    &nbsp;&mdash;&nbsp;For women with treatment-related bone loss due to aromatase inhibitor therapy, we suggest bisphosphonates or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/53/21335?source=see_link\">",
"     denosumab",
"    </a>",
"    . Denosumab is FDA approved for the management of postmenopausal women with osteoporosis at high risk for fracture and has been newly FDA approved for use to increase bone mass in women receiving adjuvant aromatase inhibitors at high risk for fracture.",
"   </p>",
"   <p>",
"    Postmenopausal women comprise a subset of patients with breast cancer that are at increased risk of osteoporosis due to age and gender [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33336/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. Adjuvant endocrine therapy with an aromatase inhibitor is associated with loss of BMD and interventions to preserve bone mass in the setting of aromatase inhibitor therapy, including bisphosphonates and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/53/21335?source=see_link\">",
"     denosumab",
"    </a>",
"    , are indicated in this setting. A more detailed review of aromatase inhibitor-induced bone loss is covered separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/42/37545?source=see_link\">",
"     \"Evaluation and management of aromatase inhibitor-induced bone loss\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     PREVENTION OF BREAST CANCER RECURRENCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Preclinical and early clinical studies have suggested that bisphosphonates may possess inherent antitumor activity, including antiangiogenic properties and antiproliferative and proapoptotic efficacy, which may be synergistic with chemotherapy agents and their ability to reduce the prevalence and persistence of disseminated tumor cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33336/abstract/30-33\">",
"     30-33",
"    </a>",
"    ]. Until more data are available, we and others reserve bisphosphonates for premenopausal women with evidence of decreased BMD and risk for fracture [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33336/abstract/20,34,35\">",
"     20,34,35",
"    </a>",
"    ]. Similarly, we reserve use of osteoclast inhibitors with either bisphosphonates or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/53/21335?source=see_link\">",
"     denosumab",
"    </a>",
"    for the management of osteopenia or osteoporosis in postmenopausal women. However, the role of bisphosphonates in preventing breast cancer recurrence and improving outcomes continues to be an active subject of clinical research. Similarly, a phase III clinical trial investigating the impact of denosumab on risk breast cancer recurrence is ongoing.",
"   </p>",
"   <p>",
"    Bi-directional interactions between tumor cells and osteoclasts lead to both osteolysis and tumor growth [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33336/abstract/36\">",
"     36",
"    </a>",
"    ]. This \"vicious cycle\" suggests that cell signaling between breast cancer and bone may promote progression of the cancer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33336/abstract/36,37\">",
"     36,37",
"    </a>",
"    ]. Bisphosphonate-induced osteoclast inhibition might make the bone microenvironment less supportive of tumor cell proliferation, and preclinical data suggests that bisphosphonate therapy can reduce the likelihood of bone metastases developing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33336/abstract/38\">",
"     38",
"    </a>",
"    ]. In addition, epidemiologic data suggests that bisphosphonates used in the management of osteopenia and osteoporosis may decrease the risk of developing breast cancer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33336/abstract/39-41\">",
"     39-41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite these theoretical advantages, the available evidence does not support the use of bisphosphonates as adjuvant treatment. This is illustrated in the following examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a meta-analysis of trials that randomized patients to bisphosphonates or not in the adjuvant setting failed to find significant reductions in the overall number of deaths, bone metastases, overall disease recurrences, distant relapse, visceral recurrences, or local relapses [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/35/33336/abstract/42\">",
"       42",
"      </a>",
"      ]. Nevertheless, in subgroup analysis, use of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?9/1/9241?source=see_link\">",
"       zoledronic acid",
"      </a>",
"      (ZOL) was associated with a statistically significant lower risk for disease recurrence (odds ratio [OR] 0.68; 95% CI 0.48-0.95), but not death (OR 0.62; 95% CI 0.39-1.06) or bone metastases rates (OR 0.66; 95% CI 0.38-1.15).",
"     </li>",
"     <li>",
"      A 2012 systematic review and meta-analysis confirmed that the use of bisphosphonates did not reduce the incidence of bone metastases when compared with placebo (relative risk for bone metastases [RR] 0.94, 95% CI 0.82 -1.07) or when used as early versus delayed treatment (RR 0.73, 95% CI 0.40-1.33) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/35/33336/abstract/43\">",
"       43",
"      </a>",
"      ]. &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Specific studies examining the role of bisphosphonates on the risks of breast cancer recurrence and mortality have continued and are discussed below.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?9/3/9270?source=see_link\">",
"       Clodronate",
"      </a>",
"      &mdash; A meta analysis found no evidence of a statistically significant difference in overall survival, bone metastasis-free survival, or nonskeletal metastasis-free survival in patients with advanced breast cancer receiving clodronate therapy versus those who did not receive active treatment [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/35/33336/abstract/44\">",
"       44",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Long-term results of the National Surgical Breast and Bowel Project B-24 (NSABP B-24) study were presented at the 2011 San Antonio Breast Cancer Symposium (SABCS) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/35/33336/abstract/45\">",
"       45",
"      </a>",
"      ]. In this trial, 3323 patients with stage I-III breast cancer were randomly assigned to three years of clodronate (1600 mg orally daily) or placebo for three years. Twenty-two percent of these patients were hormone-receptor negative and all received chemotherapy and endocrine therapy (if hormone-receptor positive). Of note, approximately 40 percent of patients did not complete protocol-defined treatment. With a median follow-up of 7.6 years, clodronate therapy showed the following outcomes compared to placebo:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      A trend towards a reduction in the rate of distant metastases (5.4 versus 6.6 percent).",
"     </li>",
"     <li>",
"      A nonsignificant improvement in overall survival (hazard ratio [HR] 0.85).",
"     </li>",
"     <li>",
"      A nonsignificant improvement in the nonskeletal metastasis-free interval (HR 0.74).",
"     </li>",
"     <li>",
"      Women over 50 years appeared to benefit the most from treatment in terms of recurrence-free survival (HR 0.76), skeletal metastasis-free interval (HR 0.61), nonskeletal metastasis-free interval (HR 0.63), and overall survival (HR 0.80).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?9/1/9241?source=see_link\">",
"       Zoledronic acid",
"      </a>",
"      <strong>",
"       (ZOL)",
"      </strong>",
"      &mdash; Two trials evaluating",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?35/26/36261?source=see_link\">",
"       letrozole",
"      </a>",
"      treatment in combination with either delayed or immediate (upfront) ZOL therapy, the Zometa-Femara Adjuvant Synergy Trials (Z-FAST and Zo-FAST), had a secondary endpoint of time to disease recurrence [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/35/33336/abstract/46,47\">",
"       46,47",
"      </a>",
"      ]. Zoledronic acid 4 mg was dosed every six months for five years. Although a pooled analysis from both studies at 12 months of follow-up suggested that upfront ZOL resulted in fewer episodes of disease recurrence or death, the final analysis from the Z-FAST study with five years of follow-up showed no difference in either endpoint [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/35/33336/abstract/46\">",
"       46",
"      </a>",
"      ]. A preliminary report of 60 month follow-up of the Zo-FAST study, presented at the 2011 SABCS, showed that treatment with immediate ZOL was associated with a 34 percent decrease in disease recurrence when compared with delayed therapy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/35/33336/abstract/48\">",
"       48",
"      </a>",
"      ]. An exploratory analysis of survival outcomes stratified women by menopausal status at the time of breast cancer diagnosis showed that postmenopausal women who began immediate treatment ZOL had a 29 percent reduction in the risk of recurrence and, in addition, had an improvement in overall survival by 35 percent. The impact of upfront versus delayed ZOL therapy on bone health from these studies is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/42/37545?source=see_link\">",
"       \"Evaluation and management of aromatase inhibitor-induced bone loss\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      In the Austrian Breast and Colorectal Cancer Study Group (ABCSG)-12, 1803 women were treated with GnRH therapy and were randomly assigned to type of endocrine therapy (",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/27/33208?source=see_link\">",
"       tamoxifen",
"      </a>",
"      versus",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?21/49/22294?source=see_link\">",
"       anastrozole",
"      </a>",
"      with a second randomization to ZOL 4 mg every six months for three years or not) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/35/33336/abstract/49\">",
"       49",
"      </a>",
"      ]. Initial results showed a significant improvement in disease free survival (DFS) and a trend towards a reduced risk of death [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/35/33336/abstract/50\">",
"       50",
"      </a>",
"      ]. At the 2011 SABCS, results with a median follow-up of 84 months showed that compared to women who did not receive ZOL, treatment with ZOL was associated with the following [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/35/33336/abstract/51\">",
"       51",
"      </a>",
"      ]:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      A significant reduction in the risk of a DFS event (HR 0.72) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/35/33336/abstract/50\">",
"       50",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A significant reduction in the risk of death (HR 0.6).",
"     </li>",
"     <li>",
"      Among patients over 40 years, ZOL was associated with a significant reduction in the risk of DFS events (HR 0.66) and the risk of death (HR 0.51).",
"     </li>",
"     <li>",
"      Among patients 40 years or younger, there was no benefit in either risk of DFS events or death.",
"     </li>",
"     <li>",
"      With seven-years of follow-up, there have been no cases of jaw necrosis or renal failure reported following ZOL treatment for the protocol-defined duration of three years.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the randomized Adjuvant Treatment With ZOL in Stage",
"      <span class=\"nowrap\">",
"       II/III",
"      </span>",
"      Breast Cancer (AZURE, BIG",
"      <span class=\"nowrap\">",
"       01/04)",
"      </span>",
"      trial that included 3360 patients with stage",
"      <span class=\"nowrap\">",
"       II/III",
"      </span>",
"      breast cancer, patients received standard adjuvant therapy with or without ZOL (4 mg intravenously over three to four weeks for six doses, then every three months for eight doses, and then every six months for five doses to complete five years of therapy) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/35/33336/abstract/52\">",
"       52",
"      </a>",
"      ]. All patients were instructed to take daily oral supplements containing calcium (400 to 1000 mg) and vitamin D (200 to 500 IU) and standard adjuvant radiation therapy was given per institutional protocols. Most patients received both endocrine therapy and, in contrast to the group of women treated in ABCSG-12, more than 95 percent received chemotherapy. After a median follow-up of six years, ZOL resulted in the following outcomes when compared with standard adjuvant therapy alone:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Similar rates of disease free survival at five years (77 percent in each arm; HR 0.98; 95% CI 0.85-1.13).",
"     </li>",
"     <li>",
"      Similar rates of overall survival at five years (85 versus 83 percent).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In a preplanned subset analysis based on estimated menopausal status, treatment with ZOL in 1041 postmenopausal women (defined as &gt;5 years postmenopausal or age &gt;60 at study entry) was associated with a significant benefit in both invasive disease-free survival (HR 0.75; 95% CI 0.59-0.96) and overall survival (HR 0.74; 95% CI 0.55-0.98) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33336/abstract/52\">",
"     52",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    Whether ZOL is beneficial for postmenopausal women and premenopausal women treated with GnRH therapy to induce ovarian suppression, the population in the ABCSG-12 trial described above, is hypothesis generating, but needs further investigation. The improvements in disease free survival and breast cancer recurrence reported in ABCSG-12 support the preclinical data suggesting that bisphosphonate therapy may have antitumor effects. The results of additional clinical trials are needed before bisphosphonates would be used in the adjuvant setting for the indication of improving breast cancer outcomes.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?12/8/12423?source=see_link\">",
"       Ibandronate",
"      </a>",
"      &mdash; Ibandronate in combination with chemotherapy was evaluated in the GAIN study, which randomly assigned 3032 patients to treatment with two different chemotherapy regimens and to ibandronate 50 mg orally or placebo for two years. In an interim analysis presented at the 2011 SABCS, there was no difference in DFS (HR 1.059; 95% CI 0.861-1.301) or OS (HR 0.961; 95% CI 0.705-1.31) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/35/33336/abstract/53\">",
"       53",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The use of bisphosphonates to prevent breast cancer recurrence has not been clearly delineated. However, the benefits do not appear to extend to women under 40 years as noted in the AZURE, ABCSG-12, and NSABP B-24 studies. The evidence now suggests that a benefit may be seen in women who have entered menopause. Further studies are required to inform this potential indication for bisphosphonates. Until then, we continue to reserve bisphosphonates for women with evidence of decreased BMD and risk for fracture.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     TOXICITY ASSOCIATED WITH OSTEOCLAST INHIBITORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Therapy with bisphosphonates is generally well tolerated; however, bisphosphonate therapy has been associated with the risk of developing a number of complications including, electrolyte disturbance (most notably hypocalcemia), acute phase reactions, nephrotic syndrome, renal insufficiency, and osteonecrosis of the jaw. Similarly treatment with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/53/21335?source=see_link\">",
"     denosumab",
"    </a>",
"    is generally well tolerated. The side effect profile includes electrolyte disturbance, particularly hypocalcemia, skin infections, dermatologic reactions, suppression of bone turnover and osteonecrosis of the jaw. However, the incidence of osteonecrosis of the jaw with bisphosphonates during adjuvant treatment appears to be uncommon (0.7 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33336/abstract/54,55\">",
"     54,55",
"    </a>",
"    ]. Further discussion on the risks of therapy and recommendations for monitoring are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/43/39610?source=see_link&amp;anchor=H1928329#H1928329\">",
"     \"Risks of therapy with bone modifying agents in patients with advanced malignancy\", section on 'Osteonecrosis of the jaw'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Of particular importance to premenopausal women, the safety data regarding future pregnancy are unknown. Bisphosphonates carry a Category C rating for safety in pregnancy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/35/42553?source=see_link&amp;anchor=H11#H11\">",
"     \"Evaluation and treatment of premenopausal osteoporosis\", section on 'Bisphosphonates'",
"    </a>",
"    .) Similarly,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/53/21335?source=see_link\">",
"     denosumab",
"    </a>",
"    carries a Category C rating.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H77440423\">",
"    <span class=\"h1\">",
"     CLINICAL TRIALS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Often there is no better therapy to offer a patient than enrollment onto a well-designed, scientifically valid, peer-reviewed clinical trial. Additional information and instructions for referring a patient to an appropriate research center can be obtained from the United States National Institutes of Health:",
"    <a class=\"external\" href=\"file://www.clinicaltrials.gov/\">",
"     www.clinicaltrials.gov",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Bone health is an important component of the survivorship plan for women with breast cancer. Calcium, vitamin D, and weight bearing exercises remain the foundation for maintaining bone integrity in all patients. Both premenopausal and postmenopausal women with early breast cancer are at risk for cancer therapy-induced bone loss. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Bisphosphonates and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?20/53/21335?source=see_link\">",
"       denosumab",
"      </a>",
"      are potent inhibitors of osteoclast activity, appear to prevent therapy-related bone loss, and compliment nutritional (calcium and vitamin D), exercise, and lifestyle modifications. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Premenopausal women with surgical (ie, oophorectomy) or chemotherapy-induced ovarian failure or with ovarian suppression due to adjuvant endocrine therapy (eg, gonadotropin-releasing hormone agonists) are at an increased risk for cancer therapy-induced bone loss. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Breast cancer therapy-associated bone loss'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      We recommend that premenopausal women be screened for bone loss in a similar fashion to that used for other premenopausal women at risk of bone loss (eg, secondary to other causes, such as glucocorticoid-induced osteoporosis). Monitoring bone mineral density over time will permit diagnosis of bone loss and aid in assessing the individual's risk for fracture. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Premenopausal women with treatment-related bone loss'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?41/35/42553?source=see_link\">",
"       \"Evaluation and treatment of premenopausal osteoporosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For premenopausal woman found to have osteoporosis based upon a DEXA scan (T score of -2.5 or lower) or a history of fracture due to low BMD, we suggest the use of bisphosphonate therapy in addition to nutritional, physical, and lifestyle modifications rather than these modifications alone. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Premenopausal women with treatment-related bone loss'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Aromatase inhibitors place postmenopausal women at an increased risk for therapy-induced bone loss. We suggest the use of bisphosphonates or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?20/53/21335?source=see_link\">",
"       denosumab",
"      </a>",
"      for bone loss attributed to aromatase inhibitors. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/42/37545?source=see_link\">",
"       \"Evaluation and management of aromatase inhibitor-induced bone loss\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?10/55/11128?source=see_link\">",
"       \"Diagnosis and evaluation of osteoporosis in postmenopausal women\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For women without osteoporosis or a history of fracture due to low BMD, we suggest the use of nutritional, physical, and lifestyle modifications alone rather than these modifications plus bisphosphonate therapy. This is primarily because bisphosphonate therapy is not without risks and the potential fracture benefit of bisphosphonate therapy in this population remains unproven. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Prevention of breast cancer recurrence'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33336/abstract/1\">",
"      Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011; 61:212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33336/abstract/2\">",
"      Greep NC, Giuliano AE, Hansen NM, et al. The effects of adjuvant chemotherapy on bone density in postmenopausal women with early breast cancer. Am J Med 2003; 114:653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33336/abstract/3\">",
"      Zmuda JM, Cauley JA, Ljung BM, et al. Bone mass and breast cancer risk in older women: differences by stage at diagnosis. J Natl Cancer Inst 2001; 93:930.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33336/abstract/4\">",
"      Zhang Y, Kiel DP, Kreger BE, et al. Bone mass and the risk of breast cancer among postmenopausal women. N Engl J Med 1997; 336:611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33336/abstract/5\">",
"      Van Poznak C, Sauter NP. Clinical management of osteoporosis in women with a history of breast carcinoma. Cancer 2005; 104:443.",
"     </a>",
"    </li>",
"    <li>",
"     Bone Source from the National Osteoporosis Foundation (nof.org). file://www.nof.org/professionals (Accessed on September 01, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33336/abstract/7\">",
"      Gralow JR, Biermann JS, Farooki A, et al. NCCN Task Force Report: Bone Health in Cancer Care. J Natl Compr Canc Netw 2009; 7 Suppl 3:S1.",
"     </a>",
"    </li>",
"    <li>",
"     Surveillance Epidemiology and End Results (SEER) Stat Fact Sheets for breast cancer. file://seer.cancer.gov/statfacts/html/breast.html (Accessed on September 01, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33336/abstract/9\">",
"      Shapiro CL, Manola J, Leboff M. Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer. J Clin Oncol 2001; 19:3306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33336/abstract/10\">",
"      Powles TJ, McCloskey E, Paterson AH, et al. Oral clodronate and reduction in loss of bone mineral density in women with operable primary breast cancer. J Natl Cancer Inst 1998; 90:704.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33336/abstract/11\">",
"      Saarto T, Blomqvist C, V&auml;lim&auml;ki M, et al. Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomized study in premenopausal breast cancer patients. J Clin Oncol 1997; 15:1341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33336/abstract/12\">",
"      Delmas PD, Balena R, Confravreux E, et al. Bisphosphonate risedronate prevents bone loss in women with artificial menopause due to chemotherapy of breast cancer: a double-blind, placebo-controlled study. J Clin Oncol 1997; 15:955.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33336/abstract/13\">",
"      Vehmanen L, Elomaa I, Blomqvist C, Saarto T. Tamoxifen treatment after adjuvant chemotherapy has opposite effects on bone mineral density in premenopausal patients depending on menstrual status. J Clin Oncol 2006; 24:675.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33336/abstract/14\">",
"      Gnant MF, Mlineritsch B, Luschin-Ebengreuth G, et al. Zoledronic acid prevents cancer treatment-induced bone loss in premenopausal women receiving adjuvant endocrine therapy for hormone-responsive breast cancer: a report from the Austrian Breast and Colorectal Cancer Study Group. J Clin Oncol 2007; 25:820.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33336/abstract/15\">",
"      Sverrisd&oacute;ttir A, Fornander T, Jacobsson H, et al. Bone mineral density among premenopausal women with early breast cancer in a randomized trial of adjuvant endocrine therapy. J Clin Oncol 2004; 22:3694.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33336/abstract/16\">",
"      Powles TJ, Hickish T, Kanis JA, et al. Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women. J Clin Oncol 1996; 14:78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33336/abstract/17\">",
"      Chen Z, Maricic M, Bassford TL, et al. Fracture risk among breast cancer survivors: results from the Women's Health Initiative Observational Study. Arch Intern Med 2005; 165:552.",
"     </a>",
"    </li>",
"    <li>",
"     Van Poznak C, Morris PG, D'Andrea G, et al. Bone Mineral Density (BMD) Changes at 1 Year in Postmenopausal Women Who Are Not Receiving Adjuvant Endocrine Therapy for Breast Cancer (BCA). Cancer Res 2009; 69:559s (abstr 1066). (Available online at file://www.abstracts2view.com/sabcs09/view.php?nu=SABCS09L_1670&amp;terms=, accessed January 8, 2009).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33336/abstract/19\">",
"      Love RR, Mazess RB, Barden HS, et al. Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. N Engl J Med 1992; 326:852.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33336/abstract/20\">",
"      Reid DM, Doughty J, Eastell R, et al. Guidance for the management of breast cancer treatment-induced bone loss: a consensus position statement from a UK Expert Group. Cancer Treat Rev 2008; 34 Suppl 1:S3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33336/abstract/21\">",
"      Favus MJ. Bisphosphonates for osteoporosis. N Engl J Med 2010; 363:2027.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33336/abstract/22\">",
"      Body JJ. Prevention and treatment of side-effects of systemic treatment: bone loss. Ann Oncol 2010; 21 Suppl 7:vii180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33336/abstract/23\">",
"      Vehmanen L, Saarto T, Risteli J, et al. Short-term intermittent intravenous clodronate in the prevention of bone loss related to chemotherapy-induced ovarian failure. Breast Cancer Res Treat 2004; 87:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33336/abstract/24\">",
"      Fuleihan Gel-H, Salamoun M, Mourad YA, et al. Pamidronate in the prevention of chemotherapy-induced bone loss in premenopausal women with breast cancer: a randomized controlled trial. J Clin Endocrinol Metab 2005; 90:3209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33336/abstract/25\">",
"      Vehmanen L, Saarto T, Elomaa I, et al. Long-term impact of chemotherapy-induced ovarian failure on bone mineral density (BMD) in premenopausal breast cancer patients. The effect of adjuvant clodronate treatment. Eur J Cancer 2001; 37:2373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33336/abstract/26\">",
"      Shapiro CL, Halabi S, Hars V, et al. Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: final results from CALGB trial 79809. Eur J Cancer 2011; 47:683.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33336/abstract/27\">",
"      Gnant M, Mlineritsch B, Luschin-Ebengreuth G, et al. Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy. Lancet Oncol 2008; 9:840.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33336/abstract/28\">",
"      Raisz LG. Clinical practice. Screening for osteoporosis. N Engl J Med 2005; 353:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33336/abstract/29\">",
"      Rosen CJ. Clinical practice. Postmenopausal osteoporosis. N Engl J Med 2005; 353:595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33336/abstract/30\">",
"      Gnant M, Dubsky P, Fitzal F, et al. Maintaining bone density in patients undergoing treatment for breast cancer: is there an adjuvant benefit? Clin Breast Cancer 2009; 9 Suppl 1:S18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33336/abstract/31\">",
"      Winter MC, Holen I, Coleman RE. Exploring the anti-tumour activity of bisphosphonates in early breast cancer. Cancer Treat Rev 2008; 34:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33336/abstract/32\">",
"      Vincenzi B, Santini D, Dicuonzo G, et al. Zoledronic acid-related angiogenesis modifications and survival in advanced breast cancer patients. J Interferon Cytokine Res 2005; 25:144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33336/abstract/33\">",
"      Aft R, Naughton M, Trinkaus K, et al. Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trial. Lancet Oncol 2010; 11:421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33336/abstract/34\">",
"      Hillner BE, Ingle JN, Chlebowski RT, et al. American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer. J Clin Oncol 2003; 21:4042.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33336/abstract/35\">",
"      Body JJ, Bergmann P, Boonen S, et al. Management of cancer treatment-induced bone loss in early breast and prostate cancer -- a consensus paper of the Belgian Bone Club. Osteoporos Int 2007; 18:1439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33336/abstract/36\">",
"      Mundy GR. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2002; 2:584.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33336/abstract/37\">",
"      Roodman GD. Mechanisms of bone metastasis. N Engl J Med 2004; 350:1655.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33336/abstract/38\">",
"      Hall DG, Stoica G. Effect of the bisphosphonate risedronate on bone metastases in a rat mammary adenocarcinoma model system. J Bone Miner Res 1994; 9:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33336/abstract/39\">",
"      Chlebowski RT, Chen Z, Cauley JA, et al. Oral bisphosphonate use and breast cancer incidence in postmenopausal women. J Clin Oncol 2010; 28:3582.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33336/abstract/40\">",
"      Rennert G, Pinchev M, Rennert HS. Use of bisphosphonates and risk of postmenopausal breast cancer. J Clin Oncol 2010; 28:3577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33336/abstract/41\">",
"      Newcomb PA, Trentham-Dietz A, Hampton JM. Bisphosphonates for osteoporosis treatment are associated with reduced breast cancer risk. Br J Cancer 2010; 102:799.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33336/abstract/42\">",
"      Mauri D, Valachis A, Polyzos NP, et al. Does adjuvant bisphosphonate in early breast cancer modify the natural course of the disease? A meta-analysis of randomized controlled trials. J Natl Compr Canc Netw 2010; 8:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33336/abstract/43\">",
"      Wong MH, Stockler MR, Pavlakis N. Bisphosphonates and other bone agents for breast cancer. Cochrane Database Syst Rev 2012; 2:CD003474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33336/abstract/44\">",
"      Ha TC, Li H. Meta-analysis of clodronate and breast cancer survival. Br J Cancer 2007; 96:1796.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33336/abstract/45\">",
"      Paterson AHG, Anderson SJ, Lembersky BC, et al. NSABP Protocol B-34: A Clinical Trial Comparing Adjuvant Clodronate vs. Placebo in Early Stage Breast Cancer Patients Receiving Systemic Chemotherapy and/or Tamoxifen or No Therapy &ndash; Final Analysis. CTRC-AACR San Antonio Breast Cancer Symposium 2011; Abstr S2-3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33336/abstract/46\">",
"      Brufsky AM, Harker WG, Beck JT, et al. Final 5-year results of Z-FAST trial: adjuvant zoledronic acid maintains bone mass in postmenopausal breast cancer patients receiving letrozole. Cancer 2012; 118:1192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33336/abstract/47\">",
"      Brufsky A, Bundred N, Coleman R, et al. Integrated analysis of zoledronic acid for prevention of aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole. Oncologist 2008; 13:503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33336/abstract/48\">",
"      de Boer R, Bundred N, Eidtmann H, et al. Long-Term Survival Outcomes among Postmenopausal Women with Hormone Receptor-Positive Early Breast Cancer Receiving Adjuvant Letrozole and Zoledronic Acid: 5-Year Follow-Up of ZO-FAST. 2011 CTRC-AACR San Antonio Breast Cancer Symposium 2011; Abstr S1-3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33336/abstract/49\">",
"      Gnant M, Mlineritsch B, Schippinger W, et al. Endocrine therapy plus zoledronic acid in premenopausal breast cancer. N Engl J Med 2009; 360:679.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33336/abstract/50\">",
"      Gnant M, Mlineritsch B, Stoeger H, et al. Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial. Lancet Oncol 2011; 12:631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33336/abstract/51\">",
"      Gnant M, Mlineritsch B, Luschin-Ebengreuth G, Stoeger H. Long-Term Follow-Up in ABCSG-12: Significantly Improved Overall Survival with Adjuvant Zoledronic Acid in Premenopausal Patients with Endocrine-Receptor&ndash;Positive Early Breast Cancer. 2011 CTRC-AACR San Antonio Breast Cancer Symposium 2011; Abstr S1-2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33336/abstract/52\">",
"      Coleman RE, Marshall H, Cameron D, et al. Breast-cancer adjuvant therapy with zoledronic acid. N Engl J Med 2011; 365:1396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33336/abstract/53\">",
"      Mobus V, Diel IJ, Elling D, et al. GAIN Study: A Phase III Trial To Compare ETC vs. EC-TX and Ibandronate vs. Observation in Patients with Node-Positive Primary Breast Cancer &ndash; 1st Interim Efficacy Analysis. CTRC-AACR San Antonio Breast Cancer Symposium 2011; Abstr S2-4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33336/abstract/54\">",
"      Mauri D, Valachis A, Polyzos IP, et al. Osteonecrosis of the jaw and use of bisphosphonates in adjuvant breast cancer treatment: a meta-analysis. Breast Cancer Res Treat 2009; 116:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33336/abstract/55\">",
"      Coleman R, Woodward E, Brown J, et al. Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01-04) for women with stage II/III breast cancer. Breast Cancer Res Treat 2011; 127:429.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 776 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-122.72.76.133-518C2F532B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_35_33336=[""].join("\n");
var outline_f32_35_33336=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H10\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      BREAST CANCER THERAPY-ASSOCIATED BONE LOSS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Premenopausal women",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22072931\">",
"      Postmenopausal women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      PREVENTION OF TREATMENT-RELATED BONE LOSS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Premenopausal women with treatment-related bone loss",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22073031\">",
"      Postmenopausal women with treatment-related bone loss",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      PREVENTION OF BREAST CANCER RECURRENCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      TOXICITY ASSOCIATED WITH OSTEOCLAST INHIBITORS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H77440423\">",
"      CLINICAL TRIALS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/33/41496?source=related_link\">",
"      Acute side effects of adjuvant chemotherapy for early stage breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/55/11128?source=related_link\">",
"      Diagnosis and evaluation of osteoporosis in postmenopausal women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/42/37545?source=related_link\">",
"      Evaluation and management of aromatase inhibitor-induced bone loss",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/35/42553?source=related_link\">",
"      Evaluation and treatment of premenopausal osteoporosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/42/29354?source=related_link\">",
"      Osteoporotic fracture risk assessment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/52/39754?source=related_link\">",
"      Overview of the management of osteoporosis in postmenopausal women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/43/39610?source=related_link\">",
"      Risks of therapy with bone modifying agents in patients with advanced malignancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/28/40393?source=related_link\">",
"      Screening for osteoporosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_35_33337="Use and utility of stroke scales and grading systems";
var content_f32_35_33337=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Use and utility of stroke scales and grading systems",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/35/33337/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/35/33337/contributors\">",
"     Larry B Goldstein, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/35/33337/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/35/33337/contributors\">",
"     Scott E Kasner, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/35/33337/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/35/33337/contributors\">",
"     John F Dashe, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?32/35/33337/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 25, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H20964997\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to their importance for assessing the impact of therapeutic interventions in clinical trials, stroke scales are useful in the routine clinical setting as aids to improve diagnostic accuracy, help determine the appropriateness of specific treatments, monitor a patient's neurologic deficits through the continuum of care, and gauge outcomes. Not only are different types of scales needed for these different purposes, but no single scale is suitable for capturing all of the effects of stroke.",
"   </p>",
"   <p>",
"    This topic will review stroke scales and grading systems that are used for ischemic and hemorrhagic stroke. Grading systems used to classify patients with subarachnoid hemorrhage are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/25/406?source=see_link\">",
"     \"Subarachnoid hemorrhage grading scales\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Categorization systems used in the classification and etiology of stroke are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/63/9208?source=see_link&amp;anchor=H13#H13\">",
"     \"Etiology and classification of stroke\", section on 'TOAST classification'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/63/9208?source=see_link&amp;anchor=H60049534#H60049534\">",
"     \"Etiology and classification of stroke\", section on 'SSS-TOAST and CCS classification'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24273480\">",
"    <span class=\"h1\">",
"     USE OF SCALES IN THE ASSESSMENT OF STROKE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stroke scales are useful for clinical and research purposes as aids to improve diagnostic accuracy, determine the suitability of specific treatments, monitor change in neurologic impairments, and measure outcome. There has been considerable progress in the clinimetrics of stroke since the 1980s [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/1\">",
"     1",
"    </a>",
"    ]. Although there are numerous general and stroke-specific scales that have established reliability and validity, no single scale is suitable for all clinical or research situations.",
"   </p>",
"   <p>",
"    The International Classification of Functioning and Disability and Health, developed by the World Health Organization, categorizes the impact of disease into to three dimensions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Body Dimension, referring to the structure and function of body systems",
"     </li>",
"     <li>",
"      Activities Dimension, referring to the complete range of activities performed by an individual",
"     </li>",
"     <li>",
"      Participation Dimension, classifying areas of life in which an individual is involved, has access to, has societal opportunities or barriers",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These three general dimensions correspond to what clinicians might describe as neurologic impairments (ie, deficits such as a hemianopsia, aphasia, limb paresis, gait imbalance, or sensory loss), disabilities (ie, loss of the ability to perform daily tasks, such as eating, dressing, and bathing, resulting from physiological deficits), and handicaps (ie, the impact of deficits and disabilities on social participation such as employment) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/3\">",
"     3",
"    </a>",
"    ]. Additionally, it is becoming increasingly important to assess the effects of disease and treatment on quality of life.",
"   </p>",
"   <p>",
"    Although the impact of stroke as reflected by these different domains is generally consistent, it is important to measure each domain, as focusing on any one could be misleading. As an example, consider a patient with a paralyzed hand. This deficit would be measured in the Body Dimension as a motor impairment. By the use of compensatory strategies such as the use of the unimpaired hand or prosthetics, that same patient might have no disability (ie, able to eat, dress, bathe). If he was a truck driver, he might be able to return to work by driving a modified vehicle (no handicap), whereas if he was a watchmaker, he might be unable to return to his previous employment (ie, a social handicap). Thus, the impact of a neurologic impairment on quality of life can be quite different depending on individual circumstances. In addition, a stroke considered to be mild based upon a measure of one dimension may be severe when measured on a different dimension [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/4\">",
"     4",
"    </a>",
"    ]. Therefore, when choosing a stroke scale, one must first consider why it is being used and what it is measuring.",
"   </p>",
"   <p>",
"    In addition to assessing stroke severity as an index of outcome, different types of stroke scales can be used for a variety of other purposes. Diagnostically, the rapid identification of possible stroke by emergency services personnel is facilitated by the use of stroke scales designed for that purpose. Stroke severity as assessed with an impairment-level scale such as the National Institutes for Health Stroke Scale (NIHSS) may be useful when discussing the bleeding risk associated with thrombolytic therapy with an individual patient or family [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/5\">",
"     5",
"    </a>",
"    ]. In addition, the NIHSS score is part of the assessment that determines whether a patient is a candidate for intravenous thrombolysis with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?11/41/11929?source=see_link\">",
"     alteplase",
"    </a>",
"    between 3 and 4.5 hours of symptom onset [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/8/41098?source=see_link&amp;anchor=H34#H34\">",
"     \"Reperfusion therapy for acute ischemic stroke\", section on 'Stroke severity'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Stroke prognosis is largely determined by the severity of the patient's initial impairments, and several schemes have been developed to provide an estimate of functional outcome to help guide decisions such as discharge location [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/7\">",
"     7",
"    </a>",
"    ]. A plethora of stroke scales have been developed for each of these purposes as discussed in the sections that follow. A general stroke related outcome measure that incorporates some of the properties of individual scales has been proposed (American Heart Association Stroke Outcome Classification), but has not yet been adopted for clinical use [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. Whether the stroke community will embrace it is not yet clear.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24273487\">",
"    <span class=\"h1\">",
"     STROKE DIAGNOSTIC SCALES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because of poor recognition of stroke symptoms, stroke scales and grading systems have been developed both to aid the general public and emergency responders in the identification of persons with acute stroke, and to hasten transport of stroke victims to appropriate medical facilities. These tools must be simple and rapidly applicable.",
"   </p>",
"   <p>",
"    The best studied scales for stroke diagnosis are the Face Arm Speech Test (FAST), the Cincinnati Prehospital Stroke Scale (CPSS), the Los Angeles Prehospital Stroke Screen (LAPSS), and the Recognition of Stroke in the Emergency Room (ROSIER). The FAST and CPSS are similar, with each evaluating the presence or absence of facial weakness, arm weakness, and speech difficulty. The main difference between the two is that FAST incorporates assessment of language function during normal conversation, whereas CPSS tests language by asking the patient to repeat a short sentence. The LAPSS",
"    <strong>",
"    </strong>",
"    and ROSIER scales incorporate additional items to exclude stroke mimics and to increase sensitivity and specificity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24273494\">",
"    <span class=\"h2\">",
"     Face Arm Speech Test",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Face Arm Speech Test (FAST)",
"    <strong>",
"    </strong>",
"    evaluates patients with suspected stroke by assessing them for the presence of a speech impairment, facial weakness, and arm weakness (",
"    <a class=\"graphic graphic_figure graphicRef54134 \" href=\"mobipreview.htm?34/47/35583\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/11\">",
"     11",
"    </a>",
"    ]. A prospective study found good agreement for the detection of the acute stroke signs between emergency medical responders using the FAST system and stroke physicians [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24273501\">",
"    <span class=\"h2\">",
"     Cincinnati Prehospital Stroke Scale",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Cincinnati Prehospital Stroke Scale (CPSS) focuses on the assessment facial paresis, arm drift, and abnormal speech (",
"    <a class=\"graphic graphic_table graphicRef62856 \" href=\"mobipreview.htm?38/11/39099\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/13\">",
"     13",
"    </a>",
"    ]. In a prospective report evaluating the CPSS, the diagnostic accuracy for emergency department physicians compared with non-physician emergency medical personnel was similar with high correlation for total score between these groups [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/14\">",
"     14",
"    </a>",
"    ]. The presence of an abnormality on any one of the three stroke scale items was associated with a marked increase in the likelihood of stroke [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24273508\">",
"    <span class=\"h2\">",
"     Los Angeles Prehospital Stroke Screen",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Los Angeles Prehospital Stroke Screen (LAPSS)",
"    <strong>",
"    </strong>",
"    assesses for unilateral arm drift, handgrip weakness, and facial paresis (",
"    <a class=\"graphic graphic_form graphicRef78128 \" href=\"mobipreview.htm?13/4/13377\">",
"     form 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/16\">",
"     16",
"    </a>",
"    ]. The criteria for an \"in-the-field\" stroke diagnosis are met when the patient age is &gt;45 years,",
"    <span class=\"nowrap\">",
"     seizure/epilepsy",
"    </span>",
"    history is absent, symptom duration is &lt;24 hours, the patient is not wheelchair bound or bedridden at baseline, the blood glucose is between 60 and 400",
"    <span class=\"nowrap\">",
"     mg/dL,",
"    </span>",
"    and a unilateral deficit is present in one of the three items (arm, handgrip, or face). The LAPSS was evaluated in an observer-blind prospective study of all non-comatose, non-trauma patients with neurologic complaints compatible with stroke who were transported by emergency medical technicians to a single hospital [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/16\">",
"     16",
"    </a>",
"    ]. Compared with the final diagnosis, a prehospital stroke diagnosis made by paramedics with LAPSS had a sensitivity of 91 percent (95% CI 76-98 percent) and specificity of 97 percent (95% CI 93-99 percent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24273515\">",
"    <span class=\"h2\">",
"     Recognition of Stroke in the Emergency Room scale",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Recognition of Stroke in the Emergency Room (ROSIER) scale was developed to facilitate rapid stroke patient identification and triage by emergency department clinicians [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/17\">",
"     17",
"    </a>",
"    ]. The ROSIER scale incorporates the Glasgow Coma Scale (",
"    <a class=\"graphic graphic_table graphicRef81854 \" href=\"mobipreview.htm?28/62/29676\">",
"     table 2",
"    </a>",
"    ) and measurement of blood pressure and blood glucose along with assessment of a seven-item stroke-recognition scale.",
"   </p>",
"   <p>",
"    The first two items inquire about clinical history to exclude stroke mimics [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/17\">",
"     17",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Loss of consciousness or syncope (yes = -1; no = 0)",
"     </li>",
"     <li>",
"      Seizure activity (yes = -1; no = 0)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The next five items inquire about specific neurologic deficits of new acute onset (or present since awakening from sleep):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Asymmetric facial weakness (yes = +1; no = 0)",
"     </li>",
"     <li>",
"      Asymmetric arm weakness (yes = +1; no = 0)",
"     </li>",
"     <li>",
"      Asymmetric leg weakness (yes = +1; no = 0)",
"     </li>",
"     <li>",
"      Speech disturbance (yes = +1; no = 0)",
"     </li>",
"     <li>",
"      Visual field defect (yes = +1; no = 0)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Stroke is unlikely but not completely excluded if total score is &le;0 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/17\">",
"     17",
"    </a>",
"    ]. When prospectively validated at a cut-off score of &gt;0, the scale had a sensitivity of 93 percent (95% CI 89-97 percent) and specificity of 83 percent (95% CI 77-89 percent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1412591\">",
"    <span class=\"h2\">",
"     Comparison studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are only limited data comparing the utility of the diagnostic stroke scales.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a cross-sectional observational report of 356 patients with suspected acute stroke evaluated in the emergency department, the ROSIER and FAST scales had similar good sensitivity (83 and 81 percent respectively) but suffered from relatively poor specificity (44 and 39 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/18\">",
"       18",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a study that compared neurologist-recorded signs from a cohort of 160 patients with suspected stroke or TIA, the sensitivities of the ROSIER, CPSS, FAST, and LAPSS scales were 93, 85, 82, and 59 percent, respectively [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/17\">",
"       17",
"      </a>",
"      ]. Corresponding specificities were 83, 79, 83, and 85 percent.",
"     </li>",
"     <li>",
"      In a prospective questionnaire study that investigated 31 patients with acute neurologic complaints transported by emergency medical services, FAST and CPSS had identical high sensitivity and low specificity (95 and 33 percent), while the LAPSS had a lower sensitivity and better specificity (74 and 83 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/19\">",
"       19",
"      </a>",
"      ]. Small patient numbers limit the strength of this study.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The inconsistent findings likely reflect differences in patient populations and study methodologies among these reports.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24273522\">",
"    <span class=\"h1\">",
"     STROKE IMPAIRMENT SCALES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The main stroke impairment scales are the National Institutes of Health Stroke Scale, the Pediatric National Institutes of Health Stroke Scale, the European Stroke Scale and the Canadian Neurologic Scale. While these scales are useful to assess the severity of neurologic impairment due to stroke, they are",
"    <strong>",
"     not",
"    </strong>",
"    useful for making the diagnosis of stroke.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24273530\">",
"    <span class=\"h2\">",
"     National Institutes of Health Stroke Scale",
"    </span>",
"    &nbsp;&mdash;&nbsp;The National Institutes of Health Stroke Scale",
"    <strong>",
"    </strong>",
"    (NIHSS) measures neurologic impairment using a 15 item scale (",
"    <a class=\"graphic graphic_table graphicRef61698 \" href=\"mobipreview.htm?39/33/40477\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/20\">",
"     20",
"    </a>",
"    ]. A full version of the NIHSS is available online at",
"    <a class=\"external\" href=\"file://www.ninds.nih.gov/doctors/NIH_Stroke_Scale.pdf\">",
"     www.ninds.nih.gov/doctors/NIH_Stroke_Scale.pdf",
"    </a>",
"    . Training and certification is available at",
"    <a class=\"external\" href=\"file://www.ninds.nih.gov/doctors/stroke_scale_training.htm\">",
"     www.ninds.nih.gov/doctors/stroke_scale_training.htm",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    The NIHSS is both reliable and valid, and has become a standard stroke impairment scale for use in both clinical trials and as part of clinical care in the United States [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/20-23\">",
"     20-23",
"    </a>",
"    ]. In addition, the baseline NIHSS score is predictive of long-term outcome after acute stroke [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/7\">",
"     7",
"    </a>",
"    ]. Both physician and nurse stroke providers can be trained to use the scale with similar levels of accuracy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/24\">",
"     24",
"    </a>",
"    ]. Reliability can be further improved through the use of standardized video training [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. The NIHSS has been validated for retrospective use based upon information available in the patient's medical record over a range of severities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/27-30\">",
"     27-30",
"    </a>",
"    ]. The NIHSS can also be assessed remotely and may be useful in telemedicine programs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/31\">",
"     31",
"    </a>",
"    ]. An important limitation of the NIHSS is that it does not capture all stroke-related impairments, particularly with infarction involving the vertebrobasilar circulation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/32,33\">",
"     32,33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H224175\">",
"    <span class=\"h2\">",
"     Pediatric National Institutes of Health Stroke Scale",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Pediatric National Institutes of Health Stroke Scale (PedNIHSS) was developed by modifying the adult NIHSS so that examination items and testing materials are age-appropriate (",
"    <a class=\"graphic graphic_table graphicRef76120 \" href=\"mobipreview.htm?42/5/43103\">",
"     table 4",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef83404 \" href=\"mobipreview.htm?16/17/16669\">",
"     figure 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef83405 \" href=\"mobipreview.htm?14/22/14695\">",
"     figure 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef83406 \" href=\"mobipreview.htm?11/49/12057\">",
"     figure 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/34\">",
"     34",
"    </a>",
"    ]. In a multicenter prospective cohort study of children with acute arterial ischemic stroke, the PedNIHSS showed good interrater reliability when employed by trained pediatric neurologists.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H224182\">",
"    <span class=\"h2\">",
"     European Stroke Scale",
"    </span>",
"    &nbsp;&mdash;&nbsp;The European Stroke Scale, available online at",
"    <a class=\"external\" href=\"file://www.strokecenter.org/trials/scales/European_Stroke_Scale.pdf\">",
"     www.strokecenter.org/trials/scales/European_Stroke_Scale.pdf",
"    </a>",
"    ,",
"    <strong>",
"    </strong>",
"    was designed to evaluate patients with stroke involving the territory of the middle cerebral artery. It is similar to the NIHSS and is also reliable and partially validated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H89237217\">",
"    <span class=\"h2\">",
"     Canadian Neurological Scale",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Canadian Neurological Scale (CNS)",
"    <strong>",
"    </strong>",
"    is simpler and more rapidly performed than the NIHSS, but does not capture many stroke-related impairments (",
"    <a class=\"graphic graphic_table graphicRef55644 \" href=\"mobipreview.htm?15/51/16189\">",
"     table 5",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/36,37\">",
"     36,37",
"    </a>",
"    ]. Like the NIHSS, the CNS has been validated for use retrospectively based on information available in the patient's medical record over a range of severities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/29,38\">",
"     29,38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24273537\">",
"    <span class=\"h1\">",
"     SPECIFIC NEUROLOGIC IMPAIRMENT SCALES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Scales to measure specific types of deficits have been developed and validated in patients with stroke.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Motor impairments (eg, Fugl-Meyer Assessment [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/39,40\">",
"       39,40",
"      </a>",
"      ], Motor Assessment Scale [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/41\">",
"       41",
"      </a>",
"      ], and Motricity Index [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/42,43\">",
"       42,43",
"      </a>",
"      ])",
"     </li>",
"     <li>",
"      Balance (eg, Berg Balance Scale [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/44\">",
"       44",
"      </a>",
"      ])",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Arm/hand",
"      </span>",
"      function (eg, Research Action Arm Test [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/45-48\">",
"       45-48",
"      </a>",
"      ])",
"     </li>",
"     <li>",
"      Mobility (eg, Rivermead Mobility Index [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/49\">",
"       49",
"      </a>",
"      ])",
"     </li>",
"     <li>",
"      Aphasia (eg, Frenchay Aphasia Screening Test [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/50,51\">",
"       50,51",
"      </a>",
"      ] and Porch Index of Communicative Ability [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/52\">",
"       52",
"      </a>",
"      ])",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These scales are most useful for research studies targeting specific types of deficits.",
"   </p>",
"   <p>",
"    In addition, depression commonly complicates the recovery of stroke patients, and several instruments are available to aid in its diagnosis and measurement, including the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Beck Depression Inventory (BDI) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/53\">",
"       53",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Center for Epidemiological Studies of Depression (CES-D) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/54\">",
"       54",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Hamilton Depression Scale [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/55\">",
"       55",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Personal Health Questionnaire (PHQ-9) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/56\">",
"       56",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Of these, aphasic patients and the elderly may have difficulty with the BDI, CES-D, and the PHQ-9. The Hamilton Depression Scale is observer rather than patient rated, but its inter-observer reliability may be limited. These depression rating scales have been used primarily in research settings. The PHQ-9 has been validated for use as a depression screening tool in general practice settings.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24273544\">",
"    <span class=\"h1\">",
"     DISABILITY SCALES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The two most frequently used stroke disability scales are the Barthel Index (BI) and the Functional Independence Measure (FIM). Both were similarly responsive to change in disability in one study [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/57\">",
"     57",
"    </a>",
"    ], while another report found that the FIM was more sensitive to change [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Instrumental activities of daily living (IADL) scales attempt to bridge the gap between disability and handicap. Combining basic scales such as the BI or FIM with IADL assessments may provide more comprehensive information than can be gleaned from either type of scale alone and can be a useful strategy for both clinical and research applications in stroke patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/59\">",
"     59",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24273552\">",
"    <span class=\"h2\">",
"     Barthel Index",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Barthel Index (BI) measures 10 basic aspects of self-care and physical dependency (",
"    <a class=\"graphic graphic_table graphicRef77371 \" href=\"mobipreview.htm?36/39/37501\">",
"     table 6",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/60-62\">",
"     60-62",
"    </a>",
"    ]. A normal score is 100, and lower scores indicate increasing disability; a BI &gt;60 corresponds to assisted independence, and a BI &lt;40 corresponds to severe dependency [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/61\">",
"     61",
"    </a>",
"    ]. Interrater reliability of the BI is considered good [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/63,64\">",
"     63,64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although not specifically designed as a stroke scale, the BI correlates moderately well with radiologic infarct size [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/65-68\">",
"     65-68",
"    </a>",
"    ]. In addition, the BI is frequently used as an outcome measure for stroke trials [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/62\">",
"     62",
"    </a>",
"    ], and limited evidence suggests that the BI can predict outcome after stroke [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/65,69,70\">",
"     65,69,70",
"    </a>",
"    ]. However, the predictive ability of the BI for outcome is reduced in the setting of acute stroke, particularly within the first 72 hours [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/32,71\">",
"     32,71",
"    </a>",
"    ]. In addition, the BI has significant limitations related to floor and ceiling effects, meaning that the BI is relatively insensitive to change in function at the extreme ends of the scale [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/4,58,62\">",
"     4,58,62",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H89237790\">",
"    <span class=\"h2\">",
"     Functional Independence Measure",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Functional Independence Measure (FIM) is a proprietary instrument that assesses patient disability in 13 aspects of motor function and five aspects of cognitive function [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/72-74\">",
"     72-74",
"    </a>",
"    ]. The FIM is widely used for monitoring functional improvement through the course of rehabilitation therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/75,76\">",
"     75,76",
"    </a>",
"    ]. It can be assessed by telephone as well as in-person [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/77\">",
"     77",
"    </a>",
"    ]. A systematic review concluded that the FIM may have some utility for predicting outcome after stroke, though high-quality evidence was limited [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/73\">",
"     73",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24273559\">",
"    <span class=\"h2\">",
"     Instrumental Activities of Daily Living",
"    </span>",
"    &nbsp;&mdash;&nbsp;As noted above, Instrumental Activities of Daily Living (IADL) scales attempt to bridge the gap between disability and handicap [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/78\">",
"     78",
"    </a>",
"    ]. They are intended to capture the patient's ability to live independently in the home and assess a variety of activities (cooking, home management, recreation, etc.). Several IADL scales are available, but the Frenchay Activities Index was specifically developed for use with stroke patients and is reliable [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/79-81\">",
"     79-81",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24273566\">",
"    <span class=\"h1\">",
"     HANDICAP SCALES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The main stroke handicap scales are the Rankin Scale and its derivatives, the modified Rankin Scale, the Rankin Focused Assessment, and the Oxford Handicap Scale [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/82-86\">",
"     82-86",
"    </a>",
"    ]. Of these, the modified Rankin Scale is the most widely used. The Craig Handicap Assessment and Reporting Technique (CHART) was specifically designed to assess handicap [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/87,88\">",
"     87,88",
"    </a>",
"    ], but has not been used as extensively as the modified Rankin Scale in the assessment of patients with stroke.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24273574\">",
"    <span class=\"h2\">",
"     Modified Rankin Scale",
"    </span>",
"    &nbsp;&mdash;&nbsp;The modified Rankin Scale (mRS) measures functional independence on a seven grade scale (",
"    <a class=\"graphic graphic_table graphicRef75411 \" href=\"mobipreview.htm?22/32/23051\">",
"     table 7",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/82,83\">",
"     82,83",
"    </a>",
"    ]. The mRS",
"    <strong>",
"    </strong>",
"    has been used as a measure of stroke-related handicap in many interventional trials and is frequently used as a global measure of the functional impact of stroke [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/23,89,90\">",
"     23,89,90",
"    </a>",
"    ]. In addition, the mRS score at 90 days after intravenous thrombolysis or endovascular interventions for acute ischemic stroke is a proposed &ldquo;core metric&rdquo; of comprehensive stroke centers in the United States [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A systematic review published in 2007 concluded that interrater reliability of the mRS was moderate and was improved with structured interview [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/91\">",
"     91",
"    </a>",
"    ], although a subsequent study found no significant difference between standard and structured mRS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/92\">",
"     92",
"    </a>",
"    ]. A systematic review published in 2009 found that the overall interrater reliability of the mRS was moderate but varied widely among included studies; the effect of structured interview was inconsistent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/93\">",
"     93",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The mRS score shows moderate correlation with the volume of cerebral infarction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/67,68,94\">",
"     67,68,94",
"    </a>",
"    ]. The mRS (",
"    <a class=\"graphic graphic_table graphicRef75411 \" href=\"mobipreview.htm?22/32/23051\">",
"     table 7",
"    </a>",
"    ) places particular emphasis on the patient's ability to walk. Because it is weighted towards physical function [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/89\">",
"     89",
"    </a>",
"    ], the results of the mRS correlate closely with scores on the Barthel Index [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/95-97\">",
"     95-97",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24273581\">",
"    <span class=\"h1\">",
"     QUALITY OF LIFE SCALES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Health-Related Quality of Life (HRQOL) reflects the physical, emotional, and social aspects of life that can be affected by acute or chronic disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/98\">",
"     98",
"    </a>",
"    ]. These types of assessments are generally used for research and not clinical purposes. Several generic scales have been used for the assessment of HRQOL in patients with stroke, including the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Sickness Impact Profile [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/99,100\">",
"       99,100",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Short Form 36 [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/101\">",
"       101",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Health Utilities Index [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/102-105\">",
"       102-105",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      EuroQol [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/106-108\">",
"       106-108",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The use of these HRQOL scales in patients with stroke is particularly challenging because the scales are generally lengthy, and because the disease itself can affect the patient's ability to respond, often necessitating obtaining responses from proxies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/109\">",
"     109",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The physical subscore of the Sickness Impact Profile correlates with stroke-related impairments as measured with the National Institutes of Health Stroke Scale and Canadian Neurologic Scale [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/96\">",
"     96",
"    </a>",
"    ]. Disability scores measured with the Barthel Index and handicap scores measured with the Rankin Scale explain only 33 percent of the variance in Sickness Impact Profile scores [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/110\">",
"     110",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One response to the difficulty of assessing quality of life in stroke patients with generic scales has been the development of stroke-specific HRQOL instruments, such as the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Stroke Impact Scale [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/111\">",
"       111",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Stroke-Specific Quality of Life Scale [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/112,113\">",
"       112,113",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Stroke-adapted version of the Sickness Impact Profile [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/114\">",
"       114",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The Stroke Impact Scale (SIS) was designed to measure changes in hand function, activities of daily living, mobility, emotion, communication, memory, thinking, and participation after stroke [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/111\">",
"     111",
"    </a>",
"    ]. The SIS is reliable, valid, and sensitive to change [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/111,115\">",
"     111,115",
"    </a>",
"    ]. A briefer version focused on physical functioning has also been developed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/116\">",
"     116",
"    </a>",
"    ]. In addition, the SIS has been evaluated for postal administration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/117\">",
"     117",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As with other HRQOL scales, a major limitation of the SIS is that assessment is made by self-report of the patient, posing an obstacle to its use in patients with aphasia or other cognitive impairments [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/32\">",
"     32",
"    </a>",
"    ]. This limitation can be partially addressed by use of a proxy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/35/33337/abstract/118\">",
"     118",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H232085\">",
"    <span class=\"h1\">",
"     ADDITIONAL STROKE SCALES",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of stroke scales specific to transient ischemic attack (TIA), intracerebral hemorrhage, and subarachnoid hemorrhage are discussed in separate topic reviews. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Scales to assess risk of stroke after TIA, such as the ABCD",
"      <sup>",
"       2",
"      </sup>",
"      score. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?10/11/10426?source=see_link&amp;anchor=H16#H16\">",
"       \"Initial evaluation and management of transient ischemic attack and minor stroke\", section on 'ABCD2 score'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The ICH score, intended to predict mortality after intracerebral hemorrhage. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?31/56/32650?source=see_link&amp;anchor=H9#H9\">",
"       \"Spontaneous intracerebral hemorrhage: Prognosis and treatment\", section on 'ICH score'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Grading systems used to classify patients with subarachnoid hemorrhage, including the Glasgow Coma Scale, the Hunt and Hess scale, the World Federation of Neurological Surgeons scale, the Fisher Scale, the Claassen Scale, and the Ogilvy and Carter Scale. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?0/25/406?source=see_link\">",
"       \"Subarachnoid hemorrhage grading scales\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24273596\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Stroke scales are useful for clinical and research purposes as aids to improve diagnostic accuracy, determine the suitability of specific treatments, monitor change in neurologic impairments, and measure outcome. No single stroke scale is available or appropriate for all purposes, and each available scale has its own inherent limitations. (See",
"      <a class=\"local\" href=\"#H24273480\">",
"       'Use of scales in the assessment of stroke'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The Cincinnati Prehospital Stroke Scale (CPSS) or the Face Arm Speech Test (FAST) are suggested for use by prehospital personnel because they are easy to learn and rapidly administered. (See",
"      <a class=\"local\" href=\"#H24273487\">",
"       'Stroke diagnostic scales'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The National Institutes of Health Stroke Scale (NIHSS) is a good choice as a measure of general stroke impairment and is useful for both clinical and research purposes. (See",
"      <a class=\"local\" href=\"#H24273530\">",
"       'National Institutes of Health Stroke Scale'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Despite their shortcomings, the Barthel Index and Rankin Scales are the most widely used measures of stroke-related disability and handicap, respectively. (See",
"      <a class=\"local\" href=\"#H24273552\">",
"       'Barthel Index'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H24273574\">",
"       'Modified Rankin Scale'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Health-Related Quality of Life (HRQOL) in patients with stroke may be best measured with a stroke-specific instrument such as the Stroke Impact Scale (SIS).",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/1\">",
"      Asplund K. Clinimetrics in stroke research. Stroke 1987; 18:528.",
"     </a>",
"    </li>",
"    <li>",
"     World Health Organization. International Classification of Functioning, Disability and Health (ICF). file://www.who.int/classifications/icf/en/ (Accessed on April 21, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/3\">",
"      Orgogozo JM. The concepts of impairment, disability and handicap. Cerebrovasc Dis 1994; 4 (Suppl 2):2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/4\">",
"      Duncan PW, Samsa GP, Weinberger M, et al. Health status of individuals with mild stroke. Stroke 1997; 28:740.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/5\">",
"      Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the NINDS t-PA Stroke Trial. Stroke 1997; 28:2119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/6\">",
"      Jauch EC, Cucchiara B, Adeoye O, et al. Part 11: adult stroke: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2010; 122:S818.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/7\">",
"      Adams HP Jr, Davis PH, Leira EC, et al. Baseline NIH Stroke Scale score strongly predicts outcome after stroke: A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology 1999; 53:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/8\">",
"      Kelly-Hayes M, Robertson JT, Broderick JP, et al. The American Heart Association Stroke Outcome Classification. Stroke 1998; 29:1274.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/9\">",
"      Lai SM, Duncan PW. Evaluation of the American Heart Association Stroke Outcome Classification. Stroke 1999; 30:1840.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/10\">",
"      Dawson J, Walters M. Development and validation of a stroke recognition tool. Lancet Neurol 2005; 4:691.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/11\">",
"      Harbison J, Hossain O, Jenkinson D, et al. Diagnostic accuracy of stroke referrals from primary care, emergency room physicians, and ambulance staff using the face arm speech test. Stroke 2003; 34:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/12\">",
"      Nor AM, McAllister C, Louw SJ, et al. Agreement between ambulance paramedic- and physician-recorded neurological signs with Face Arm Speech Test (FAST) in acute stroke patients. Stroke 2004; 35:1355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/13\">",
"      Kothari R, Hall K, Brott T, Broderick J. Early stroke recognition: developing an out-of-hospital NIH Stroke Scale. Acad Emerg Med 1997; 4:986.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/14\">",
"      Kothari RU, Pancioli A, Liu T, et al. Cincinnati Prehospital Stroke Scale: reproducibility and validity. Ann Emerg Med 1999; 33:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/15\">",
"      Goldstein LB, Simel DL. Is this patient having a stroke? JAMA 2005; 293:2391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/16\">",
"      Kidwell CS, Starkman S, Eckstein M, et al. Identifying stroke in the field. Prospective validation of the Los Angeles prehospital stroke screen (LAPSS). Stroke 2000; 31:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/17\">",
"      Nor AM, Davis J, Sen B, et al. The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument. Lancet Neurol 2005; 4:727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/18\">",
"      Whiteley WN, Wardlaw JM, Dennis MS, Sandercock PA. Clinical scores for the identification of stroke and transient ischaemic attack in the emergency department: a cross-sectional study. J Neurol Neurosurg Psychiatry 2011; 82:1006.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/19\">",
"      Bergs J, Sabbe M, Moons P. Prehospital stroke scales in a Belgian prehospital setting: a pilot study. Eur J Emerg Med 2010; 17:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/20\">",
"      Brott T, Adams HP Jr, Olinger CP, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989; 20:864.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/21\">",
"      Goldstein LB, Bertels C, Davis JN. Interrater reliability of the NIH stroke scale. Arch Neurol 1989; 46:660.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/22\">",
"      Wityk RJ, Pessin MS, Kaplan RF, Caplan LR. Serial assessment of acute stroke using the NIH Stroke Scale. Stroke 1994; 25:362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/23\">",
"      Leifer D, Bravata DM, Connors JJ 3rd, et al. Metrics for measuring quality of care in comprehensive stroke centers: detailed follow-up to Brain Attack Coalition comprehensive stroke center recommendations: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011; 42:849.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/24\">",
"      Goldstein LB, Samsa GP. Reliability of the National Institutes of Health Stroke Scale. Extension to non-neurologists in the context of a clinical trial. Stroke 1997; 28:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/25\">",
"      Lyden P, Brott T, Tilley B, et al. Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group. Stroke 1994; 25:2220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/26\">",
"      Albanese MA, Clarke WR, Adams HP Jr, Woolson RF. Ensuring reliability of outcome measures in multicenter clinical trials of treatments for acute ischemic stroke. The program developed for the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Stroke 1994; 25:1746.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/27\">",
"      Kasner SE, Chalela JA, Luciano JM, et al. Reliability and validity of estimating the NIH stroke scale score from medical records. Stroke 1999; 30:1534.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/28\">",
"      Williams LS, Yilmaz EY, Lopez-Yunez AM. Retrospective assessment of initial stroke severity with the NIH Stroke Scale. Stroke 2000; 31:858.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/29\">",
"      Bushnell CD, Johnston DC, Goldstein LB. Retrospective assessment of initial stroke severity: comparison of the NIH Stroke Scale and the Canadian Neurological Scale. Stroke 2001; 32:656.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/30\">",
"      Lindsell CJ, Alwell K, Moomaw CJ, et al. Validity of a retrospective National Institutes of Health Stroke Scale scoring methodology in patients with severe stroke. J Stroke Cerebrovasc Dis 2005; 14:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/31\">",
"      Wang S, Lee SB, Pardue C, et al. Remote evaluation of acute ischemic stroke: reliability of National Institutes of Health Stroke Scale via telestroke. Stroke 2003; 34:e188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/32\">",
"      Kasner SE. Clinical interpretation and use of stroke scales. Lancet Neurol 2006; 5:603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/33\">",
"      Martin-Schild S, Albright KC, Tanksley J, et al. Zero on the NIHSS does not equal the absence of stroke. Ann Emerg Med 2011; 57:42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/34\">",
"      Ichord RN, Bastian R, Abraham L, et al. Interrater reliability of the Pediatric National Institutes of Health Stroke Scale (PedNIHSS) in a multicenter study. Stroke 2011; 42:613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/35\">",
"      Hantson L, De Weerdt W, De Keyser J, et al. The European Stroke Scale. Stroke 1994; 25:2215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/36\">",
"      C&ocirc;t&eacute; R, Hachinski VC, Shurvell BL, et al. The Canadian Neurological Scale: a preliminary study in acute stroke. Stroke 1986; 17:731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/37\">",
"      C&ocirc;t&eacute; R, Battista RN, Wolfson C, et al. The Canadian Neurological Scale: validation and reliability assessment. Neurology 1989; 39:638.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/38\">",
"      Goldstein LB, Chilukuri V. Retrospective assessment of initial stroke severity with the Canadian Neurological Scale. Stroke 1997; 28:1181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/39\">",
"      Fugl-Meyer AR, J&auml;&auml;sk&ouml; L, Leyman I, et al. The post-stroke hemiplegic patient. 1. a method for evaluation of physical performance. Scand J Rehabil Med 1975; 7:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/40\">",
"      Duncan PW, Propst M, Nelson SG. Reliability of the Fugl-Meyer assessment of sensorimotor recovery following cerebrovascular accident. Phys Ther 1983; 63:1606.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/41\">",
"      Carr JH, Shepherd RB, Nordholm L, Lynne D. Investigation of a new motor assessment scale for stroke patients. Phys Ther 1985; 65:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/42\">",
"      Collin C, Wade D. Assessing motor impairment after stroke: a pilot reliability study. J Neurol Neurosurg Psychiatry 1990; 53:576.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/43\">",
"      Demeurisse G, Demol O, Robaye E. Motor evaluation in vascular hemiplegia. Eur Neurol 1980; 19:382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/44\">",
"      Berg KO, Maki BE, Williams JI, et al. Clinical and laboratory measures of postural balance in an elderly population. Arch Phys Med Rehabil 1992; 73:1073.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/45\">",
"      De Weerdt WJG, Harrison MA. Measuring recovery of arm-hand function in stroke patients: a comparison of the Brunnstom-Fugl-Meyer test and the Action Research Arm test. Physiother Can 1985; 37:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/46\">",
"      Heller A, Wade DT, Wood VA, et al. Arm function after stroke: measurement and recovery over the first three months. J Neurol Neurosurg Psychiatry 1987; 50:714.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/47\">",
"      Sunderland A, Tinson D, Bradley L, Hewer RL. Arm function after stroke. An evaluation of grip strength as a measure of recovery and a prognostic indicator. J Neurol Neurosurg Psychiatry 1989; 52:1267.",
"     </a>",
"    </li>",
"    <li>",
"     Sharpless JW. The Nine-Hole Peg Test of finger-hand coordination for the hemiplegic patient. In: Mossman's Problem Oriented Approach to Stroke Rehabilitation, 2nd edition, Charles C Thomas, Springfeld, IL 1982. p.470.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/49\">",
"      Wade DT, Collen FM, Robb GF, Warlow CP. Physiotherapy intervention late after stroke and mobility. BMJ 1992; 304:609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/50\">",
"      Salter K, Jutai J, Foley N, et al. Identification of aphasia post stroke: a review of screening assessment tools. Brain Inj 2006; 20:559.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/51\">",
"      Enderby PM, Wood VA, Wade DT, Hewer RL. The Frenchay Aphasia Screening Test: a short, simple test for aphasia appropriate for non-specialists. Int Rehabil Med 1987; 8:166.",
"     </a>",
"    </li>",
"    <li>",
"     Porch BE. The Porch Index of Communicative Ability. Administration, Scoring, and Interpretation, 3rd edition, Consulting Psychologists Press, Palo Alto 1981.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/53\">",
"      BECK AT, WARD CH, MENDELSON M, et al. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/54\">",
"      Radloff LS. The CES-D scale: a self-report depression scale for reserach in the general population. Appl Psychol Meas 1977; 1:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/55\">",
"      HAMILTON M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/56\">",
"      Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001; 16:606.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/57\">",
"      van der Putten JJ, Hobart JC, Freeman JA, Thompson AJ. Measuring change in disability after inpatient rehabilitation: comparison of the responsiveness of the Barthel index and the Functional Independence Measure. J Neurol Neurosurg Psychiatry 1999; 66:480.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/58\">",
"      Dromerick AW, Edwards DF, Diringer MN. Sensitivity to changes in disability after stroke: a comparison of four scales useful in clinical trials. J Rehabil Res Dev 2003; 40:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/59\">",
"      Lin JH, Lo SK, Chang YY, et al. Validation of comprehensive assessment of activities of daily living in stroke survivors. Kaohsiung J Med Sci 2004; 20:287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/60\">",
"      MAHONEY FI, BARTHEL DW. FUNCTIONAL EVALUATION: THE BARTHEL INDEX. Md State Med J 1965; 14:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/61\">",
"      Granger CV, Dewis LS, Peters NC, et al. Stroke rehabilitation: analysis of repeated Barthel index measures. Arch Phys Med Rehabil 1979; 60:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/62\">",
"      Quinn TJ, Langhorne P, Stott DJ. Barthel index for stroke trials: development, properties, and application. Stroke 2011; 42:1146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/63\">",
"      Shinar D, Gross CR, Bronstein KS, et al. Reliability of the activities of daily living scale and its use in telephone interview. Arch Phys Med Rehabil 1987; 68:723.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/64\">",
"      Wade DT, Collin C. The Barthel ADL Index: a standard measure of physical disability? Int Disabil Stud 1988; 10:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/65\">",
"      Hertanu JS, Demopoulos JT, Yang WC, et al. Stroke rehabilitation: correlation and prognostic value of computerized tomography and sequential functional assessments. Arch Phys Med Rehabil 1984; 65:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/66\">",
"      Saver JL, Johnston KC, Homer D, et al. Infarct volume as a surrogate or auxiliary outcome measure in ischemic stroke clinical trials. The RANTTAS Investigators. Stroke 1999; 30:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/67\">",
"      Schiemanck SK, Post MW, Witkamp TD, et al. Relationship between ischemic lesion volume and functional status in the 2nd week after middle cerebral artery stroke. Neurorehabil Neural Repair 2005; 19:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/68\">",
"      Schiemanck SK, Post MW, Kwakkel G, et al. Ischemic lesion volume correlates with long-term functional outcome and quality of life of middle cerebral artery stroke survivors. Restor Neurol Neurosci 2005; 23:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/69\">",
"      Huybrechts KF, Caro JJ. The Barthel Index and modified Rankin Scale as prognostic tools for long-term outcomes after stroke: a qualitative review of the literature. Curr Med Res Opin 2007; 23:1627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/70\">",
"      Pan SL, Wu SC, Lee TK, Chen TH. Reduction of disability after stroke is a more informative predictor of long-time survival than initial disability status. Disabil Rehabil 2007; 29:417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/71\">",
"      Kwakkel G, Veerbeek JM, Harmeling-van der Wel BC, et al. Diagnostic accuracy of the Barthel Index for measuring activities of daily living outcome after ischemic hemispheric stroke: does early poststroke timing of assessment matter? Stroke 2011; 42:342.",
"     </a>",
"    </li>",
"    <li>",
"     Uniform Data System for Medical Rehabilitation. The State Univeristy of New York at Buffalo. file://www.udsmr.org (Accessed on April 22, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/73\">",
"      Chumney D, Nollinger K, Shesko K, et al. Ability of Functional Independence Measure to accurately predict functional outcome of stroke-specific population: systematic review. J Rehabil Res Dev 2010; 47:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/74\">",
"      Granger CV, Hamilton BB, Keith RA, et al. Advances in functional assessment for medical rehabilitation. Top Geriatr Rehabil 1986; 1:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/75\">",
"      Kidd D, Stewart G, Baldry J, et al. The Functional Independence Measure: a comparative validity and reliability study. Disabil Rehabil 1995; 17:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/76\">",
"      Fiedler RC, Granger CV. Uniform data system for medical rehabilitation: report of first admissions for 1995. Am J Phys Med Rehabil 1997; 76:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/77\">",
"      Smith PM, Illig SB, Fiedler RC, et al. Intermodal agreement of follow-up telephone functional assessment using the Functional Independence Measure in patients with stroke. Arch Phys Med Rehabil 1996; 77:431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/78\">",
"      Chong DK. Measurement of instrumental activities of daily living in stroke. Stroke 1995; 26:1119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/79\">",
"      Schuling J, de Haan R, Limburg M, Groenier KH. The Frenchay Activities Index. Assessment of functional status in stroke patients. Stroke 1993; 24:1173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/80\">",
"      Tooth LR, McKenna KT, Smith M, O'Rourke P. Further evidence for the agreement between patients with stroke and their proxies on the Frenchay Activities Index. Clin Rehabil 2003; 17:656.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/81\">",
"      Post MW, de Witte LP. Good inter-rater reliability of the Frenchay Activities Index in stroke patients. Clin Rehabil 2003; 17:548.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/82\">",
"      RANKIN J. Cerebral vascular accidents in patients over the age of 60. II. Prognosis. Scott Med J 1957; 2:200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/83\">",
"      van Swieten JC, Koudstaal PJ, Visser MC, et al. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988; 19:604.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/84\">",
"      Bamford JM, Sandercock PA, Warlow CP, Slattery J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1989; 20:828.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/85\">",
"      New PW, Buchbinder R. Critical appraisal and review of the Rankin scale and its derivatives. Neuroepidemiology 2006; 26:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/86\">",
"      Saver JL, Filip B, Hamilton S, et al. Improving the reliability of stroke disability grading in clinical trials and clinical practice: the Rankin Focused Assessment (RFA). Stroke 2010; 41:992.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/87\">",
"      Whiteneck GG, Charlifue SW, Gerhart KA, et al. Quantifying handicap: a new measure of long-term rehabilitation outcomes. Arch Phys Med Rehabil 1992; 73:519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/88\">",
"      Segal ME, Schall RR. Assessing handicap of stroke survivors. A validation study of the Craig Handicap Assessment and Reporting Technique. Am J Phys Med Rehabil 1995; 74:276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/89\">",
"      de Haan R, Limburg M, Bossuyt P, et al. The clinical meaning of Rankin 'handicap' grades after stroke. Stroke 1995; 26:2027.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/90\">",
"      Lees KR, Bath PM, Schellinger PD, et al. Contemporary outcome measures in acute stroke research: choice of primary outcome measure. Stroke 2012; 43:1163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/91\">",
"      Banks JL, Marotta CA. Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis. Stroke 2007; 38:1091.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/92\">",
"      Quinn TJ, Dawson J, Walters MR, Lees KR. Exploring the reliability of the modified rankin scale. Stroke 2009; 40:762.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/93\">",
"      Quinn TJ, Dawson J, Walters MR, Lees KR. Reliability of the modified Rankin Scale: a systematic review. Stroke 2009; 40:3393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/94\">",
"      Lev MH, Segal AZ, Farkas J, et al. Utility of perfusion-weighted CT imaging in acute middle cerebral artery stroke treated with intra-arterial thrombolysis: prediction of final infarct volume and clinical outcome. Stroke 2001; 32:2021.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/95\">",
"      Wolfe CD, Taub NA, Woodrow EJ, Burney PG. Assessment of scales of disability and handicap for stroke patients. Stroke 1991; 22:1242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/96\">",
"      De Haan R, Horn J, Limburg M, et al. A comparison of five stroke scales with measures of disability, handicap, and quality of life. Stroke 1993; 24:1178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/97\">",
"      Burn JP. Reliability of the modified Rankin Scale. Stroke 1992; 23:438.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/98\">",
"      Williams LS. Health-related quality of life outcomes in stroke. Neuroepidemiology 1998; 17:116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/99\">",
"      Bergner M, Bobbitt RA, Carter WB, Gilson BS. The Sickness Impact Profile: development and final revision of a health status measure. Med Care 1981; 19:787.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/100\">",
"      Rothman ML, Hedrick S, Inui T. The Sickness Impact Profile as a measure of the health status of noncognitively impaired nursing home residents. Med Care 1989; 27:S157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/101\">",
"      Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/102\">",
"      Mathias SD, Bates MM, Pasta DJ, et al. Use of the Health Utilities Index with stroke patients and their caregivers. Stroke 1997; 28:1888.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/103\">",
"      Grootendorst P, Feeny D, Furlong W. Health Utilities Index Mark 3: evidence of construct validity for stroke and arthritis in a population health survey. Med Care 2000; 38:290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/104\">",
"      Rothman ML, Williams KHR. Validity of the Health Utilities Index in evaluating therapies for acute stroke [abstract]. Qual Life Res 1997; 6:710.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/105\">",
"      Goldstein LB, Lyden P, Mathias SD, et al. Telephone assessment of functioning and well-being following stroke: is it feasible? J Stroke Cerebrovasc Dis 2002; 11:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/106\">",
"      EuroQol--a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy 1990; 16:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/107\">",
"      Dorman PJ, Waddell F, Slattery J, et al. Is the EuroQol a valid measure of health-related quality of life after stroke? Stroke 1997; 28:1876.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/108\">",
"      Dorman P, Slattery J, Farrell B, et al. Qualitative comparison of the reliability of health status assessments with the EuroQol and SF-36 questionnaires after stroke. United Kingdom Collaborators in the International Stroke Trial. Stroke 1998; 29:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/109\">",
"      Sneeuw KC, Aaronson NK, de Haan RJ, Limburg M. Assessing quality of life after stroke. The value and limitations of proxy ratings. Stroke 1997; 28:1541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/110\">",
"      de Haan R, Limburg M. The relationship between impairment and functional health scales in the outcome of stroke. Cerebrovasc Dis 1994; 4 (Suppl 2):19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/111\">",
"      Duncan PW, Wallace D, Lai SM, et al. The stroke impact scale version 2.0. Evaluation of reliability, validity, and sensitivity to change. Stroke 1999; 30:2131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/112\">",
"      Williams LS, Weinberger M, Harris LE, et al. Development of a stroke-specific quality of life scale. Stroke 1999; 30:1362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/113\">",
"      Post MW, Boosman H, van Zandvoort MM, et al. Development and validation of a short version of the Stroke Specific Quality of Life Scale. J Neurol Neurosurg Psychiatry 2011; 82:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/114\">",
"      van Straten A, de Haan RJ, Limburg M, et al. A stroke-adapted 30-item version of the Sickness Impact Profile to assess quality of life (SA-SIP30). Stroke 1997; 28:2155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/115\">",
"      Lin KC, Fu T, Wu CY, et al. Psychometric comparisons of the Stroke Impact Scale 3.0 and Stroke-Specific Quality of Life Scale. Qual Life Res 2010; 19:435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/116\">",
"      Duncan PW, Lai SM, Bode RK, et al. Stroke Impact Scale-16: A brief assessment of physical function. Neurology 2003; 60:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/117\">",
"      Duncan PW, Reker DM, Horner RD, et al. Performance of a mail-administered version of a stroke-specific outcome measure, the Stroke Impact Scale. Clin Rehabil 2002; 16:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/35/33337/abstract/118\">",
"      Duncan PW, Lai SM, Tyler D, et al. Evaluation of proxy responses to the Stroke Impact Scale. Stroke 2002; 33:2593.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 14084 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-41.222.196.37-062E1C4994-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_35_33337=[""].join("\n");
var outline_f32_35_33337=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H24273596\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20964997\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24273480\">",
"      USE OF SCALES IN THE ASSESSMENT OF STROKE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24273487\">",
"      STROKE DIAGNOSTIC SCALES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24273494\">",
"      Face Arm Speech Test",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24273501\">",
"      Cincinnati Prehospital Stroke Scale",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24273508\">",
"      Los Angeles Prehospital Stroke Screen",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24273515\">",
"      Recognition of Stroke in the Emergency Room scale",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1412591\">",
"      Comparison studies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24273522\">",
"      STROKE IMPAIRMENT SCALES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24273530\">",
"      National Institutes of Health Stroke Scale",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H224175\">",
"      Pediatric National Institutes of Health Stroke Scale",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H224182\">",
"      European Stroke Scale",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H89237217\">",
"      Canadian Neurological Scale",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24273537\">",
"      SPECIFIC NEUROLOGIC IMPAIRMENT SCALES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24273544\">",
"      DISABILITY SCALES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24273552\">",
"      Barthel Index",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H89237790\">",
"      Functional Independence Measure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24273559\">",
"      Instrumental Activities of Daily Living",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24273566\">",
"      HANDICAP SCALES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24273574\">",
"      Modified Rankin Scale",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24273581\">",
"      QUALITY OF LIFE SCALES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H232085\">",
"      ADDITIONAL STROKE SCALES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24273596\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEURO/14084\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/14084|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?34/47/35583\" title=\"figure 1\">",
"      Face Arm Speech Test",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?16/17/16669\" title=\"figure 2\">",
"      Reading items figure for PedNIHSS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?14/22/14695\" title=\"figure 3\">",
"      Picture naming figure for PedNIHSS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?11/49/12057\" title=\"figure 4\">",
"      Cookie theft picture for NIHSS and PedNIHSS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/14084|Form\">",
"      <a href=\"#\" title=\"FORMS\">",
"       FORMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_form\" href=\"mobipreview.htm?13/4/13377\" title=\"form 1\">",
"      Los Angeles Prehospital Stroke Screen",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/14084|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?38/11/39099\" title=\"table 1\">",
"      Cincinnati Prehospital Stroke Scale",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?28/62/29676\" title=\"table 2\">",
"      Glasgow coma scale",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?39/33/40477\" title=\"table 3\">",
"      NIH Stroke Scale",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?42/5/43103\" title=\"table 4\">",
"      PedNIHSS items",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?15/51/16189\" title=\"table 5\">",
"      Canadian Neurological Scale",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?36/39/37501\" title=\"table 6\">",
"      Barthel Index",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?22/32/23051\" title=\"table 7\">",
"      Modified Rankin scale",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/63/9208?source=related_link\">",
"      Etiology and classification of stroke",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/11/10426?source=related_link\">",
"      Initial evaluation and management of transient ischemic attack and minor stroke",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/8/41098?source=related_link\">",
"      Reperfusion therapy for acute ischemic stroke",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/56/32650?source=related_link\">",
"      Spontaneous intracerebral hemorrhage: Prognosis and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/25/406?source=related_link\">",
"      Subarachnoid hemorrhage grading scales",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_35_33338="Superior sulcus PA";
var content_f32_35_33338=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F59658%7EPULM%2F79073%7EPULM%2F72484%7EPULM%2F68761%7EPULM%2F57052%7EPULM%2F78739%7EPULM%2F61004&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F59658%7EPULM%2F79073%7EPULM%2F72484%7EPULM%2F68761%7EPULM%2F57052%7EPULM%2F78739%7EPULM%2F61004&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Superior sulcus tumor",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 372px; height: 307px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEzAXQDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDNgj289CeKmkUHlGGB1BFXLi2b/WRofoBVb7LPL/qVKk4OT0oAZb3ckLb7dyrVqW+sxTALeJsboHUdfqKzryymhjaQqNvcrWQ8pLbUUk+goA6q4t0RGuPNJjzkEHI5wKi89rfAfk4x06n6VlaVNd2zDc7CHurY5x/Kt+OayvVxGQZe6dTQBRuNLiv8FBtlJ7Dr9fSsXVdOjtImSRQH+nXp0rr7h0sYTgASNxz2rHnZbuIrcYMn97FAHmV/aPE+dxHPQdKqmFiMdzxg13N5pDnJIBjIGHIrKls4rR8ou9yPvEcD6UAY9lp0hwzfIvqa3LdYIYwCS7juaoGbJYD5mx0z0pgkEfzOeT/CfWgDbSXgEBU/CnRNMXIYqUzlcVlwyysrLCo3HOGcZ57VYvLqaBECAAkdQKANRJQzFS3zdCM5qSRoZoSHRGjcFc45II5Ga56CVyyl1UsDkNjkfSrqX6KArqRz2JoA1fNSRlVSqqM5GOTUV6CIjg596rZDfdIweRTGkKxsh6dvagCMSAff5NQDy1u0cxxs/JUsPmB46enAqI5WZmBw3AOO45/xq7bzgSKXUMnQsRigDRhnnaP5sgAkfhVO5upYSyJtMBTbkHlD0xjvV0M4hwpRvdBj9KytStp5E+75cQGWJ4z/AJ4oA5icSrO7Bhweaks9ssgEyBl3A4NU9Qttt00luSQxzj3qaylLY3Lgg0Aek6XPG1km4ABRg1n6hcxiQMqAdsnmo9GuFksjHj7o4NQXYKjczAHGcdaAK0spmKbtwAOcdO3erEThAMDGT3HWqa54yuWwMkdK1LMhUDNjOOhoASSUkFAetAVgBnnvwalIBlJbjPQDp+FG1SFK547igCq0pRhgHBPpUDz7wQeAKvy20cwBbOfUVQubXZwGA9MigChdhXTaBg/zrDuECMRjH0rbjt5Wk2ngY5I6VXvbULLyOTznFAGKse1cgcH1FI7ZAOCR6Yq/JAQy/KTz2q/Y6QXy8inPYUAZmnaUJGLsDhj0Ndronhh7xgSgjtwepHJq/oei+SgmvQAmchD/AFrXl1D5BHajCdMenWgBUg03S42S1iWSY8F8AkfjUUxnu1zg1GkIw8s8oiiXJYvweKy9U8UYPlaWuADgzN1P0FAGjLYRwqskxAIORWFfaqLebNqdxwQVAGPY5xnj+tZdxdzXMytLM7MQTj+9+lPii3krGu4nvQAy4vL64B8yZgvYAU620yedhklVB6ngVtadpyqS1wM45wvoa3ra3UOXjDKrDBXsMZ6CgDK0rw/D/rJ2kZ3AGHHTGe1b1tp8FuQd/wB48D8KsLGFUZ60wowlUMrZOdvHWgCSKa3mUmPDhWKE7T1B560VFJaSbshwM9vSigBLTdxtfH4Z/CtRLNpVDRr83Ydqo6VpT4JM6LjvnIFdSJxDbBIFVnUce5oAy1sj5eJlwM85GQfauM18QWFwVt0POCD/AJ6126Xe47piYz1INc7rbtJdZhhTAGA5AOf0oA5hUnkQySgrGOSzA449BjmtWzWGyCzeY5LfdBGMdOgxn86rNPsOSd8vdiOn51UkkYghixPqe9AGr/ay3ZxccMThSOe+KmEIIVxyo6Y71z8EQlkA/E1tWr+VFFAhRUXCgAcBRjjFAFtJQyGNx+7/AJVl3mlfuhIoXy8ZYA5xW0sAKkrwo74qpcXcVv8Ae+76CgDkbi0G/MKAEfKWxzVJ9PPmASlPLI5BHNdDqIMyk2kZEndeuawJ/tJUh4yp759aAJo54II+CN4yBu9atLdW06DeQfXA4rAnt5GAYLkeoqLLQLuk4UDJ4oA6hDZRYy6AkZGaryJCz5iG4c8561yEt47vlsDsoFSwahLAwZWwO49aAOpWWSPsMdhinSzLKhyADUWl3MV5HuJAbuKsXEKgAgDFAGfLH3UkN2qEfvVaKRc5GCMdR6VZmbCnCM3cY64piEGQp8vmjqAeQDnr+VAGpZKETywSMDjPpSay/wDxLmG4jkf1qNCwA55x3rM1++8i2VWbJPfHegDFmchxg8k5zirEBVyAyevIFYkl/ucBSR361tabMryKX6Z7etAHQ6W3lKSqnAA49asyxqw8xgQ2Puk1Y062Bg80dAefypzQs27ZgHsSMigClbw7jhVxjr6VaXyYxs3Lv6HByaytX1RbdWRGAx3WuNn1Us7iPjcfmxxmgD0yJIf4plz6A81OkUZb5X474FeTw65cRuB2/lWtZeJLjKsh/OgD0ZbaPAww+nNVrq0D5wVYnjisew8RCUfvSof61abW7WQhXmUY7bT/AIUAZ93bTwN8gbGferFpG16myZDuA4bHIrUtGguCDFKjE8de3FaVrpzfaAyrgfxZ6Y+lAGJa6WUkChN/Oc+ldJZ2VvAoeUAyenYVcMKQjbEoBxjd61QmglkZiTxkYFAEsySTsNpBXsq9vwqtdmDSoHuJlJkPbHNQXt+tgoOcygn5RzjtmsC91KS4k3THcpyPTFAFHWtYm1CXDkrGDgLVO0DTSiKMFmPAUdasS2wlOVZST0B61reG7SK1vkM4xI6sqD1OP/rUAaWn6CuAZ13OR1HQda1To8EKbbZtr+p56fhUjStGCwBBNRwPI8m+VtqryT/9agCvHZzbtmVCLWrbqsQEfmANjoOcVSuLuNk+QZcHr+dJp8bM7MTkZ+UAYAFAGpDbTM+Qytk9+w9eldZpFut9pradkfaI8yQt3J7r+P8ASsfToiqggfeOOlXpJBaZeM4bHGOuaAJm8PwwHbeX8EUx5K4LY/EUVzM93KZP3jlmHBOOtFAEd1qMVqVgg5YcEgVTe9mdgWkGD05rMjXzXDEcZzVny1xgjOOR7UAWnuiWAJJ9TUJn3SN852kYqvkAMeAehFV3c9c/TFAC3BbeRj6VXMMkkkYXhOp7Zq0oLEcrzjqOtaFla5BI49z/ACoAqW1uqoAilmzy2MEfnViKzKqrvha1bO18pXDZYhuGI7df6/pWJr2rQQEx+YvHLc8+3HWgB9zqggYQ5zH0LE9KzLy6LMfLGR14FcvrHiGFJX8tCCOPmOc/hWCPFkscpKplTwecdPT86AO7hMxlywwucDJ5qy9stwv70hWHQ/41xUOuTz5dHJXAwT6+lXYdWuRt5+UetAGxcWbxErtwuevY1iaufKiVDjBq+2tyx7sAMmeVPORVHVHF9bF4Y8OPm20AYcwRwG2gnp71UuIVVhyQPrVpUEbMs25Cc/fHH5025tWJBx1PUdDQBo6A7AMASAMck9a6SOVpPkbBzxXP6PEYIyr8qea1Y3A6HJNAFqRcSNgcgdxwarxKQ+9o0EuAHZe+M4/z70NcANtwRxnd/SpEGXOMlcZoAtRkeXuI6Amua1qRJ97SAElTtXHAAzzW5dHy4vLyOetc1ekG4PHCrt5+lAHNNAm/cWIA7VuaXL8ybiMZrLmhBf8AGtnR7NnmjVVPUHmgD0jSdj6eAehIH6VS129Gn2myPAZhj6dOlW9y2emqCecZ+lcLr101zcktuI4AHtQBj6nK0r/NnnoAM1nRWzEFjwPcfzrSZ1bJHJGc4rIvLpi2FOAKAGSskbHHJ6Z7VGZGA4bjPSq74JLMSW7CpEBfAXr6DvQBYgnZWBViCK6nTt17Ejxhi3RlA5JrJsdOZyjTYUf3ccmu10B47WORIYVCkcsRk0AP02BbUqbgndx8nv7101nq8hbG8hBwAO1c/MVk3M4wfUcGpI3iUgglQBQB21ldR3C/vsFwcjtg4/WlvXaH/VYc5/KuHl1cLtFq/B53Zra0bUGuFEc33sZzQAy/gW8Ys2BKOhPQ1knTF3lWkVT3AB/wrp5lidiMDf1x61mX0JdOBh17igDONgF+709c1JptwthcKXy59CDjHSqc4kEh3MQfT0qv5jKxOTn3oA9Bsb601KMRZEUg6ZPBqrqls8YaOBH68nGc4rkPtLqVMZOT0IrotM1aS5jEN3ISc4V88j60ATWthKD8yHk8mtuyt3ReFDHrjPWqhEsaEMSwPOe2KdZzXCSfNjaWOMenagDpYv3Vtk4BA5HpWVc3LOcckNnBz0xVq+uRLCi8YPX3FZ8sa7PlwFXgbf4aAKEkEjtuSVlz1Cgf1oq0kQxgDGOoooAybVMYBGRn0qZ1G30OcU+NQVUHCkckUs4H45z0oAqzINiFhkjngetV0hLsCQT7gVNIwJPXk+tXrS3LrEMDJ/kaAI7O2Lygbfl7+9b1ta7iAB8oNFlbhX2AZxwf8/hTdd1MWVu0du+xxgswGTgYyB/KgDI8X67Fo9p5URD3DcEjoK8c1nWDPMzOQXbG4/Sp/Euttf38pByvQfSuZlVnOcFqAG3UzTSsc8EZqvs7txVmSNtiYHOcHikED4+6cH1oALSZ4Xypxkcjsa6KzuFljLJ17qT1PtXOeQ4OQBj606OSSPjINAHY2u6aTOPkA5JrobOKExlVQdPSuT8P38jSLG6CRG/iHWuzsolMbGMjbjI7UAYWqLGEwVUqTg5H8qqWlsnOw/IexORW3rFvG0SyOo3dSB/OsLzUU7IG6dc9aALl1bEJ8vJxxiksmd0/eKQw4NSAMkSHr6mqzXLQuXJ6ZoAsNndgjNX9L2scEkZ6g9qpLIs8ayDoehxxVq1/dA5I9B60AJrEUoO9MsAM8c1xupXWWPyEO1dxJOPm3HHFc1eQb5iQqn6igDCiUuoznd1x1rtvCtrzG8mSqDI4rDsbIlyxTOTxxxXUWmYYliTC7Tlzjr0oAm1+4DqAuBjpj0rkJEMxLOwRM9zWpfSSXJ3xZGSB8w6jPpWTq8ghidUPPXOOtAGFqN6kUnk2+dg+8fWs58zS/u0Y59OadkbgZBuJNWInZlGAFwcYAoAbFp7LuNzIFBOeeSPbirMRitiPJUk/3j1pjyYOMZz1pkcTlwdre3FAGpb3ZHXAXPAJzxXS6dMYrfcUGW7dgK57TLOSWeMMp2jknHStLUbvyY9sILZAAYjgf40Aa82pRwIBJhvTjrWbeaoJQFaHZGMYCn/Oa56W6lyGLZboST0pzzgAEsDQBrh45tphfYw6KeD/AIVt6dfS2co35wOxFcP55MhC9+9bdhqEiBEkG9R2Yf1oA9Mgdbq3JhID9g3ODVuaAbG+U7h1z6etchp95mUSWr9Oq9x7V3Gl3Ed5Blxh+h4oA5m9gDAnYPMQ9xWZPEVU8CuovrfyZyCO5yB3rEvI9shXHGc4oAyVUd8gj36VatZQj7stzj6UyeMKvcevFQW74mIZSACMH1oA7zRLgz2phk+YgZHt7VMf3DEseCePasfQ5zFImAcetb+poHkVVIxg5x/n3oAqpMWnJ2rjHynHNakbpLGxGS6jkf1rC2EEA8D2rRt2KLuRQZB0A4zQBfjTKAhOPc0UwXsKgCTG4ex/pRQBlAhMFYywz2H4Uy7BwT1OOPepiOcLxjtUEpZmwMcEcZ5A/wAigCtaRbnUAAgHk46+9dJZxhBnGDjjI7Vm6ZFiQA9SecCt1ck4UADpQBHdXC6dYtcNgHgD/H9a8y8SatJdRyrEe2Bjv0re8a3zz3AtYn2wpjcfWsCC2j8ssRu4znrQB52bCcyh2G0Z53f4VfWwjWPKZZu2T/Sta7twJ2yOR61WEkURwZPmUk7Rg5z70ARRwqUKsAAD27VnzWzpJtPI9a0Xvog7COMD6nNVLm4eRSQAOwNAFKWEAjAwahdBnkDdjAqJ7iQHDja3vUT3UnJBz9QKANPR7g2d4r44z+dek6fexy2xCBfMxu245ryqzuWk+VkVznjtXbaPqCIYwY9pwQSKAOhNvDOmJlZMqcsD/Sudt9Ni+2ZDEgNjFbMt2v2fKYdTnqD0rMmYW8guFyN36UAal1YKkYUAhQMAisTULXaCB83oRVy11XzkZJXBz0Y9vrUEsm4sHOfX2oAzYA4G0E7VPb61rlDiJw52/wB0DqarWlkFjBiY7eevXvWrLaN5aYA554oAp6gwRHKnk81jrIzMeATzWjqwcg5HJ44rFjEkcgG3j6UAbmnyKBhh+XerQmZvMI5HQZ71Qs97RkgcjvT3kaJd5UkHgZHWgClrF4bbaiffPYVy+pzzTqvU5PQCtS8/ezl2yxz2OKoag2JSoG0EA/TvQBnx28jP867VC/eJ7+mK0Y4IlKF1YnqTnis7fIJQpBK9QfX2q7FKdo8zCjHc5NAE6Ir/AHVC/QVMeCoyDJnG0CsybUECGOBev8RpbKZ1cSOuFbgUAb5UtbyRScpINuPal2C3tkgVVCBflA7CqyXGWVVUDPOfeoruaRTg4OB2oAR2QqWESsR2xUEsKNyPk9jTY7og/cz6+1TIyOMAkem7jNAFVYZI34GQep61qWURdzuHK+opIbcxtk5H1FasFvud9y49CBjNAEEE8sEwZCQwOciu88Naor7WOEkUfMM9RXC3Fu8bk4+X1qfTLyS2kiYHEnqRQB69qMImjDgckZBrl7+1iZ/NKL5igruxziul027S+0uORew+ZfSszUkWaEyKCAxIIIweP/1UAczMAjqCpO444GcdetV5IhuDBTxWhKDk9OvaoHTdnr0I4oAtaXKYiWbPA9K6q5ZngVsfNjjPWuWtIgSqksBuA4+ua6S5l2RgZ/rQBWtpSzbWGOa2LYIyncwx2wK55ZVZ/lJye4HWtaAYUZ7c0AWnnjiIURl+OTnFFZU7kyt94D6UUAWCpPGOD1qMgiT5lxjGD61IOOeAc9u9DDJHX04HNAF3TQFZz2IH5/5xWhK/k2c02doReDjNV7OI4iCr1PJp3iIkae8KZwcDigDzr5ryeSSTcSGznHWrQeCzgJc8kcIp/wA4qle6hHaFo4dpbuwHT6f41jtdhiWcZoAzvEVy8szFhsQnhV6H/GsUSEL6n1ra1ULKhZcsc9MVlG3yemAOmaAGO6lM9zTI5c5DEYx0qZbZWOOuOTjtURWPfjbwOKAK1zAsnzoeetZ0iFC2c4Hf1rcjWMrzgE9M1FcWQIIJxuHHoaAM2yJViyY45xW9aXIkbElyilhgDpisKOzdGOD6jv0pojlyV2Ej60Adzps2ZxHuJGecnp7/AJU3XLpo4XVTnD4/DmuZs7kopWXI5BzWkWMtvOM7hjIzQBPpFwky7H4J5z3rbggjdipz04z3+tclo0uy4YMvv9K6XTpd823OQfWgDesrZoyiMu0EDtUlyuyRvbjmlt53lu40JwR2Henasu2N2ycqCenWgDldTuiZ2weO1RQOHOecCqsyhJGAXG5ixHqTVzT4m3HeuRnsO1AGxp5z8gUkkc8Ut7bJIGRThV4Ax0q1ahYYwRyTziqc92JogynIbkfLjI/GgDE/sa480lJFdMcdjmsPUm2XzQzRHpw3+FdtbP8AP8xH0rK1zT1mRpcAHn8KAOUki3EfN5a5xz7017ZtpCMpB6/SmSGaPMTg/KfzqzaQlwzM3y+g60AZ0UCxtmTB74rShxJkD7oHAHammABd23g9O9XLWIpFvbhcZOBQA1GwcOuM+1RXKMEbLYHbPerS3kUbnzh5g7A1Wv8AUFmj2JAqr33YJ/lQBlGbDYUnnqRVqF2VRnp2FQRwBmBx19DV77MwC4P4GgC7p87mVUByvcHkAV08NxDLCfIHzqpBU/xEdhXM2tq0MbO+d36VYsmKy/N34GPWgDoJAQgOwDPVTVCS2Bl3xdM9Ksw3gI8uZ+vAP901IYSHXZ0J49KAOy8ETFYvIPIZa250ADIMYORjHeuV0zekqNbzGIjqwAP6Gurvol83zQvOMZ9qAOVvosKwztwCMrxj6VUABYfmBWxqUfzk4BB5/OsgxrvG8KW9SKANLTF/epkY71cvXVnKhgSB0qtYKOWPOPeppVVpHZVBfoT6+lAENvDlwCCBngVsMPLgOeMDAxVK1j/eIH3ZPoCcVPcvvYRqT8tADP8AdOBRTgnHFFAD8fP976e1WLSMsd27KkcCoWhHJYHjnjvVzT1UFFjAVQAAoHAHFAG7YRhYRgA5A71h+LrwW+kSOOGdsfT1/wAK6SJcR9egxx3rivG2+5tZYoxwvP0FAHlOoXbGX7pIz2qzZW5mAaRgq+h6mopl8qT5V3t3bFa2mwkLvlUL/EDmgBfspESr5Y4zliOe3esi7sXSZice3vW/LqEUalVOZGHUdM1gX80khOTtbtQBRSNoHbccAnge1RXMQJzFwxGc1BPcPuKvkjHI7ioULAN5bk5/h70ASeW4PQ5+mcU5vMGGIJxx0qr5jMxDHHPXpSESpyrEr3oAuSHLDAAYnmo53XcBt2kjqBUHnSr1bJ7d6ikuHD4k2k/SgCW+gzKxQ/If0rQ0PDI0L4x2z+NVLS6WO4BkjVlZuVY9c1LDcQteyiEGNcnAagCOYCG7cEndzxWjol6izqCTnNZ1/G5kMjKSG5zU+msEQbkBHY+lAHo2lKst08qkFAuR+NO1HH2d2Y9R0PaoPDDobORgWIYY/nUmphXt22nPtQBx8iFp3BzgnsK0bVcsAOv61EYwGYke1WLOPDDI6nNAGjMcxfKeMGs2SNmbPer0yg8qAR1B/TNVdjbsnI9qAFhUIuGJyf06VZVUER4BHTkVBGNvXJGPWpJAsa5ckYPAFAHK+J7VYXEwBG845HB+lY0UvkkqrDJNWPG+rJ9oSCEZK8tk1za3bOBuOM8UAdVI6NGrn7mOSegqC51JPkSLAVRzk1jby6FS5KjvUUSFnP6CgC6zrIzN2fpmnDa5GTyBzVdV+UZ6Dge9SxAs/wB3APFAGjaxrkc5PQAVtRWw8tWwCR1IHSsa2hKR7s4P8hVqC9kVlCE7R2PegDRlYBcIrH15xmjbGVGFKtkc1HFdxyEedGVJP3lq79nEiboSHj5wVOR3oArtGOOGOR96tDR7nY4jmbcnsOlQwxnYUZQUzjFTfZhFhouV7+1AHSWRaO4CjHBzXYz5aCNjjkVxeiYlQBslk6H1FdgmJLFDjBXPXigDNvwCgPBGO1Ybg5+Qd+c1vXnMXOeD0FYzqof5sBSepoAv2qAW5AblvTtTkXDY5wKEYIqqTkkdDSBuMj04zxQBowAJEWPYfjVdAGLcdRk8VMz7IFHdjt4GfU/h0pEHOcfpQAbccFlH4UVMoBHSigCTZl8Z+bvj1q9paOJh8o8sL1J5BqF0JbIx7VoabHsjIGdwwPXNAGnAuYCTjcBg4rjNbcTM8YBII/Ou8fEOnucc7c8VwV/PHbhp3XLk/Ip79KAOCu4YbKQtOGaTPCE4J+vpWLeXslxJlmIC8qg4C1Y16SQ3TO5y5Oc+tZCDLMe/6UAXhISoPUj2pXUzR7y6h14NZqTmOYZyRnkVbRzI3l4YgnBGKAKd3AWyyEH3xVZcwgOG6dq3BZTlWVYyO/Sqs2ltIgLlVIOOOn40AZk8IuYxJEBnuOlRxll+VgcDvVw2dzAu3YfUHsaZLBJhWKhWPXnrQBBKCp3Y/dnJ6VD9kkuDK8Sk7fmI6nFWVLkEbdyU4NKEYJ8mR6YNAGXKdkg8zO6nXkgZg0fy9/rWjcWj3UQLKA4HPGDWXdWzx3G0LwBzQBetLhm/dyHkjjNatpbiclcgcYwB1FY8EbOQQgBA5rotOVUAYg7ugB4oA7DR4Ra6EyA/XFVjIZEYdfrV5n2aNkkYbpmsWKXY3JGT6CgAeMEnj9KWGPa6nPWpyNxJ4ohALEYHqKAJ3UGNtxwR19qrSnHC4wKdNcYkxjg9RUIy8zjAwMdDz+VAD4wT8wIA7cVmeJNSh0y2eSTlgAFGepq/fanBYWJlIDjHGD1ryXxDqkuq6g0jn5AcKvYUAU55pLqd5pTudzk1NEPmRccDr7Uy1gYjJXgVes7Z23FuOeKAHqdqvgZyduKms0+X/aP6Vb+wMUXy1Leuav22izlRKyYTGckdaAMl1PQdR+tTWqlpQMY2jJrYSwt1uNtxIFAH3R1qULZqpSKPOT1oAoyjPyRksDyfakhkiiDEgsQMA9gatXNs2flJCkcAcDpVYWUgXJGfY8UALFM7MM5OeelaNtcyQsBExQeg6GqAjkDfMhX8OtW4tiEls5HagDpLPyZyQ/yztyADw1LGu2fBBGeoNYS3BLgnOeg4rftrpL1drEfakGc9Nw/xoA1bXbb3EbKAYyDuOelddbxFrUqTgEYJU84PpXF6bI7ThSnyk9f89672IDyUABOQOQOlAGTdp5Y2HdwQASetUBGp6gHJrU1FQrnHORmsxPmkPt2oAkZF+Q4yVOenNPVcn2PXtgU5eG9TjuKlWMs3LZUgjaR1oAkncCNV455xiozMglSHJ8xgSoweQOvPSmzhlH95gO/U/kKCdvzcgdc0AStEH5YSZ9mx/KiraIroCSc+xooA0Au8DnOK1dNiYhWA4BqhZqDuxgkVt2SYg4OM9xQAupYGnz5zgAGvJtbvftFyzZOzOFB9K9O8UzGPw9cMO+AR3xXjtwGllO08Z6npQBl61Ek0P3SG/nXNx20qvyCo6c9a7gqrQDETGQ4zkZP/ANasuS0CSsCAMc8+vrQBiJbAHDDD9jV6JVhw7nc2Mc9KttbKEJOBg4JJ4qlI1uqlVJJPIHXNAF2G7EyOjsVQ/nTpiBGAnz46Z71gyXiq/wA+fTil+3Ih4Vie3NAF5rhofkbBJ5I9qpu+5cuoKnofSpjqETkCWFRxnPemwmCWXaA2G5oAWG28tGkm+4QcAjr71nPOkkrIpyRyMVtXCrcQSW7sFhT+LH1rlbmF4pP3bZT2oA6PTJovIY7hIV4IK5A/Gq+oS27TKsKENJ1FO0KxjNurNOpDttdd20jr1z1qlqyS2krDIIJxkdKACJ1SQtHkoTjArftnQqpKAHjtXPaITJKFIznseldXbxIw/drj0xQBoGcyWKIwPHNVLmLb5ROevB/A1cSBxHt49RxUVyr7VBBOP/r0AOgUsM/ypWGHAP41LbI3k/7Q4GQeaijibd/CpJycD9aAKcq7nYnipI8Y3KeVHXuaZqDKgZd3OM8VSS4aK3kYjpx0oAx/FLmWzKQIAinoo4FcDFExlDYHWvRJXWRG+XI9R/Wube0HmnAAFACWlmWgVs9+a1NO0vzJFAYgHkk8YqZLeNbJCXw4/hXr2qjfao0UTJGNoHTPU0AbZ8nT1WSeQEA7sAZyPQUmqa9LfxD7NCIoEwNo9gOSa5D7dLO4WRuDjpVl7pokVVztXt60AWXuJHk3SDk+gqaOYhl3E5Hb1rLhuWMnOMelSg/PwSD/ADoA6GK53oCRuP8AKrO9ZXAOQD2rBtnlBBz16kVoW9yke0ld3PBJz+FAGusaJEJG+Yk4AzxUT2of7pEbd91TWc0cqgAgn+6eeakaLDksQO/NAGZLEYXBcc+9W4ZCkqTISpHINTyRpMhBTcAOKhntngMYYEqehxwKAOu0nErrOnKtzgHp2rsrdZpbC1kh2Ltf96G/u4PA984/WuB8Lv5QMBPU5GTmvRdHVl08ljuLOcAdhQBn6mMFTgnjg9fWsxFweeBWvfqSeRjn9Ky1+bcSpXBIwe/PWgBwOGUep44qzFGyPI7SFkOCAwGE+nH86iUDJPAx61akCqmWHUEUAQlC8xbOeMfSlRcvwMH6U+HGSuCMAHn3qRISx2glVXBB9een+fWgA3bMDaT9AKKtiIHoCffFFAGlZqTJwcc+lbVqoEZQHcRzg9s/5NZFlzJxjGcjHcVvRISVWgDM8VReZojoemMkAeleRSyB2McQwAcc17N4gUmLyezIR6147epFp8n2m4yNpIA7n6UATW9s4jUPtH95j2FZGp3CpC6QR+Yy9Hxxj0qK51aS5BVW2qegAqkZGwUHPfn1oAxrq8nZnDMST6/0rOk8xcMpOfWtK+tmaTcpG6qoQsNw4boQaAIGncgB1U46nFPRFnGQSCO1G18H5QMDrSRYLFSfyFADvIfcAM8dM1dghNttmk5J6Cm2cimORRjKch27e1QXM0+CIlDnHAzwTQA69eRJt5ZirciqEzytuIGPXFadqqyWDLc7fOX5jg8D2rNmvYyrkrhhkYHSgCnZ3Dw3alyx7FTWx4hAC7omOH5K+/tWfY+VcXiLt57k1tXsEbwhP4gM5NAGdoMgid2cA5GB685ruLGHzFBiKhPU1wnlmGZUQHnvXcabHIltHyeVBOKANQMRwp9cVXdMDYFOM5656nNXIoyqKXxznH0qG8ZQMDgH9aAGqVLYI4FSiDqwyB2FUUc+YOcVprnyjx2oAwNZC7gRwe+B1rCnvU2mEEnJ/lWnrJZAqszM2OSetcpcHF2MZwO9AFr9+yMo5Ufw461UfMeDtAY9RWtpNzG7hZ1yOxovIoJZODmQ8nB/pQBWswPKDOFAzjms7WbEyyhoFyvfHatSeDzVjwSWHAFaxi/s7SWi8vdNN1OOnSgDiVsxG4BbL49KJFUNsGfrUt956EmVcZ6HpVa33tyCDjrQBYghjIPHPc1PGkeR97ANSR8IFBUH1xStEwTnBU98YoAWJQFO08jirCxjA3Pn6+tVRA4XOcg0uHjVnlBCjrQBfj+QLl1ZR/drRtbsqwRwJISODnkVz8bEv8mTj1q/akbuMe/tQB0/ksI1eL5lPGR0xVu2h82Iow6HP0rF067a2ZRhWRvvDPUV1MSI8QktjuVhn0+uaAM9FFvOrqN6k546EV6lpoA0xGUcMSa89S381lUY4bI4/SvQNLDjR7dTkEDk49zxQBV1MsGjCrnJ5Pp15rLIJYnnk/StbUPuKT0B5rKYcg9c80AWYIwSMjk96SQ5lC445x35qWHC85/KmIA5bf07jpmgCWNM8YOatW8JVArEtgYLHqfeiCLIIHfrV+JclQqk7ienb3/z60ARBMDGD+VFS3NzBBKUZQxHfFFAFixVUaNVwFHAAH8hXRQKOD3NYlqi7lOOhz9K3YkKiMAk8dzQBk68MXKlz8qrk14d48mlbV5WB2xnG1favY/G0p2qkZAPUivKvGFt5tkLgJuKcHFAHGWspibJyynpk1YaRlGT0NZ+/Dqox9CKtWxeWTEiAA8GgCGeRnm5bhRVG6hZnDxjIPIFbzWMW/5mbBHbFK1rEiEDBGSAQKAOeit59udrc+3SrZsZjaiXyyvPKY5PvWjsEMRESYLMSQOPxNPXznG7n5O2eTQBzWy53eWqFVzjjilt2uILhVY7lVsEH0rX3RZdmUccj1zTP3aovA3ngHHOKAKV1DNNcssRGw/wVmTafdbtoANXpXdZsoCW7Eda29Cinub1Dcruh/vEc9Ov6UAY2kWrpcRCRMEfe9a0vNiE0iMdo7Ej3rodTs4on32qEqM9BXE66PKdTu6dvegDoLe0jaXei7sHG6uss4SwUgHAHOK4zw2xltWYt8xPT1Fd5pOEtw3J4GR6EigCO9c5AXAUDHNZlznIIJ6VbvJCLhhgkZPNU53yCo4GfTpQBHC2WU1sWjsYvmXaSCMZzWIhO8noPYVq28g2cdaAMbW4wSSOPw61yV1GnmMBy1dvqHzNtwMHrXM3NkGvH2HGTj6GgCC2RUUFRk+3aqup5tn888AjA+tbVrYyK6CRRx1OKzvGUSSwxCF12g4AFAFvw+32mCSR2JC84z3qV5GM2ZTkE9KyPD032SJQ7g7ztGK07nZAu8OHJPQdRQAana297CqrtAXr681Rt9GjSQh22gH1z+NVW1Bmn2hQu7+H1qKdp4/3hQoq9MigDZ/srcT5JB4zx/KqskMqt84wvfimWWqSxWjsqnzM4yR19P61ENQZiC43nsBQBOwO5Tj5fUjilCea20DP4VFFfk9FDH+6au2t4GXZsCnuRQAfZFg4ZAr46MKi+xAzb0XDEbfwrRit/MXc/wAwGTirKKBgkDHT0/CgDOiJj2oB9eK39A1AwTiOQ5jbgg1mvGsh+QYx3B6UQJJBKPMBwfSgDuI4wjKw7njiu6s1A08Yzx2ri/D5+0WwBXc8Y546iuz08s9vKoYZAGKAKV6mYyPSs0xgH5gPSta6XO7k/iKzynz55xn0oAcF2q2MfSpbaMbmJQZHQ+v+cmowAybRg59Kt28eT0znigC5aR9M9farskiQwFuC+Dj2ptjEuT8vUDjtjntVbxBOI1YAgEL+JAoA47Wb9vtzcjp6Z70Vw/iXXlg1WSMk8Dt+NFAHvliTLKdgHlg4B7t9Pat0HDjtWVagidVAwvGCK0wNoJLElV6+tAHB+MLkvcHgLwDj0OOa5CQG5jaFwSjcE9AK6vxIA8qyycKcge9c4u1pMAAc9qAOGudM+y3TcbmHAzTFhV8OC3HO3GDXZavZF1EsQBbB3ZH0rj7q5ELEDPU5oAlWWFMLMvQ4APf8Kasv8UsQT5iFC85HrWR5nmyY5IPHSrEV2kWUYb2A47jPpQBopLHMSGx74FVmureNdsYYHPJPeiC9BjkU2yAkduDVJ4JHUlEw2eR2oAhkj3SCSJGfd2HNPlXZOrzxgBQML+FW7a6lso8wBDIRgsRkD8KivbhryJy64cc7sYzQBRm1SNSwiihBPGSuSD9at2+qSwmNUIBxjgYFYMFq8t2qlGIDcitJ4DGMSIeD0oA6W51hIdKlfbG0ic4Oc1wd7qC6hNl1CZORjkVs62C+m8LtLjkVyqI0Rww+7yB60Ad/4PMMlvLGijgcMBXdWARrKNUxkDBOK818NMTbKYwFZyQVr0PRy0NlGH5fnnHuaAK93Bic4257g88d6zrpc7gSfYD8a0593mFm9euKpXC5JOMCgCg4PmYClsnn2rQ0+BoVmeSVpdxJAIACj0FUnAz06+tacTZtzgc8/jQBRu13vkZHHNYcm9b0eWoILYOewraufY8gc1ls3785Aye9AFiCVXaQS5HH3q5bVSt47iIgiIleD3rpZ42WLeoPK81jywbYmkiUDcTnigDlbPUDaXIjnjJAbIrbEyStu3HafasvWNOdiJVUkrzkd6ktLg+VGNoxigBb3Fpexkp1wRnvV86hHdxM0qHOMEjj8MVQ1KJ3gSRhl88A+lRW0f7rGfmPtkUAXmfy7fIAKt2PaoN8ecQ/KfU85q9Z7ZbZoJkByeG7iq7aYyqQzBUPGQefwoAlSzbyecknstS264/1udq9AOtLajyQMyZx3PerNw4uGXoGxxnpQBYhunBK/wAOOi9amMo37Gzknj296yy8keO46celSw3Ajc7wSxGOT0oA2gMKGwN3Qn+lXLIecQGUH0z3rItptzoGJkjz+R+tdNZxBkDw42n0oA6Hw9GbW5BJ+Q8ZxxXX2UZ3SKxIB4BHXvXOacqiNcnluRXS2CZVWIHTHrQBBOuZGGeRmqh4B+v6VoXKZY9ORVGRNqnpg+1AEC53k7srnjjHFadmNyBsED0IIrKhiMkrMzPtU4UA4H41uWCBkGxiVI4IPWgDStgFUnHQVyXjK8WC1lkboASSOwrsMbbdjj2+teS/FK8KWvlDHznGB6c0AeSalMbq9lmYnLsT+tFDLk9aKAPr+0jAZMcgLjBOfzq2UEVk4GSETGT1qtajBJUqrYHLc85q1fBhpk4AAJ6HOcjigDz/AF/MkOUHC5rn2cQxb3BUjIwcZNdRqEZWzlkZCwHPA5rzq9u3MrB85J+6ewoAt3uobkKkYU9QK46+iKykA7l6gmttLh35YA7hxVW7QSRbwn7xeFxxkUAYTT+QrJ14znHWoEkLfdIHfkVLOhZiXGG61DFtdWAQrgdqAJlkZl2+ZjcMZA57VPbkRud7E5GDiqADu2wMqge9F15kC+WqnnnIoA0Z7iC2iRY1LkdSafPeiTTmd40Vm4GABms6wsJ7nLOreWOrHoelTX9nLIFyU2A4AB6DHpQBf8LJJfXqxRQhmY7B7mt7XtPt7V3jYKGBKFh2pnh6OHTo90BbzgA3mdMdawvEmorNctFncxOSc9Tk8/WgBdb+yJp23YzMDnINcNeEDc4yATgYrrFjH2KZbh9rAcZ5rk7uSN5vLUYUUAdP4KtnkAdyNo5BPFel2FuVtUJPuCK47QI1sLGMFSSygkg967q0uQURETt1NAGfeE52/wAPrWdMcrn/ACa0b9+X2gcGslnIRuOnoM0AV2AV2IYnp8vYVo2hfymBx7VngOzgKVxnnPpWrEuIgMc+lAGdeId5x2rN2DzvX+la16McjgVkSSbZlAxk+vQ0AWpwPJCjJb37iq90ipCibQB3xVrDNsI6HpUV1hiASc4oAwkjKBxIMh+MY7ViT6fLa3WNreU/KsRXYQQJMR5YO5fWofESeVYMwBIIG4ehoA5yGUyROjxkqPSoY8GTATbx1pto5CuisAzDjPBNOQtuw6kOenFAD7uKWNI2B455H9as2jH7OXcF1P8AD71PZKLi2dJjgryKjtoxENkzErnsKAI5UxGpHCn1FPt9znDY2Dv1xUqKX3LEGCA5waWOyMhIjdRk9M9aABZPKiKEZU5Ge9Oji34CrvHY45FP+z5TYcnHoOlTwxPABgH6jmgB1sqxKTzz2rodDkYTAAfK3UeorKhhE6EYJYGtWzVYAqn7xyRgHj1oA75YxhXj2kEfKcVu6NloCSfmBzg1ymi3G8CGXkEYUnt/+uuv0j/WGMgYI6UASXC5y2OQewrNuCFBJXHf1rYmTlx0IHArKldVieRiNiqWLdsetAFcQhgy8jcMFgcVq6eBhgEZQp2gEYzjuPaqixYIIzjuK1LFNw5zQBZuzstD/ntXgPxFvhc6u0a8CLIx+Jr3DxRdrZ6TI+cYUn8e1fOuru093LLJ1ZifxoAxjgHvRSykB+ePwooA+wdOhAdiFGGOSD68f4Va1CMNaN8o3AYDY5A4/wAKj0kFmYnGAtO11xFpdw4HzBcdO9AHnGt3wed7ZH+QZH1yK84v1LTM25gx6E1v3VwzXL5JBPfpisvU23OSCFJwf05FAGduKFSVGB97NStcbtvyqB2A7VFFC5kJdP3fGc57+lalna2zGMjKknGTQBj3WnifdjK7jkM/8uBVNbKSEEFC3JDNj2rtJdPWO3eQ4IXBXB5IrHvpFUBZWCqPQdKAOanj8vaQFLHuKTQ7C5leMXL7uMOcYBPHb0reiEIjDzxZiXqw4z0qpNeiQM1mNkXQKB24oAlku4wwtok/dp1YcDp3rOZF8wlM7j696pzSmBT8xOfWnaRI95PgKdgP3u1AHSTTxjTgIxiRuBjuP84rjtTtWgvYnZ1csenpWv4kvjHCYbd+I+Cw74rl9Ne5uLvLsWABJz6YoAt65cqYPLDHnqDWFBEXvFYsBzxz1rb1BI7gvOBxvAI9KoJBmdfLB9enSgD0vShD9ggJQOSo4J4z610yDYFwiqx61yXhwMqQQv8AMqr1HauzeAxqPmz70AZV9y5+UevSs5k27iq43elbF4qq5wNynkVnTMMLjGT0HSgCmF2tjAzmtCCPbGAQQKp/8tDjtWjb4KD1FAGffDPrWFeRjzuDtHaugvlIUt271hXCf6RyetAFmJtgQvyo/SoZAWbI/Skm8x41SMnIOaaIw8iNIBgGgCzpEINwCcCpPEECG3VMEgnnFOslSG+QfeGegrVvIo5YvRjnFAHkmu2ht7gvGGAwCtVIL1lCs5zg9CK9A1nS0mVUCjdgfjXCaxYGxutrKNjdCKAJf7RlGXhIA7gVp2dx57LLjDAcg9K5tIljGCe/WtC2vTb5CoGUjnNAG7LMCVEZCnGT70AFkDofmX0/wqmkkcsayBST3XPQVetQpjEiHAB6YzmgC1abpD+8Ykt0wMYq2iEKApyexA7VWWGLLZYqo9vpV60uFQbTyvAHGCOtAF+1gKyDd165FaksCiMSIuefmAqk5YEGIgj27j/Oa09MkIH7wAqeuRQBPps/zqCB057c/Su80Vy6pIcbs4Y9vauD8jdJvQgDPTFdX4ZdixWRieRg0AdRdx4YnsaoGLax+XgVqzIdvAznnB4xVJwNwKjjvQBUaIBicHj1rQ00MVO9cc465/GoVXO7d9au2fykZHy4yTnpQBx/xLud0UdqOwy36141qibWPGO9en+KS1zdXEueXY47gda861mPaSTnOe1AHKTf6w4JxRTLv/XHg/gKKAPtDR1xATzVTxXKY9LcEZO3OPxq/puBAv5/WsTxi29vJ6DYSfyoA8YvCz35ii5YZySOO3er8lmJLMMqBnXkk+9MuAA7ADHPOBWhbNutgABjODnrigDCdHjYtKMBfz6U4X8cUShIlVj7c/8A1qsaiUQbWByBgVgsHuQNmNpPBHegC3FfzSsU3Fz346+g6UklnbtHmaUjnLBajjAtUMmcPjByaz7m782LyxkL3x3oAt3+yaNIID+7AwpqKTSjBbxhJV7ElumaYmlytZJOl39mYPu3eWHYr3AzwPrzU8vm3R3AMEHegDDvdPa5uPLA+Ucbu2f85qPU50sbYW1rkHGC2OScVuowcRxorgE43rjI9+QaoahAklyQ/KqMb+7fWgCimnSS6WXnBL7e9Z8UK2yS7MZxjJrr9Umih0PagBdvf0B/xrj/ACWnG58hfegCrbHzhKvJIPOOhp0bx282w5Ut3PNXdPSCzDySNuYnIArCuJDc6i2RtVmwCO1AHpnhBGmkDNjaq8ECusllk5AHGcn1zWJ4cRbSOKOIEhE5PU10UxDRkxqAepoAzpwWXnn3quLdnLAKxwOdvrU5LDJ+p6ZpEkClt2STz6etAGZJHIjFSgUdye9XrdeFx+dRSMXYE8nsMVdhGNpIHIxQBVvYwYycd881zVyxNzz2rq7tVMZ4xXL3EYM755Pf34oAhZthIz1H5VM0e+AZzgc8Gq7Z35wPerluGMeDyPSgBttCTNFJk4zWxJvaMFecDBqnGoMMZGOD1q5AGKcA7iMGgChPMyyBtuewzWbrGmw39oY3Xa7cqTzg1sTROASFJ9/WmWyjhZRkN2x0oA8kMUsNy8M68rx9KV0KDKnJPb0rsvG2iEf6XBhSOW47cda52GJJ7bIy0qYyB/OgCHT5CsgyCM10NmjxkSIQ2OdvrWEFKt7eord0vcQrDnHB96ALUbb282PIHcehqwJWWRd4B9yKrE/6SREuCR0x0q0myZ9h+8OaANCzndXU5+QnOAOtdBaiGd8RkjP3gD0rl4pBGEwCB0+ta1juDDaTk88dc0AdLFGUA5+Ve5rZ0oeVtdQRlskVgWcxm+SQlZfQd66SxBTaTkg9TQB2qZe1jbjOOap3AyQR09qtWKI1mJQCGYDJ+maibbJGGXJX16gigCGJQTyCM065lEVtKF6lSKegwQuOKz9XJEaoM4+maAOQ1qPO7jnGa4bXYflPAJr0bUI8hiQduK4jXIRsbBGQcGgDza9jK3DBeR9KKm1NSt2wDY46YooA+y7QqGROQ20HkEA59+lcp4snH9syJnIXAGPpXY2kIj8vc3GABk+n9a868TygaxcMzHlvX2oA4i8jMd/LHwWPOKljnWJiE5OMfSoPEFxi43QE5bkt3rPR2SVVCkk9v8aAHXStcO7FsAYPWqrYt498pxk/L6irsv8Ao8WXID9Cg5I71ms24vxkeh5xQBWaQSOfMGUPGKltdN3SBgmPTjircVrEkYlcHLYKgj3/AJVBeaiJlVVPzIMkdPxoA0rx1SwjRSFccM2OlZkbPcFYYRiELywHWqCzTzhoYizDOWOO1alqCkbLBHxjGcY5oAluGhs7IbmHmN93jnFczO4YgyEoBkknjHufStTVYXhdZ7lwW7KO1Zluou70JKm9CMEEZzn1oAuJjUDawwKz25Xc068p1PQ+vT86y71TNK8MUYjjTK57mt6/ZrW3gtoQscYXhUGAo54AHSq4gjks3kyC7GgDkruNowqEEEnJzUEMYWQMygkNitS6z54+VcKerfWs0vtu0xKu3OMY70Aen+FLmOUzAL864DZHeuomkCIoK9R0/pXOeBreN7qTcMyBQQe3euo1GAhjgDGM570AY0vzPkcAZqJ4wTnsKlmXDHA3HsCetAUnGeM9s0AUtmGyc1fTlABVaRcHgcVchTMa4BOD+VAFS6X5Dk9utYEyAznBOa6a7B8vp1zXOvgXDE4LA5FAFZ4h5mD19qkhBckDPTpUkp538YPtnrTkLIwKryaAFiTYQGU88/Sr8AKqPlPSoplOwNg/UVLDKrkKVKsAMH3oAmGOABn605bdJCQMqWFV5GCMCzd6edwKsvOPSgBmo2X2uwlhdQdo4J9K8mmik07VCjAgqf0r2tGUwMxU5PBHr71574407j7ZCp3Icke3FAGM8cV2DLGu05+6OKntUlhAaPoDyBWJpt6TcBJMgE4Oa6GxnWIljg80ALLMI5WDIQXHJH8qsAApuGcEcGtS6tIL3T/tSph1GDgdcVmwQMq5XGOuD3+lAFm3O5V3DPpxWog2rnke4qhbhWUblKkdvStKFEMSMkufm5U9aANbSg7soY9B17j8a7LTpN6iNvmI6nHBrjtNXYNpbkniun0dyJAxBO39KAO/0pt1uYyo4GPrQYlj+RBtQDaFAwFx6VU0OcMRgnr0zWvLH827HUdfWgDLPB6E8Y/Gs++XzBg89hWndgqWqjInHXGMnHrQBhSxgoRjp+lcnrdqgMjBPmY8nHXFdvOo5A6H1Fc3rUa7Dnpz2oA8k1WILeNkHnnhSf6UVsarCBevkUUAfWLRqFBZVYryM9j614z48u9moTRD7xbnH8q9jv5fKtSzdB2FeC+PZNurTMGOc85oAx72Rn2lBlgME46f55qjDMkfy+Zhicg9TRLcGS1bHDAZAB/+t9axTLIrK5faM5GR/SgDohJHIrL3OCD15qOC1fzkLjj0UVRs7lcLhh83qO9dd4fMbXMk1yjiJRwpHU+1AGNq7uFhjUZY+nY9hVe30cRKDdh2llI/djrj1J7V38mnWBQ3Mi4WTlQB3rE1BoI5cshAwAGz1HQUAZd4bTT1MVqgaboRjOKhhmjt7W4dwBIy4T2+tVJXQ3JeLBH93NZ+oXzPcuhGI1+UY74FAFKdpHk3yvxj5RWzp1pHZaO+pTdc7Ix6nFYEST3d0PKKFc/NuXJx6D0NanicP9htLNWztG7HvQBma1d+e8UjOVDDpnFSmXy9JAyVbflSe5rKmRd4E3SMYFWr+UNp9oBx6Ljn60AY+oSGRWX+L+IDtUdnDumhRgOBxT5V+ys8ksbMp+YALkkVb0tg2qQq+M5+97UAeseBbQxO8mPlKgc+2a6a/iAG4sSfb+tUvCjrIrLwypjB9+a1dTjOMgcZ5zQBykyYfOST6GhVBTg5YVbuIlDMQAarYIYjB+tAFZgTz2z0NXoVzGpXAPuM1WUbn4xjNaEcO7a29gApBQDHXvmgCteoGiY+o4rlZkXzsE9CcV3E8Si3cMrEfXp/nFcXdJtuTjpk0AQR5DDjAqzGAzZ75zSRDex3DjtUsKkSD5eh/CgC61uDGQCAf/1VWkj2uhHbrjvWhCOPrUcsbBht4Oc9O1AEMgDrk4BHBNTWsYdMDG4HPqTT5IRgsB054p9mT5gYKApAx7/XigB4tmVHLhm3cnJ4HtWVqFmJ7eRHHykYII611KpvTnqevFZOo2DrkoMDJOB0z6/zoA8LvoGstQmiKkbTwe/1rQspXWZXyCpxkVseO9MkS6FzEmQR8+B0PvXPWcqshQkBhyKAO60rUNkiKgBQjDL29+Kt38MUMxlVf3Tt8oxXG2d6yMqhe/B7iuvsL1Z4xDKevBDDjPrQA2GJJWUEZB/OtQWDBfMRP3fcd6rLazQy5Ze/GPSti3uZkj2AZBHcdRQBUguigCKRn3rchvFSIHcqgnkk1nTWyTMTEiiXHIHSmWqPE6iQbD6GgDv/AA7dGOVD145BNd9t3xKRjkda8u0OXLkqzAA9Mdetej6PMJ7Meqn86AK16nPPpiqMkQYjdjg5rYvY9y5BwM81mPGC7HHtnuaAM27iBAJzweMVgapGGBHJOeeK3/Jugs/2lomDSsY9gI2pjjPqaxtWgEsTI6o8LKQ4P+FAHmmrx4vWyxPFFWdTjxdFQANoxgHFFAH0L4jmKRwqpwMZNeGfEKbfdybRuHfAxXr3jS4VLsFj90bRzgdq8O8c3LtfbSCocDHtwKAMRbxRtCKdzcc9Ky7hmacpGFkI647CktbaaefbkhAfvY6/StsWcUallCnbwT6dOtACaZbPDIN67iORnpXa2Cm5QIF5GCeMDGRzXKWio0ihW4XnjpmtqDVDAyjeoDnBPp0oA63VpY4rSJYgWES9K5q/VHszOwLPg7c9uOtVhqxuZ9mCVUkEnmlu7yFkjj2HkEBc0Ac08flRjMmZCSSScYrPmE07hQhCEfLhetaN6gMbFiAznP0AqXSoQgeWXJjCkgfj2oAXSbELcQRtuicnJPtVfxIY4XjRXyfUjnpzWjpkvmTtcOuzHB9hWVrMZmnDs289PlHSgDMuLVbgK7blGfmJ6n3qXVYxG8aAggDAGMYxVq0nia4EMwHknCk1W1tg10xUMR2IoAzrj51Bcjd0/CpdIhIv0cDG08ZpqgBWM3yjuMdatWDmVowgwFJPHegD1rwfcRq8gVSdo5wM/pXRaozCPcY5GyQCF5xz1+lc54FhItXlAxlhya6e9OVKkZyenrxQBz10nDEEA+1USuTzgkdMc1oXq4LKP8MVTjBBc7VC9sfSgCERDeMkgA54rYgjwlZ6jMgPfGa04RmPaen86AIb4FbV+K5CTbJIxIGc9a7PUF3WrKfTmuQaIl9/ByfSgCCOIDjkd6uW0Ks+SOQMZPamQRneM9CcYNXEj8sdOc85oAIeZNjcg96JlMe1AjcccDgU+NFWcbjVqQ/u+nzd6AK8KCSMqwPTn0NLGRFjIBHvUkYImBxwRUrQrJ1HO6gC3bMHQdQahui4hAYAnufWi0UxOFK/KeOKnvISVBA7UAcd4lslntjuyuVOcDrXkdzbSWd46MvIP4V7hqKZ6/KcdCe9cJrVql3LvKLGxHP1FAHJQFxIuA2c11GkSrFOC/8AHjINZMNttUs2QegFXbcARo+4NjjFAHfWUzOBFLtZP4T04qe4i2sAGATHQ9/xrjRqTK6BflbODg1Z/tdog0ch4PPtQB00NzGkoVFIfOCavEi6ChyfMH8XpXI2mqAOwcAkccjpW/p00ksieWOozjFAGvayyWkJViM57fpXoHg64LwIM8NwePrXnersYLRC0beazYUdTjnn+ldN4IvB9iQgEYbH6mgDv54l2yEY8zHJ7nH/AOusmVGIBB6E5yK3ZEG0+4rJlXBYHtQBmuPkJ2hCeWA55+tYGqsqwEE9Aa6C+OxG57elcnrMpEUgZdoB4/2qAPPdXkH25+aKzNVmBvZCfX+tFAHs3xBugHwpwAMAHtjFeceIrb7TDDNLwf7vQsBzmu28RRC9ml3Z2oxGOuax5Fjk03KoGaL5QCOwOKAOGkKsgkiBUDgqO1SEj7PmMnJ+8DTp5EjlYlWiGRjPc1Qt2a+vvl+SPIPPTtQBfCyWmmNvTBk5UkcfnXPy6o73EaIfkzgmpPF2ovc3CQwY8uNQoI/Dp+VczHKY5Fw2WB5oA7F9TFrCUXqxyT6cf/rqS21aKWMEnOzge5rh0vWlkIdtvfNWFDeQZNyhFOMA80AdUkq3UgJOfm4xU2oXwsp47dwJABkgHGMjgVxseqyErDArEd9oyT7VZhsNW1K6JjtpmZ+NzDtQB0n9qA2zMThF6/XiqI1M3ZkSFdxdcKB2GOtXbLwLq80RWZkjRuNvJP410Oi/D6W2l3GVuUKgL24+lAHF2kkVvNFHOd8iuMgcY56VFqupNJdNsIAPOAOldt/wq+cTl1uiqDONwyaz5vho/nM0t2zbumwUAcJdaiCCCcIfWug8BW6XeoRIztjOenBFaknw3QOp88soGeRzW/4b8JPZ3ySK+MdMLQB6TpEKQ2uI1UdsAVJcByp28sM4z61JbqbaIAYzkZOPzpk8wIIVeSOPSgDIvY8jdjt6VSMJBzkYPNasoLFtw6dMVXWMsTgEDtQBTt4tsmBk8Z+tbEEAKhvTnvVdIwr8fnjNacKnOMZFAFO8i/0ds45BriZG/eMoGAPT1r0WeDfEykE5HrXnOoxeRcSK2eCe1ACqMsoXrxnircSHgc9c1UtWJ2nHPfNXUk/efLyB60ATRREnJGceoqRuWIoilkBbDFdwwcHqOv8AQUh5fGNuec0ASQfJHgrk96kMh+VuMjg1X8zE5B5LcD3prMGj3Jk8DI96ANG3mjkGxsBuu7pU0ZBQo4yQMD1rnRdgHHQj9KlN9swWPPUY9aAF1lUMRjkUkflmuJuSnnn5s5/nXYXM0t9FtiRiT7Vzc2gajcykJAVJIGW4xQBxd7M9nPzynXkZGPSo3vkDEwZKnqPSu4m+Hl7exsbidET2BJ/lVG08HR29w0W1mPTMg4OPwoA4uS+kkPyAg5zwKtKbmaRgYpeR6V6NF4btiFKxKjA8gDitKPSYkK4jHvgUAcDpmkX7p/qn59RXoOi6Vc6dZqzL82eMmuj0azVYWeRMbeBkDrUWrBhGWJOMkgZx2oAwPEl2s0MSK6+ZGCGwOmT/AImuj8F7WtY8PuYkbieMnnmuA1AMbsq5ZT1GK7rwE8SpGF+6zY545oA9aT/j1RlBJwB0rLvMI7EZrVtx/oqjoazdQQlmLL930oAwdR+ZuoKDn8a4XxZdLbpKxkIXHOTwOvNdvq52Rkk44ryLxvfHzmBPAoA47UbwSXJYZII4I9KKwL69BuGJbH40UAfSWoqFublVAA254rEt+WkB6HqPwoooA4TXvmSVTyByP0rD8+SGxPlNtyxBwOwNFFAGFduyk4NY90xVmIJBOKKKAIEY5HPWuu8N2cF1GBPHvGAcEn2oooA9F8NaTp8e4paQg5AyFrv9JsbWDb5UEa5HOBRRQBrxQRYPyLxinKqnOVHBOOKKKAG3Sjy1GBjpWVdqBHgDHP8AjRRQBmt0NWbPieMDpg/yoooA25VDREMAQRggjrVV0VU2qoAA4A4xRRQBGVAzgD/Iqufvgds0UUATRKplXIHT/GrgYqvB7j+dFFAFpeYiT1rhvESj7TJwOo7etFFAGNH94VNAx3daKKALSsSoyfWnTO2Op4/xoooArTMTjJz2psDHzQc9TRRQAixq87BhkelblpaW4UYiTr3Ge1FFAGnZxR7k+QVdliTzG+Ucf/WoooAmhVcAYGD1rI1O3h37vLXdjqBRRQBQhUGToOv+NSz/ACyqq8KM8CiigC+GJskJPOSaz9ZGNPJ7gE/jRRQBwt1y755weM9q7TwbxHb47P8A1oooA9isSfsqD2B/nVTUO9FFAHJa+cqwPSvDfGjHzXOecf40UUAeX6gx+0nntRRRQB//2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Patient with superior sulcus tumor at the right apex. Chest radiograph shows a right upper lobe nodule with adjacent apical cap.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Superior sulcus tumor",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 367px; height: 235px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCADrAW8DASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5WFFAo7UAGKKKKACiiigAooooAWiiigBKKKWgApKWigAopKWgAooooAKKKTtQAtJRRQAtFFFABRSUUALRQKQUALRSUtABRShGPY0uwjrxQA2inYA9TRtPYUANop+w5o8tuwoAZRTzE2OhppBHUUANpaKCKAEooooAWkoooAKD0opDQAvaigUUAFFFFABRRRQAUopKKACloqxZWc15KEgQsT+lAFenrG7HAUmuy0zwpGqh7xyz/wB1eldDb6NawgbIUIHfFAHmQs5iP9W/5UhtpFPzKR+FerixhZfljGPYUyXSYJs/u1P1FAHk5jI6g/jSbPwr0y68KxSKdqYPXI6VhyeE5vtBVGGKAOP8s5pRC56Ln6V6RZ+Co4o99028+gFasHh+yjGFhQY9RQB5GbeUD7jflUZVl+8CK9im0K3aM4jUE+1cprOghcmMUAcNRVq7tvJcgkVXIHrmgBKKdsOMgGkC0ANpafsq5Y6dLdtiKMt70AUKVVLHCgmti60S7tk3tFlfVRmqC5V8EEGgBYbRmxuHJ7VoW+mSOflQAU2yS5ZxsiZ8egzXVab520ebbspoAx4NAZ8l2AqT/hHY+hYmurijAXPfqaR1+Xjj0oA4+fww4GYXBPoahTQZg2H7dcV2bcEZNNCjpjigDnotCiUDeTjvVlNJgVT+74HqK1ivzHPT2p4XgnGPagDK/s2Bk5iXHuKrzaPaSAgJg+orbCbs5B68U1owOw47CgDjb/QSmWtm3f7J61hyRtG5VwQR2Ir0l48nAX9KxtV02O7QsMLKOh9aAOMpO1TXELwSFJFII9ahoAWkoooAKDR9aQ0AFLSCloAKKSl9KAEFLR9KKAAUtAFamhaY2o3IXpGPvNQAmjaTNqU4VBtjH3mI4r0XSdKisYUSJVIxye596l0+zhs4UjiUADuB1q8rADrzQA5IcDnGD/hUnl4U46+1IJAFJ4xUiSLjBPB9aAGoChweKsogIyRx61VuDgZQ5A96t6c/mrg5BHagC9BEGQ8c/lVVosXI+UZz1IrWs0DHkc9Kzipk1AKAeGoAsXEP7nlT06VWhGCVbr6EVpXakp0Pp1rPQEyjpj60APli/dnjAx+FcH4rvEtkby3y3TjpXp8WnLejyySR3A7VjeI/BfnW0jQWEjAc5KE/0oA8ImczSHI5Patrw/4f+1nzrlSsYPCnjNX7vwzLbTM3kPhOeRxUUV1fECKFOnA4oAvapYWNpbHzVVMdAoGTXFTACQheBmtrVrDUDIDcZMjDIBptr4emkhMs7bMDOO5oAxUXJA9a6LTr06SRDOisrjcGHamaPo5kucXNvKy9scVs6pocUi4jyjAcZNAHQWM9tJpYuvlkZyVRT7Y5NUrbQk1S5KyQJz0OMfyrltNnudHukjuIy9uHyfT3xXtXgO88PajqMMV0/wBlL8K5PBPoRigB2gfB67urMy6bIA4GTHMcZ+hArE1vw1quh3Bj1KykiI4DMp2n6HGDX1JpWnyaZayNaSLLHjKheSa4jxF8TtMtLl7HV9PWZQcOjLu/QigD52lJQgEDFQuzYzgYr6H/AOEK8J+OdPe90JmsrggnagwoPPVSP5V49438E6x4WuGW7iMlufuTICVPX2/SgDlFBJ7c1KUGME1WS5Cf6xcY74p32pN3Xk9KALOBjpz7dqAoI65NVhOCOuAaVnbDYOD6UATKADyfpilfYuTjrWcblmbkEEdqbHdsygtgZOKALbNv5XuKrNGAM5wKmVwUGG47U35cdM/WgDB1vTftEZeMEyKO3euTdCrFSCD716KwHOSPoBXMeJLNVIuIxgE4OB3oA540U4imkUAJRRmg0AFHailoASlopaAEpcUU9Rn6UACDLAevFej6DbJaWMaKmGIBY45rztcK3B/Gum0LXTDEIJctj7pz0FAHbpIM+nsRUnmg9RzWfa30c2CoYE+9WGZj02496AJZpkjQs/3Ryayo76S7lLY/cjovrT7qB7hsMcJ7UqwCFMR/MB7UASR3ZeXyjkD0pllrY07VDBKSQ3vUczhiD92RRXG6/efaNQ3x8MnHB70AfQFnPENKuL5ifLUAkY781i6TfRTtLdNgRgnn/CuUg1K9PgeOOEM7XLYYAc4Ga6TwZ4avbq1SIIdn3nY9vagDUlvY5wscZJJ6cV2Hh34eapq1uJRGsEZ582UFRj245rv/AIefD7SLG1ivrpEvLkjjzFBVPoPWvQru3E9pJAp2BkKgr2oA858OeGvDfh+4VJ52v7zOG3/cU+w/xzXf3OnWt5YmARqkTDgKAK8wufBGuWeuxzW0iTWxk3li3TnvXo+paxY6Fpi3GsXkNvGijczHv7CgDzXxx8ObMWLtZFw7nn5c/wBK8N8QeHm0aQ4gwynrtxXp/jP466bcXw0/QkeVe8zDGenQGvOtZ1/7cGadyxJzyxPNAHMm1EiLLcgs4PBNSx2rSPlBtXrzSxTefNyxbA6EVcN2sQCspAoAWGNWaMmLDqMemaluNPS5wSNp9qwr/wARWdnLh3IOfcmn2fiqzu5AgmIPuMUAQ3WmlXZHUN9Bmsi70mSJvNtWaOYHOM8V2UF0kkhKoGz3rM1NoRNiUiPnqKAOu+H/AMV/EPhq1S21CIXtovRXO0r9CBXVvrnw98c6iJdRmk0fVX48tz8jnJ5zjH6ivLLe1jaPesgKnpletclr2nyC8Yo27PTHSgD7T8DeFrTQ3M9jeCaFhhdpBB/EVt+MtNh1fQLq3liWQlCVBGecV8V+CvFWseH5PKt76e29MHKn8DxXpEfxh8TWmBLPFdxkYJ2Af0oA4DxXps1hqNxEEMZRiNpHvXHXF8SxSZcEGvQdV19fEmoyzyxmKRuSvv8AlXH+INEkeUyRDk9QKAKtrqSL8pXLE9zXQQyK6jLDPsK4aa3uLNxvQj0OOK6zw5MtxbAtkkcNQBauLcseOtIYQoLdccYxWkVXA4OKY6jbmgDIQmPpnZ1xinrMAOtWWQHPAFZepzLa2jybeRwM0AJd36QruZ+fSsPUNUW4iaPblT39KyriaSeQs7ZJqPGBk0AI3HFJmnj5hSMAF96AGUhFLRQAnaigU4CgBKUe9Lz04ooAcduKQEVNb20lwrNGv3Rk1AQRQAdTTkYowZe1C+9PVN3SgDt/DF4l1bgMMSJ1roSPl6c4zXE+CZAuqiJjgSDA+tejyWZSMlGI4PH4UAYU0zJ0AwKzrnV/JB3L+VWtRlWNiDJz09a5TUpZnY/3emaAJtS1sSxssSYc8Zqt4d0HU9fvxBpdlcXcnUiGNnx9cDitHwF4M1PxlrsNhp6bVdvnmcHYg7kmvuf4f+FNE8E6HFYaYsIKAebMQoeRueWI69aAOX8GfCTTbLQLI3KOL1YhlZAMIx68YrttH8Iafp0JjEatzksOC31roRICOMH8aHmVepAFACW8MdvEIoUCIvQAU92KoSo3N2GcZrjviZ43g8F+FrrVZUEroNsUZON7noM1414U/aXiu9Tit9f01bS3c4NxFIXCemVxnFAHp3jPU/FsV3izNtaWgPXIJYfU/wBK8++IHhtrLwZdeJvEV805XaUhXLBwxAHPbrXtNjq2mazBHNGYLmJhlW4YVH4u8P2Pirw1caLdYS0mAB2KMrggjH5UAfBy6fqV9Zz61ZwMtuZPLYhfu9K6HRkKWI+1K8kh9RxXvXi7wlpvgHwTqqicPpiwbIYpCN7SErg8DrnvXzo3ifydpiiUr6kUAboEiKSkBx6gVla9qLWVozzd+FXoSauweJ/MhQ7E+mBXF+NNS+3XqICPkHIA45oA5+eVppGkc5YmiJzG4ZTyKZRQB6N4dvnezD56DHFYetao8l2cFsZ55qfwtcboDCTtyo6Vr6jplhHYvcZDye59qAF0vWoRY7XwWA7msjUdXicuyuMisC7IRSyNkHiswkk0AbF3rDSqAqgY74q1pOtyRsFmbcnYZ6VztAoA9an0prjSoNUs1Ox+GAzjNVo5ZQux1/Sr3wcvm13T7jwvPLskBM9q5PA67gf0Ndxq3w+1SyiV5ZI3Q/xr/WgDzOeKKYESoCfUiqlraLaXLNETg8Edq7O+8J3C7mLg1zd9Z3EEvGGx1GaAJgRzjIzUbNg96hil52sCG71G8q8dc9KAHPLjk8DPeuc8T3O5EjXPXJrTv5T5R2Mdw9q5u7ErZ8w5Gc80AVmgJtRL+GKqg8YNWHmfyynaqx60AOT7wpZAC+BRAoaVQxwCetS3cSxzbV5FAFdlIOKTFXraya4J2navvV+PTDDkrIhJ4IKBv5igDGijZ8bVJq7Fp08nSMj68Vv6XaobKBgnzbVOR34FbSpHgAp9e1AHHf2LdlSyx5ArPubWaBv3kbJ9RXoiFcAL0J6VR1Sz8+2kVG5x0NAHP+HrGWWWOQtth3Ddgdqj12G1TVZ4rYkRjoan0LUGgbyNpJzgduaztamWa9d0G32oApTLskIzkDvUkM3lxOuAS3rTEwxGQas2+nXF1KvkxEK3c8AfjQBo+Greaa/iMKtuByCte46Po91Lp4luIpCcenX9KtfAr4fadIUudV1C0EgwRCrAk9O9fR76HpC6d9nKRCILkkEDI9c0AfI8/he81LUWhsYI3kzjYpyxqpq3gO902E3Gu2txaWUZ+Z3QjcfReOTX0bcy+HPDkssmhWiT6jggSuM7T6jivKfinrmq6p4Nvb/Uc/6POiAEcc7u2PagDya+8ZX9jby2ehA6XYsNp8vG+Qe7Yz+Vc/aeJr+C5Ej3czZOSC55rGv7t7mYs7ZqrmgD33TvjdLbaasLSSF88j9PSqmofGWZ1cxSSFgRtGTjFeG5ozQB6L8QvidqHjDR7TTrldkUEnmEg/eOCB29zXnu+mZpM0AbWheI9U0K7S4027lhkQ5G08flXofhD4wa9YXU7TX0pEoyATkA8dsV5FTo3KOGHUGgD6I8d+LdI8aWmiXN1dPFfLG0N1FsJDdMMDjHPNcL4q0nTodN82ylOByAe1cta6nC9uqyAh1HykVW1XWZLm3FuCdmeeetAFK3u2hcnPQcZrPdi7lm5YnNKSRkU2gBKKKKALkDugjZGII710un6VNfWLNLOeeQK5Y5VE9MVv6b4gWzsfKdMsOhHegDF1OF7aYwueVNUqsX1w13cyTMMFjVegApaQUUAdB4E1s+HvFFjqXO2JjuHqCCP617Gvxolunlt5wot2ztGBx6c4r58pwYg5BoA+jLXXI9UAMdyC55IY9RXEajqxTVZ0dPlDdjXm9lqlzaSB4pCD061Zg1N5bhnlOWY5zmgD0HfDc4ZGxxyKr39m6WheNizegrK0tXmG9GJJ6+1dBZ3BIMMwBAHagDj7mV4ywckAdQayLu5Dng10fii38mRtq/Keua46YgtgLgUAI7ZplOjjLthRk1oWOlTXHIG0dMmgDOUYIParzReaysFIUgCtpdAgVBvcls0ktsIGEbH9yRgEfw0AXLeNYoVVUUAAc4qORgxKoBnuarwMwbynfAXoezCrDZXhQv5UAaGjon9n22R1jXn8BWiiliMFD74rN0jAsbY5H+qXj8BWlv/dkbTgUAEsAYZztbtUVyPLt2xhn6AY71MCrqMMM+lNVJBk8E54B5oAx9N0dbUkuokuH6gjhf/r1dk0eykX95bgsepUc1p2lmdu6RvmPJIrWjtUMfv69KAPP9V8MmBPOsQ7oDyhGSKnsUuraw868iYWoO1X29/Su9ZAoAQA8elLcyMuhajYPGktvcINyOo+Vsghl9D70AeXPfSQ3Je3ncDORg4r2b4U+IbqW80lbyeSaLdjazE9QRXg94jwTGJ/4T+dd54Qu2trKB4tymIhgfQ0Ae6eO7iOx1JvKYxpuycc15j8UPGNre+FLzS4G+dpEbB9s5P61oeO/FC6hbrcBiFZMsR2OOa8G1O6a6u5ZGYnce9AFSik/CigBaKSigAooo70AFHeiigBwYgcUnJrQs9Lluh8vy+5HFatt4akAJldSP9nmgDAiiDjltvvTorKaZ9sQDn2rZutHkiBUK2OoOKm0O1lhmLEEEd8UAY40e+z/qGH1FSro9wvMijjtXo/2SS4tkIhYHHXFZ19pkqJyBkY+UUAcPfweUEVhg1mscmt7xKpikVTxgdMVgCgAooooAKKBRQAfWiiigApQcHIpKBQB6F8PYn1G1v8KWaBAwx7nFdPpOlzNMWnjIH0zXJ/DrXl0q0urVY1L3LBmc9QFzgf1r17wmyapb7g2UxyQMAGgDz7xlYqZgMA5XpXmF5GUuGTvXp3i6587WrhYSGjj+QEe1ef3K7tTYFc84wKALWgaezsJX4VT+ddLHDtAAxgH0xUWlxCK3Vdu1j1q/Eoxjbk+tAFWQYGduOarSxB0IbvxV6TGPl5x7VXmchOe/egDFvbcouwNx1HtVK2uSCY5DyK2mhEzHdziuf1iPyrnjA+lAG7otyjWkCbgCFUYP0rYb5YyxIOBnrXE6RLHvRJAw9CK6cq8kOyNyc9M+lAGrpZE8JmkxjOF461oQxlXJLDH9Kx7VjbQRRSKVI9O9btsCw++AMdMUASADI2Kv1q9borZ5HPrVRothXOcnuOK0LFd+OGZc4PtQA5ICV3EYx+OajvYi0TR4Xc4wKvSOIhhwTjnpis+4nEnqB9elAHnXirSls5UKksG6962/DyZ0mMJ6dD1qbxHbRsIycnccdataCii28tODnHNAGPcRmaKaGUsM5Arzy7ha3uZInHzKxFeuX2mSiYsox71w/jWweKaO428Y2sQKAOVooooAKKPwooAKKB0ooAKltYzLOiqCTnoKi+laWgQtLfYT7wXIoA6zTYGigAK49sVqxRM4PpjOMVBaRkgbsfh61fh+Xk7cj64FADNPt/tdwlskbvJIwRVAzya9Dm8GWGgWax6iyyXWAzxr1UnBwTirvwY0CPUfESX80amKzXziTz8+RtH5/wAq3vG2g3Vv5suQ0jsWLYz1/CgDk4bnTVjERj2AdGUcZqjc2Vvf3ZgjMapIMRnplqr3GlTfYGdBlx6c496gtEnjnR5WYSIA3zDuPT0oA8r8dQyQX/lSKQVJH1rlq9f+MunI1vaakoH+kqDwOhAAI/OvIKAA0d6WkoAKKO1FABR60UUAFFLRQBe0dHlvEjj+83Fe7adPH4X8ClHcHULviJfQcZavGfCMBfUVlYfu4+WPtXdvPNrF+N6nagCqD0VRQBiRqyljySTk5rFEbPqTYQ8HNdnqtsttKAAApUdKy7W2HmvIQDk/jQBNbIylMcqetXI8HIxjmmxoFfaykLVmK0aRVEanPrQBUuNgzu9KpNbz3RURJgD2ruNM8F3166/uJHdwD0PA/Ku5tfBEGnMqXDoZyoARe36UAeFTRNDxIpQjqCMVzmoQtdXhESkgV7r4t8Ii4guJh8s0WDjpkV5ZJbCFiEUA9DQBT0KG2W2hZo4yxUElhXQRbMfcXHtWHo5zZwDbn5F7e1ayQ55AwfSgCd2hYhejDpmtnw1E+oTmBELSD05rGjh/eDcnBPXrX1p8MPB+gWPhaxngtYJ57iJZJJ3UFixAyPYCgDxKTw7KcxOq7x/AeDR/wjeo22JDZzNCR1UHH8q+jF8I6auofazHubshA2/jW55EDQmPyozFjGzaMflQB8i3wEeQdxY/w1nvGSMkDBHbtXqfxm8MLpF0l7YoBbT5+UH7p4zXkvm+uV7etAFTULUSxqysMJ2qPS1dXKqBtJAGByMn+VWbht8LIfpwKgtcQoCAcg9c0Aek6z4TuIdMtrqBPNRlBbbzt69a4bx54fdNNI8vekiZ3AZwa9f8Cq17okckE4uDt/1XcGofGuk7NIuSYT5rEFTjGOuRQB8a3ELQSsjjkHFRV6d4m8JNOks0cDJIMnI6GvN7i3lt5GSVGUg45FAEIooooAKKKWgBK3PCUTSalkZwFIzj6VQ0uz+2z+XuKjGTxXceH9Lt7VcIx3HkkmgDYitkC5OePQcU5oDKMKSfQCtFEUJtBBP5Vf0DTXu9QjSPnnnjpQB7f8HNNTSfAckroGnnfeQBzjAwK3rmP+2NLmcJtdD91uc1xvhTWL+xWfTLQM4jYg5HA/Srup+KrjSkkSRLdWcDoehoAyptJjDkpG23kMW/wqZvBa31k1xH8rryo7tXPJ4mnnn3rcx8nkMoFdBF4qv0jRdPRJCo+6uDz6jIoA83+JulY8EzwXSsLi3nDRAjG4Hhh+gr50njMchUjGK+k/GUepatqTtrW9V2lySBwuOwrwPxTbpFqDNCpWFvu560AYtFFFABSe9LSUAFFFLQAlKBk4FFTW0TyyqsaM7E4AUZJNAHYeBbJ7y7S2gQvJIwUADqa9htfCP9kBkndHvW+8g5CDrg8da0PgT4CXRdPOtaqB9vPMUL/wDLLrycjrXV+Kb63022urt9guHGAeM545oA8R8UyK986hdqrwAB6Vl2hKkAgkfTFTavMbi8MirxUdrG8hBC5OelAFyFWdlGzaD04r074YeEDqspu7xf9FibIHPzNxx06VleC/CVxqt1b+cm2DIyema+hdH0+LTdPitoI1REXHyigCNbe0022LJGkaKOSBXP2FvY3OqG4jfzJGbdg1sa9azX1s0VvgN2LdKzNB0H+z28+6l8yf8A2TwKAK+v6LDMnnRx+YpGGUc596+UvEu2PU5YlaWFkdh+6Yqfxr658T61a6NpVxdXMgVVUkDuTXx5qu67vZZ5dxZ2LY+tAEeg5azh6jCj+Vb8MeQCAc+ua43QJSY0XcOBjk11NvLjADLzQBpxKEwSpLZ656V3fg7xnqmiIEtrmRYeuw8j8jXn8JBxyoPTk1oRMVHyulAH0L4b+LEM7pFq0O0HgzJ2+oxXp1heW99bJcWkqywuMhlr41hnnXaEkQLnJr1r4MeKZl8QLpUufKnQ8E9GGOaAPSfilpn9o+FZcKWeIhhgZOM818s31lcRXTKgOM9NtfaN3AlzbSQyDKOpU184eMtANvfTpGpyp6kc0AeYvBMAdzIx9xiomVu+TgdjkVs3dtJDnehAPt1ql5QKc7gT6jINAF3w74h1LQJxNp8zREdVGMH8DXfw/Ee11uD7NqwME5GN5GVJ/KvLjEOduePY1SuYSWO4n24oA7HWBLDfOhf5ZDlePlI+tcd4n8PQTMZDGo385B61Ztru5toljMq+WDwj/wD6q0IbxJk2zQfLnscigDy7UPDqwq7xl8L2rJjtE3FX37vavXptEGoS5hUKOuAcH8qoXXhSGVigDBx/dWgDy42PzYWZMe+c1GbOQylI8Sf7ua9NbwXBErMZCTjow/8ArVS/4R8QZc7Dj+7QBzmj6W9tKJJHAb0HNdTbqynK4b9MUx7Pai7Rhh2zUtpayyzJGpGScDJFAEiTOknLBW7/ADV6X4FFpBIt5qE7LbqAWAIBzxjFclB4dnlkJUqwXBJYEA0k88kCFHCZ3cKmcCgD0vw7rDfbZniZRHLOM4HUZ6Vn/EotB4gnwrxpJggNwBkA8VzfhXUJhMGEP7pCNxIzj3rrPGmoW/iQQwRZFxGgw5GA3QUAeY6hevbsNjfQivVvgVo8mvG4nvFk+yRn768AnjivKbjRry51MQxKzlmCgDnrX1v8NtBHhzwhYWJULNsDy8fxkDNAFvUPDOkXNsyXFlAcJt3lBux9a+TfFvh3SNa1K9061mEZR2+zTcYJ98DpX1T4w8U6botnJHeSBndduwE5wa+YdS0iyOsxf2BcOzSNzDO3P/ATgc0AeGa1pV3o99Ja30TI6kgHHDD1B7iqFfQXjPwjezwva6pbYk27o2KnjjqDivFdU0G6sLh422kLk5zjpQBj0lKRjrRQAUUU5ELsAo5oAlsrWS7nWKIZZq9q+F/hSKG5QrbiW7J4kZN2z6elcn4E8MzTSJNKqxRE8s5xXtMHizRfB9jJDp8aXN9jHmHnB/KgDtbvULfw7okk+ouI4xwkfRnNeDeLPElxr99JI4YRg/KgOABVXxF4hvtcvXnupmkLE7Rs4HtV3w34S1TVlVliKRHkvIpUYoAxreF3IAX5mPrXoHgfwnNdXKTzQgxBhwe9dt4F+G1nE6yXZ889c4+XP4163Y6fa2UKxW8KIqjAwAKAMvRdEjtFjIVUVQMBRitmbIjOAT9KkyM4FNY0Acz4w16Hw14fuNQnAyoAVT1ZjwBXzfqHxB1y/u3k/tCdSx4WM7VA+gr1r9oyzubjwWstsxCQTK0mPQ8fzNfNllCUG5mYn86ANvV9Yu70f6VcSSHnq2awpCN+4DJ6dakuWI29Rk9KqSTeW3zAfjQBzGm3BiJA+tdlpVwssaHcAfeuBicxurDsa6HTJvKlRwSUbqPSgDtkcgAnDD1xmrMT5AA4z7Csu0n3lcAMuPoc1fikO75UIz3IzigC/bOVOVY5/Kuu8C3wtPEmnXM0qr5Uyk+4yK42JpAMgqfqoFWre6aGZJCVBUggjHY0AfasTrJGjocqwBBHeuF+I2iTXLx3VokrsRhwgyBjHNVvhd4yh1bTLaylcCeNQoJHUAdPrXo2MjHFAHzVrWhEqWw+71xXJXVnJHIECO/rX0Z4+8Pvc2nn2KDePvJ/hXj8kM63JiljwT1BoA4OeN9xXYAfXFVpbeZsbFAHfHevT28OpNCZGjIbswGa5nUdKEEjKyknPGCcUAcPcQFGw8WD1zg02I7XGGIHupFdzbaWt3blRHH5g7M2T+FV7nwy3ymGaNJG/gcHn6dqAM2wd7YLKrHPqDWrfeRfRK9vMTKvLL3xULaHdWcebqBgO0gGVP49KotHHCS2ACO4XmgCGZ8EgmQnoQTxVC5w4Py4UdB61qLB58Z4cH16GpLPw9qF24S1tpJ/92Isf5UActKpIO2PIHcLTbYGOYMwwwORxXcy+Ebq0ANzNFFzjy+rD8BWdf6IVUtHFJJjqQOlAFm01eWLQ5Yg+GZuGxyaq6I1vNdB9Wkzbk4O1SW/WqEtxFDDsDfd7dajtZQ+47yPcigDrpzZafFMLIs1vIcI4GD+PpWTbXhgv0lQsT93HPNZ4uApC+aWHqOlPjuYsgFsvngdKAPavhhotnc3S6hcN88R+WPjrwcmjx98SBY30tpaTFcfLuVsc8e1cromtLpXh+4l2t5p4HzevevMNRvpb28ctGeuc460AdXc+Llu7gtqEEtzGTywfn9RVa+e0a6ttS0uX5NwO1m+ZWGODXOMwWLL8HpgkY/lUFtcT27Fo2DLnOzYCD+lAHuet/Eeym8Lyz3WnI8kK5AJ3AN2xx9a8t1i+8JeMNAukkd9N1UcxfJlCeeCQOlUtQ1abUdPS2mgjjgB6JgZPqfXrXPvpyRO7Ruq5HQHFAHH3/hqe3zsmt5eeDG+f061kS6fdRMA0L5PTA612zwQFcyqMg9Q3NVriTyZD5aucLkHtQBgWPh6/ugCIGVT3YYrqNJ0Oy0t1kv5A8w58tRn9cVBb63MyJHI0jr6AcVoRujgE/LnuRmgDQu9RubrCQDyoFGAqiqYLBeTnn+LvTGjb7qlnJ7Lya9N+GvhKzRl1DxFH5mPmhtWHU8/e46UAaPwq+Gsmo7db12FltlGYIGBBfryRjpXrWrXGjeGrAPdLEcD5YiBz9BWD4h+IEel2pito49wAA28BK8S8S+KLjVbppZVZy3c96APX1+KFnC22Gz2Kv8AdAArZ074iW98mUgwc45f/wCtXzYL52HKvWhY63c2/ESjj1oA+m9A8RJqN9JbsymTGRt9K6Njxj1rw34Ta+lzrapLtEzjbk8+le35JFAHLfEmOOfwbqccoypi/XIxXyjcxLB8oGcV9GfG7Vks/DZtgwEk7AYzjgEV833jh8YOQfRqAM27JJySMD2zWNefvG5bH0FaN3uH8WR7jmsm5kAPXJoAwhWtos/zGJvwzWSOlPhkMciuOxoA9EsflRcOOlaKhSBliT9cVzukXazRDGCcdK3IJFwuI8/QUAaMG0YIGTVuMgrgIGHXpWckgXkI303VbiYEghTk++aAN7w3qs2m3gaJXVg2RjgZr6e8L6zNqng6G9TBuAm04Ockda+SUYmTcvPGRg17R8L9ent/Cd6gcny5ARjsCBntQB2XibxdFLoTrBII7vdtaM9/xryOfWfKfcUZnbknNZHiy+mbVJ1jkYRk9jiualZw3+sbaePvUAdyPGd5DhI5FWEcFSuePar1hqNtrkgiulRJH4V1GB+PFebfvGPDgZ4+9VjTZZLK6jmjkKurZwW60AenS6Beaa7AwjeD8pC9vwqPzkDtHqEHlyEYD7doNdT4d8W2WqWsEcpQXCjBRufyPcVr3MOj6zAYL2AxkHAYHBHv0zQBg2UU/wDZpFuT5eclcBgR79qYbGKUGX+xbR26ZMYA+vFZOs2WqeD5WaGQT6dJwrY3YB7E4rIl8deXCU2PGcY3A8UAd5p1rDDGZotFsYpAephHP50ajdXuGRpY7eCRSCI1CgfkK8muPF2qhWSJxycgnBrH1LV9UvVIubiR0PI2sBQB2up3Om2s+XvUkbPrn+lZGq+LLKC1eHTYMSOuHkLAn8BivP7m2uS+Uyc9mNP0/TTDI8pIy3Yc4oAdbN9omLTHA67QMZq6kUeTtP4ZqlsKSAuXGO+BThcBGwWGz/dA/pQBM4c5JywX+4MGsz7Q7zA+UQynjeK0GuEVGbzflHcc/wBKybuZWR5IWLPnHQ8UAdrrt3HdeDLGGNws8shDgYAOMVyUMKWqnzZM49WwKtXivZ2WlrcAqCpcFsjOcc1japI77/KTfnpgZoA2EIeIyDyzxx/FSwk+SrMME+vArNsbvy7ZVcktjoDWlbt5iA7ACR0I5NAC5Y/xRYHoTVe4dPKYcM3sKtkEY3fLjsDUJG5ThsjuAKAMgxjycMrDPI5xVP7CNxYeYQfetyVYwp+VvxA5qBgOzFW9KAKUNsI1XywB7soNaFjaSXLYjyx6EgEAU2FfnAdsjvgYrXS7S2iKxFgO/tQBt6JZ21g+91iaf+8wzj6cV1MuvR2NruSZWcj7qrzXmz3s0jAecee1KJn6yfN9TjFAFrxBqkmoTMz7T6AZrGJcEcIPXmrU8qsMlm5PSqrNjnk/hmgBylsdRntgUjkj5mzzxzTBMT94j24p/mZG3AoA6H4fztB4q0/ysAmZR9ckV9TPcpHGC7bcjvXzd8LbZbrxVYbkXzEcOc4PTmvZPGUzxyo6MAI4iTz3oA8c+NOuJqniLykbdDCNq49a83mK7MDgj0q3rEhudQnndyWZiea57Ub9ICVzlsdKAIb6RQfvMR71h3U3YHJoubp5Tk8CqTHJ5oAUxkRK5IwxIAzzxj/GnpDut3l3rlCAU5zg9+mMfjUbMWwTjgAdMdKekm2J0wDvxk+mKAN7RbKRWSSG7UD5y4A7Im9sevHHbmt9r6O2u1tpzyYopkb1V0Vxn0OGFcXHqEkUqyQokbBDHwP4Su0jHuCfzqS4uZr5xPIQWREiwBjCooVf0AoA9Et7iMr98AZ7CrkMsRxhnavN7HUri2bMb8j+E9667w9qZ1W5jt1G2ZiBtJ6npQB1NpHvnCID83HrXrPhbRr+x8PmW3jZ4ZyQxUfSuSuPD0+jWg+0QtEwALO4wOR2r2b4R6ha3/hx7VJRI8TfMOvYUAfPPieVU1iRHJPrnrWW9xGEHA/LNdN8V9ONh4ru1KbVZty54riVkweeRQBb847wAPlPenAksdijPrk1VFwivxGWPuacGds7gVHoOKANS0nlTDIQuOc10tj4pvLdhuuGcAen9cVxkTKfvAVO1xsU7A2D0wOlAHtWjeIIPEGh3FhdlixUldzck815ZqULW97NA7YCMV4HX6VV0jUpbOUSR5BPUZ7Uajcm7uWlYMM+9AEbFA2S/TrxTGdGGfmYDpgVUuJ1iyVG5jwB1qFLuSSRVC7SewPSgC+vGAseV7E8mnM65w7jHYYqq8hTBZsKO3/6qaZSxB3ZTucc/nQBbYcgoGwe+KzNTYxqM5Oe/arPmKPmyCO2KglCy4OWFAGLunmXYGOz2FSSZhh4Qt9T1rQYRRjcQo56gVj61fRLEVRt2eKAL+sT301jZtds7RCPEfH3V9KraW0bpjzSTnvWB/acxs/JLny+ygU3T72SJ+SNvuKAOrtrHLEnJweAe9aA4woUEAYFZdtcIwGCM4qcSgnG8g0AXG2E/NGPzxUcxjyD/JqgMuPufMPwpjE7SGUY9qAJWmRSPnGfemCeMty6BvZc1SkX5w+eBxjFMBUPkE7T6CgC7K6hCTwT/dNQifY24bSPc00suTtzTGcEdAaALiTLJ0CjmpVYAfLgGs1XUEAHHrVoMPU9KALMjOxAUq2O2KryyunUAfhTHY5+U5z0zVeRmIwSaAJTOxQAbR3ORQsx3chc/Wqcs6Qpl32iqp1SEthSWH0oA9n+BVs914nkuQV8uCI59ckivX/FVkk9rdPGwFw0JB59q81+DV5pekaDNeXNxGk8x5A5O0YrO8efELTdGs9TOl373+qXY8sZBCRDj29KAPFPEGoC3leGJw0mec9q5aRyzlmOWNSTytNKzt8zsck4qJsINzYLelAEUnHXqajpz/ePOfcd6bQA9k/dI4xg5H4jH+NWLaTZDkxxOBvHPU5UDn6dR71UFFAHQQXFkiOJFTdgmIgZwfKIH0+bB+tZ19cqb1ZYdv8Aqow3HVgihs/jmqNFAF9NlxzFhJe69M1LbyvBOjktHKhyG7g1mA45FWo7wnCzjevr3FAH0DovxH07xZ4Uj8P+L5pLa5jULBqKDIOMYDgDPbrXoHwZs5vDF1ctiO6sLhQftEUodR05r5HhkXkwSEex4rW0rxFqOlzBoJnTHHB60AfQ37QlzZS6hZXVlcRs7qRIB1GMV4u11GcYlX8TXP6t4hm1GQNOpDexrIeYseHI+tAHbpcKD8soJHpUn2kZOWHr61waPg/NIce1XLbUDGNplbb6AUAdkZSR99h6VJEdrAlmNc9Bq8YUfO2QPSrK6lG3IYn8aAOmSdv4BjjnNJJNLg/OoU+tc8NSVBjeFHemSazCq43ZPrQBtHDZ3SZ+maRCqLxXNza4N2RjH0zVWbXXYnbhRQB1bXSqOOKia9xjGT7muMn1iV+jEfTGapvds/3ix/GgDuJNRjU/MyKT2zmq8mrojDDgn25rizKOyinC4YY2rQB0d7q7svyEjPasOaV5X3SPVdpZH45ppIXlzQBaEq7QBRHP5bcLVM3DD7gAFH2lz97B/CgDat9VCjGSPwq5Hq4PGc/jXMeaD1GKAV/vUAdeNTi/vkfQU4anDnmRvyxXHgt/CaeJJe5zQB1/2+NsEOCPSnCUH5lYYP6Vx4lcdzSi4kHQnNAHWmbnnBHtTTPHk/NgD1rlhcyjjJoFzL60AdP9pjB+/n0zUguYxn58Hr1rlPtE396mmRj1agDqZL6IAkyHJ4+lVJNVjUEAsce9c9nP3nFJvQepoAvXt59ocHLfiarCQjoKjEqDtmg3HGAtAGhaapdW8DxxSMqtwQKqzuzj94/FVTM3bAqMkk8mgCcyqowg59agYknJOTRRQAlBoo+lAAOlFA6CloASlFFSYHkk45zQBHRSelAoAXJHSpUnkTo1Q9jS0ATm5LfeUGl89cf6vn61WFLQBMJlJwVAFPzCc/MarUlAFnMeeHP5UocD+M1WpKALXmf7VNLg96gzzSdqALGFPVxRiL+JyfwqCg9KAJi0Q6BiaTzUHRPzNRUUAS+d/dRRSec3bA/Co+9IaAHmRiME0ylpPSgAooNLQAUCgUgoAWjJoo7UAAY+tLuPrSUd6AF3H1oyfWkooAMmijvRQAUUd6QUALRQaKACikpaACko70vegBKMUtFAH//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    CT scan confirms the tumor and demonstrates chest wall invasion with partial rib destruction.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Superior sulcus tumor",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 342px; height: 235px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Coronal PET scan shows the glucose avid right apical tumor as well as a lower rib metastasis (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Central bronchogenic carcinoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 380px; height: 344px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Patient with advanced lung cancer. Chest radiograph shows complete atelectasis of the right lung.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Central bronchogenic carcinoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 388px; height: 299px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    CT scan confirms the collapse of the right lung with heterogeneous enhancement of the nonaerated lung parenchyma. The right mainstem bronchus is markedly narrowed.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 551px\">",
"   <div class=\"ttl\">",
"    Central bronchogenic carcinoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 531px; height: 450px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Two coronal (top) and one axial PET scan (left) show marked glucose uptake in the central region of the collapsed lung as well as cirumferential uptake in the periphery of the lung. The glucose avid lymph node (arrow) in the left axilla was biopsied and proved to be inflammatory.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Fluoro-deoxyglucose scan of mediastinal metastasis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 399px; height: 219px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Primary tumor in the right lung with mediastinal metastatic focus (N2, arrow) demonstrated with FDG PET whole body scan in posterior coronal, sagittal, and axial projection.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_35_33338=[""].join("\n");
var outline_f32_35_33338=null;
var title_f32_35_33339="Noncontraceptive benefits";
var content_f32_35_33339=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F82147&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F82147&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Potential noncontraceptive benefits of cyclic estrogen-progestin contraceptives",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        &bull; Reduction in dysmenorrhea",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull; Reduction in pelvic pain related to endometriosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull; Reduction of menorrhagia, with improvement in iron deficiency anemia related to blood loss",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull; Reduction in risk of ectopic pregnancy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull; Reduction in symptoms associated with premenstrual syndrome and premenstrual dysphoric disorder",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull; Reduction in risk of benign breast disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull; Reduction in development of new ovarian cysts (true for higher dose estrogen pills only, which suppress ovulation), but no effect on existing ovarian cysts",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull; Reduction in ovarian cancer, including some hereditary forms such as those associated with mutations in the BRCA1 or BRCA2 gene, presumably due to inhibition of ovarian stimulation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull; Reduction in endometrial cancer, due the progestin effect",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull; Reduction in colorectal cancer in current users",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull; Reduction in moderate acne",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull; Reduction in hirsutism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull; More regular menstrual cycles",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    In addition, there may be a reduction in postmenopausal hip fracture risk for women who use estrogen-containing contraceptives in their 40s. Also, extended cycle or continuous estrogen-progestin contraception can reduce symptoms of menstrual migraine.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_35_33339=[""].join("\n");
var outline_f32_35_33339=null;
var title_f32_35_33340="Line infection prevention";
var content_f32_35_33340=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F75251&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F75251&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    General recommendations for prevention of infections associated with any intravascular catheter in adult and pediatric patients",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Healthcare worker education and training",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Educate healthcare workers regarding indication for intravascular catheter use, proper procedures for the insertion and maintenance, and infection control measures to prevent intravascular catheter-associated infections.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Hand hygiene",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Observe proper hand hygiene either by washing hands with conventional antiseptic-containing soap and water or with waterless alcohol-based gels or foams. Use of gloves does not obviate the need for hand hygiene.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Aseptic technique during catheter insertion and care",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Maintain aseptic technique for the insertion and care of intravascular catheters. Use maximal barrier precautions when inserting arterial or central venous catheters.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Catheter site care",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Disinfect clean skin with an appropriate antiseptic before",
"catheter insertion and at the time of dressing changes. A 2 percent",
"chlorhexidine-based preparation is preferred but there is no recommendation for its use in infants less than two months of age.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Use sterile gauze or sterile transparent semipermeable dressing to cover the catheter site.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Do not use topical antibiotic ointment or creams on insertion sites (except for dialysis catheters).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Replacement of intravascular catheters",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Remove any intravascular catheter that is no longer essential.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Replacement of administration sets",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Replace administration sets, including secondary sets and add-on devices, no more frequently than at 72-hour intervals, unless clinically indicated. Replace tubing used to administer blood, blood products, or lipid emulsions within 24 hours of initiating the infusion. Replace tubing used to administer propofol infusions every 6 to 12 hours, depending on its use, per the manufacturer's recommendation.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Parenteral fluids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Complete the infusion of lipid containing solutions within 24 hours of hanging the solution.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Complete the infusion of lipid emulsions alone within 12 hours of hanging the solution.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Complete infusions of blood or other blood products within four hours of hanging the blood.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Intravenous injection ports",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Clean injection ports with 70 percent alcohol or an iodophor before accessing the system.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_35_33340=[""].join("\n");
var outline_f32_35_33340=null;
var title_f32_35_33341="Survival in acute coronary syndromes";
var content_f32_35_33341=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F61809&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F61809&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Survival in acute coronary syndromes",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 340px; height: 248px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Among 12,142 patients entered into GUSTO IIb, the one-year survival was the same for those with an ST elevation (Q wave) or non-ST elevation (non Q-wave) myocardial infarction (NSTEMI) who did not have recurrent ischemia (90.4 versus 91.2 percent); a higher one-year survival was seen in patients presenting with unstable angina (93 percent, p &lt;0.001).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Redrawn from Armstrong PW, Fu Y, Chang WC, et al, for the GUSTO-IIb Investigators. Circulation 1998; 98:1860.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_35_33341=[""].join("\n");
var outline_f32_35_33341=null;
var title_f32_35_33342="Mallory Weiss muscularis Endosc";
var content_f32_35_33342=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F76980&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F76980&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mallory-Weiss tear",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 216px; height: 281px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Endoscopy shows a mucosal tear extending into the muscularis mucosa at the distal esophagus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Moises Guelrud, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_35_33342=[""].join("\n");
var outline_f32_35_33342=null;
var title_f32_35_33343="King LT device";
var content_f32_35_33343=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F79762&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F79762&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    King LT",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 229px; height: 576px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: King Systems Corporation. Copyright &copy;2008 King Systems Corporation.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_35_33343=[""].join("\n");
var outline_f32_35_33343=null;
           